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2  General Introduction 
African trypanosomosis are debilitating and even deadly diseases in humans as well as 
in animals. Most species of Trypanosoma are transmitted by tsetse flies present in Africa 
only. Therefore, the spread of the disease follows the distribution of the vector, except 
for Trypanosoma vivax (T. vivax), which can be transmitted mechanically, and covers an 
area of approximately 9 million of Km2, a third of the African continent (Budd, 1999). 
Human African Trypanosomosis (HAT), better known as sleeping sickness, occurs in 36 
sub-Saharan African countries with Trypanosoma brucei gambiense accounting for more 
than 98% of the reported cases (Simarro et al., 2011; WHO, 2013). At the end of the 
nineties, approximately 30,000 people were suffering of sleeping sickness. After 
continued control efforts, the number of new cases reported to the World Health 
Organization (WHO) dropped significantly from 9878 in 2009 to 7197 cases in 2012 
(WHO, 2013). While sleeping sickness is clustered in specific foci, Animal African 
Trypanosomosis (AAT) is widely distributed with about 50 million head of cattle and 
other livestock species that are at risk of the disease (Mattioli et al., 2004). Thus, AAT 
represents a major constraint for livestock breeding in sub-Saharan Africa, and the 
annual direct and indirect losses due to AAT are estimated at 4.5 billion USD (Affognon, 
2007). Indeed, in tsetse infected areas, it is estimated that half of the human population 
suffers from food insecurity and that 85% of the poor living in rural areas depend on 
agriculture for their livelihood (Mattioli et al., 2004). Considering the serious socio-
economic impacts of AAT on poor rural populations, the conference of the presidents of 
the Organization of African Union held, in Lomé (Togo) in 2000, decided the creation of 
the Pan African Tsetse and Trypanosomiasis Eradication Campaign (PATTEC). The main 
objective of this program is to improve food security and therefore reduce poverty by 
the eradication of tsetse flies. 
However, eliminating tsetse flies from 9 million of km2 of the African continent is a 
highly ambitious, costly and laborious project (Budd, 1999). Likewise, an alternative 
method such as a vaccine development is unlikely to be effective in the near future 
(Kinabo, 1993; Magez et al., 2010; Magez and Radwanska, 2009). Therefore, the 
challenge remains to make an optimal use of the few old trypanocidal compounds 
existing until the development of new drugs. Indeed, the control of livestock 
trypanosomosis in West Africa currently relies on three main molecules i.e. 
isometamidium chloride (ISM), homidium (bromide or chloride) and diminazene 
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aceturate (DA), which represent respectively 40%, 26% and 33% of the total 
trypanocidal drug market by value (Sones, 2001). 
Moreover, the privatization and the liberalization of veterinary services that started 
since the 90s in West Africa (Coulibaly, 2004) have led to a situation in which drug 
administration is often in the hands of cattle farmers or extension workers, who may be 
un- or under-skilled in AAT differential diagnosis (Van den Bossche et al., 2000) and/or 
with different levels of know-how (Grace et al., 2009). These factors contribute to the 
spread of trypanocidal drug resistance (TDR) in the cotton belt of West Africa (Clausen 
et al., 2010; Talaki, 2008; Talaki et al., 2006) and beyond in 17 African countries 
(Delespaux et al., 2008). In the context of this thesis, TDR is defined as the decrease or 
absence of sensitivity of the trypanosome strains to standard quality trypanocidal drugs 
at the dose recommended by the manufacturer and administered according to the good 
veterinary practices. This is the case when the parasite is or adapted itself genetically to 
survive the toxic effects of the drug. This TDR is a quantitative trait varying between a 
slight decrease of sensitivity to a complete resistance against the toxic effects of the 
drug. Treatment failure is used when an animal was treated and is not cured, whatever 
the reason of the failure (wrong dilution, abscess formation, sub quality of the drug, 
genetically resistant parasite, etc.). While the costs of inappropriate drug use and lost 
production can be met largely by the farmer who misuses the drug, the costs of drug 
resistance are met by the entire society and the future generations. Therefore, our study 
aims to have a better insight on the problem of TDR in West Africa using molecular tools 
and to propose alternative methods for the management of this phenomenon. 
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8  Chapter 1 
1.1. Introduction 
In the “Union Economique et Monétaire Ouest Africaine” (UEMOA) countries (i.e. Benin, 
Burkina Faso, Côte d’Ivoire, Mali, Niger, Senegal, Togo, Guinea Bissau), agriculture 
contributes to 30% of the Gross Domestic Product and employs 50% of the active 
population (Renard et al., 2004). Livestock breeding contributes to 5% (Côte d’Ivoire) to 
44% (Mali) of the agricultural Gross Domestic Product, with an average close to 40% for 
the Sahelian countries (Kamuanga et al., 2008). The part of livestock breeding in the 
Gross Domestic Product would be even more important in West Africa (up to 50%) 
when including the value of animal traction and manure in mixed crop-livestock systems 
widely represented in the region (Smith et al., 1996; Winrock International, 1992). 
Unfortunately, the development and intensification of livestock breeding in this African 
region is hampered among others by cross-border epizootic diseases such as AAT. As an 
introduction to the following chapters, we will provide some background information on 
(i) the parasites responsible for the disease especially Trypanosoma congolense (T. 
congolense) and Trypanosoma vivax (T. vivax) on which the thesis is focused, and on (ii) 
the disease: its epidemiology, pathogenesis, symptoms, diagnosis as well as the different 
strategies to control it in the presence or absence of TDR. 
1.2. The trypanosomes 
Trypanosomes are flagellated protozoan parasites that live in the blood, plasma, lymph 
and several tissues of their vertebrate hosts (Stephen, 1986). In West Africa, livestock 
are predominantly infected by two main species of trypanosomes: T. vivax and T. 
congolense (Kalu et al., 2001; Nakayima et al., 2012).  
1.2.1. Taxonomy, morphology and structure 
Trypanosomes belong to the phylum Sarcomastigophora, the order Kinetoplastida, the 
family Trypanosomatidae and the genus Trypanosoma. The genus Trypanosoma is 
divided into two groups (Hoare, 1972): 
(i) Stercoraria (subgenera Schizotrypanum, Megatrypanum and Herpetosoma) in which 
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trypanosomes are produced in the hindgut of the vector and transmitted to the hosts by 
contaminating excrements. 
(ii) Salivaria (subgenera Duttonella, Nannomonas, Trypanozoon): here the transmission 
occurs by inoculation when the vector injects its saliva at the time of the bite , which 
precedes the blood meal. Salivarian species are the only trypanosomes to exhibit 
antigenic variation (Stevens and Brisse, 2004), which allows the parasite to escape the 
host immune reaction. Apart from T. theileri belonging to the Stercoraria group, African 
trypanosomes belong to the Salivaria group. 
Morphologically, T. congolense (subgenus Nannomonas) is the smallest of the pathogenic 
African trypanosomes, with an average size varying between 12 to 17 µm. The classic 
blood forms lack a free flagellum with a poorly developed undulating membrane. 
However, certain strains present a short flagellum and a more developed undulating 
membrane (Chartier et al., 2000). In stained specimens of T. congolense, the cytoplasm 
appears diffuse, the nucleus is centrally placed and the kinetoplast terminal or 
subterminal (Uilenberg, 1998). The PCR-RFLP approach targeting the 18S small 
ribosomal subunit gene (Geysen et al., 2003) allowed the identification of the three T. 
congolense sub-species i.e. T. congolense savannah type, T. congolense forest type and T. 
congolense kilifi type. 
T. vivax (subgenus Duttonella) is longer (18 to 31 µm) with a free flagellum and a large 
terminal or subterminal kinetoplast. The nucleus is centrally placed and the undulating 
membrane is discrete even if some blood forms present a more developed undulating 
membrane (Chartier et al., 2000). 
As for all protozoan parasites, trypanosomes are unicellular cells constituted by a mass 
of cytoplasm limited by a plasma membrane and containing different organelles as well 
as a nucleus. Electron microscopy has enabled to better understand the structure of 
trypanosomes. Thus: 
- The plasma membrane or periplasm is composed by a stratum of microtubular fibers 
and a membrane of 8 to 10 nm of thickness. The latter is constituted by 3 stratums  
(extern, median and intern) of which the extern stratum is sometimes covered by an 
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amorphous layer of 12 to 15 nm of thickness, secreted by the cell. This layer, composed 
of glycoproteins, is observed in blood forms of livestock trypanosomes and is named the 
surface antigen (Uilenberg, 1998). This surface antigen is responsible of the immune 
evasion of trypanosomes in their vertebrate hosts (see later in the pathogenesis 
paragraph). 
- The flagellum starts with a small invagination of the plasma membrane called flagellar 
pocket and is prolonged by the blepharoplast, a transition zone and the flagellum itself. 
The flagellar pocket is the only site of exo- and endocytosis. Several flagellar pocket-
associated proteins were detected to contribute to the trafficking of nutrients, to the 
recycling of the VSG and to the virulence (Field and Carrington, 2009).  
Besides the usual organelles of protozoan cells such as the vacuolar apparatus 
(endoplasmic reticulum, Golgi apparatus, etc.), trypanosomes have a specific organelle 
called glycosome containing enzymes responsible for the metabolism of glucides. 
Another particularity of trypanosomes is a unique big mitochondrion called kinetoplast 
containing the mitochondrial DNA (Figure 1.1). The general organization of the genome 




Figure 1.1: Ultrastructure of a bloodstream form of T. congolense 
Source: http://ilri.org/infoserv/Webpub/fulldocs/Ilrad82/Trypano.htm 
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1.2.2. Genome 
The nuclear genome shows inter- and intra-species plasticity in chromosome number 
and size, whereas the mitochondrial genome (Kinetoplast DNA or kDNA that accounts 
for 10-20% of the total cell DNA) varies in number of minicircles and within the variable 
region of maxicircles. 
1.2.2.1. Nucleus 
All trypanosome species contain a set of large chromosomes of which there are at least 
11 pairs of chromosomes (I-XI) ranging from 1 Mb to more than 6 Mb (Melville et al., 
1998; Melville et al., 2000). These megabase chromosomes represent about 80% of the 
nuclear genome and are called housekeeping chromosomes because they carry most of 
the genes involved in the basic functions of the trypanosome. Besides, there are several 
intermediate size chromosomes of 200 to 900 kb of uncertain ploidy, representing 
between 0.2 to 1% of the genome. In addition to megabase and intermediate 
chromosomes, approximately 100 linear mini-chromosomes of 50 to 150 kb are present 
accounting for about 20% of the nuclear DNA content and serving as repositories for 
variant surface glycoproteins (VSG) genes (El-Sayed et al., 2000). 
1.2.2.2. Kinetoplast DNA  
Trypanosomes are characterized by a kDNA network, which represents the 
mitochondrial genome that accounts for 10-20% of the total cell DNA (Hajduk et al., 
1992). Structurally, the kDNA occurs within the cell as a flattened disc of intercalated 
DNA circles called maxicircles and minicircles. 
1.2.2.2.1. Maxicircles 
Basically, maxicircles are composed of two distinct regions: the variable region (VR) and 
the coding region of 3-6 kb and 17 kb, respectively. While the latter is generally well 
conserved, the VR varies in length and gene sequence content between species and 
isolates (Myler, 1993). There are approximately 50 maxicircles per cell; they encode for 
the 9S and 12S ribosomal sub-units and for enzymes implicated in the electron transport 
system (respiratory chain), which generates energy during the insect phase of th e 
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parasite life cycle. Finally, maxicircles size varies between species of trypanosomes and 
is on average 20 times higher than that of the minicircles. 
1.2.2.2.2. Minicircles 
With a size of about 1 kb, minicircles are variable among species while they are constant 
within species. There are approximately 5000-10000 minicircles per cell, highly 
heterogeneous with up to 200 different sequence classes per cell (Shapiro and Englund, 
1995). Structurally, minicircles consist of two regions: a small conserved region constant 
in all minicircles of each species and a large non-conserved region which varies between 
minicircles. Contrary to maxicircles, minicircles does not code for any proteins but they 
encode guide RNAs that play a central role in mRNA editing (Melville et al., 2004). 
1.3. Vectors of African trypanosomes 
With the exception of T. equiperdum, which is sexually transmitted, African 
trypanosomes are transmitted to the hosts by haematophagous insects. Tabanids and 
stable flies, rarely hippoboscids, are responsible for the mechanical transmission of T. 
vivax and T. evansi (Desquesnes and Dia, 2003). In these cases, the parasites do not 
multiply nor undergo developmental changes within their insect vector. However, most 
of African trypanosomes pathogenic to livestock are cyclically transmitted by tsetse flies. 
These obligate haematophagous flies belong to the order of the Diptera, family of 
Glossinidae, genus Glossina. This genus is divided in three subgenera: fusca, morsitans 
and palpalis (Buxton, 1955) in which about thirty species and subspecies can be 
recognized. 
Tsetse flies are widely distributed across the African continent, mostly in open woody 
savannahs or dense forest galleries providing optimal conditions for their survival and 
reproduction (Figures 1.2 & 1.3). 
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All tsetse species 
 
























Figure 1.3: Distribution and number of tsetse fly species belonging to the fusca, morsitans and 
palpalis groups in Africa 
Source of figures 1.2 and 1.3: http://ergodd.zoo.ox.ac.uk/livatl2/tsetse.htm 
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1.4. Life cycle 
During their feeding on a trypanosome-infected animal, tsetse flies ingest the blood 
stream form trypanosomes that have to go through a number of morphological, 
biochemical and physiological transformations within the fly to become infectious 
(metacyclic forms) again for the mammalian host. For T. vivax, the entire cycle takes 
place in the proboscis whereas for T. congolense, the development occurs in the midgut 
and proboscis (see table 1.1). Once the final infectious metacyclic trypanosomes are 
present in the tsetse fly, they will be injected in the dermis of the mammalian host at 
each blood-feeding event (Figure 1.4). 
Within the mammalian host, the trypanosomes transform, start replication and are 
transported to the draining lymph node through the afferent lymphatic system. Then 
through the efferent lymphatic system, parasites reach the thoracic lymph duct and 
finally enter the blood circulation where they continue to replicate (Akol and Murray, 
1986). While T. congolense is preferentially localized in small blood vessels and 
capillaries, T. vivax is also seen in the tissues of their host. The duration of the pre-patent 
period generally ranges from 1 to 3 weeks depending on the species and strain of 
trypanosomes and on the immune status of the host (Clausen et al., 1993). 
 
Table 1.1: Site of development in Glossina spp of the different Trypanosoma species 
(Hoare, 1970; Van Den Abbeele et al., 1999) 
Subgenus Species Midgut   Proboscis  Salivary glands 
 
Dutonella T. vivax  No development Trypomastigotes No development 
       Epimastigotes 
       Final infective 
       stage: metacyclic 
       trypomastigotes 
 
Nannomonas T. congolense Trypomastigotes Trypomastigotes No development 
  T. simiae    Epimastigotes 
       Final stage:  
       metacyclic  
  T. godfreyi    trypomastigotes 
 
Trypanozoon T. b. brucei Trypomastigotes Trypomastigotes          Trypomastigotes 
and epimastigotes and epimastigotes 
  T. b. rhodesiense      Final stage: 
metacyclic 
trypomastigotes 
  T. b. gambiense 
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Figure 1.4: Trypanosoma congolense life cycle stages (Peacock et al., 2012) 
 
1.5. Epidemiology 
1.5.1. Some general aspects of the epidemiology of trypanosomosis in livestock  
The epidemiology of AAT depends on three main factors: (i) the virulence of the 
parasite, (ii) the distribution of the vector and (iii) the response of the host 
(trypanosensitivity). These factors are modulated by local environmental changes that 
can substantially affect their dynamics and consequently influence the disease 
transmission patterns. Anthropogenic environmental changes, such as the increased 
human pressure and the simultaneous demand for arable land result in deforestation 
and loss of suitable habitats for tsetse flies and their hosts. In West Africa, over the past 
150 years, the extents of forest areas have reduced to about 13% and currently few are 
in pristine condition (Larsen, 2008). 
Considering the cyclical transmission of the parasite, the diversity of tsetse fly habitats 
considerably affects the interactions among vectors, hosts (livestock and/or wildlife) 
and parasites (levels of virulence) (Van den Bossche et al., 2010). For the savannah 
species (G. morsitans sp.), the disease is widespread due to the large dispersion of these 
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flies. For the riverine species (G. palpalis gambiensis, G. tachinoides), the areas of contacts 
with the hosts are limited. In this case, the risk of infection does not only depend on the 
density of the flies but also on the intensity of space-time interfaces between tsetse and 
livestock (de La Rocque et al., 2001). Tsetse flies are living for millions of years in 
proximity of wildlife constituting the sylvatic trypanosomosis transmission cycle. 
Nowadays, the importance of livestock as a source of food for tsetse flies is increasing as 
a consequence of human encroachment (deforestation for cultivation) and the reduction 
in wildlife species (Van den Bossche et al., 2010). These drastic changes in tsetse flies 
habitats and hosts availability have resulted either in their elimination or in many cases 
in their adaptations to those new conditions (Bourn et al., 2001). The use of specific 
microclimatic niches (Terblanche et al., 2008; Van den Bossche et al., 2010) and their 
opportunistic feeding behavior regarding the choice of the host made this adaptation 
possible (Krafsur, 2009). 
Parasite virulence is also an important factor influencing the epidemiology of AAT. For 
example, West Africa’s T. vivax strains are rapidly fatal when compared to those of East 
and Central Africa. Similarly, T. congolense induces a more chronic disease in West Africa 
compared to East and Central Africa except in the vicinity of protected game reserves 
(Leak, 1999; Van den Bossche and Delespaux, 2011). Moreover, within the T. congolense 
group, the three subgroups i.e. Savannah, Kilifi and Forest (Hide and Tait, 2004) show 
important differences in virulence with the Savannah subgroup strains being the most 
virulent (Bengaly et al., 2002a; Bengaly et al., 2002b). Even within T. congolense 
Savannah subgroup, substantial differences in virulence are o bserved between strains 
(Masumu et al., 2006) and between transmission cycles, with significantly higher 
virulent strains in the sylvatic transmission cycle (Van den Bossche et al., 2011). These 
differences in virulence associated with the level of tolerance of the livestock determine 
the level of endemicity of the disease in a particular area. 
Actually, the response of the host to the infection depends on its innate  susceptibility, 
modulated by the level of activity of its immune system (food availability, co -infections, 
etc…). In West Africa, Zebu breed are the most trypanosensitive cattle whereas Sanga 
and Shorthorn breeds are more trypanotolerant. In the vicinity of game reserves, the 
fact that wild animals are the reservoirs of the disease makes the epidemiology of AAT 
even more complex. Indeed, the higher virulent T. congolense strains of the Savannah 
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subgroup observed in wild animals may explain the rapidly fatal issue of 
trypanosomosis in those settings (Van den Bossche et al., 2011). 
1.5.2. Livestock management practices 
In sub-Saharan Africa, livestock management practices influence the epidemiology of 
AAT. Three main systems are co-existing i.e. (i) transhumance (nomadic breeders), (ii) 
sedentary agro-pastoralists and (iii) ranching (Cuisance et al., 2003). 
The alternation of seasons imposes to nomadic livestock breeders a migration for 
reaching areas suitable for grazing and watering. During the dry season, the dispersion 
of savannah flies is reduced and the risk of contracting the disease is sufficiently limited 
to allow Fulani, the best-known West Africa’s nomadic cattle keepers, to migrate with 
their livestock from North to South, far from tsetse fly areas (Affognon et al., 2009; 
Courtin et al., 2010). However, these animals will be in contact with riverine tsetse flies 
populations at watering points in gallery forest along the rivers (Figure 1.5). In the rainy 
season, cattle grazing in the Sahel or in Northern Sudanese savannah do not encounter 
tsetse flies. Nevertheless, animals are harassed by other haematophagous flies, which 
can maintain T. vivax – trypanosomosis within the herd (Chartier et al., 2000; Cuisance 
et al., 2003). 
The sedentary cattle grazing in the South-Sudanese savannah during the rainy season 
are in contact with the species belonging to the morsitans group (G. longipalpis, G. 
morsitans submorsitans, etc…). During the dry season, the sedentary cattle are in contact 
with the riverine flies (G. palpalis, G. tachinoides, etc) when they penetrate into the forest 
gallery. In the Guinean zone, these cattle are confronted year round with both the 
savannah and forest/riverine flies (Leak, 1999). Finally, in commercial ‘farms’ animals 
are usually treated when clinical signs are seen. The cattle are then in good condition as 
long as the efficacy of the drugs is preserved. 
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Figure 1.5: Zebu cattle on a watering point at the Mouhoun river (Burkina Faso)  
 
1.6. Pathogenesis 
Initial replication of metacyclic trypanosomes begins at the site of inoculation, inducing 
a swelling and a sore called ‘chancre’. This ‘chancre’ disappears after a few days (3 to 15 
days) when the trypanosomes spread to the lymph nodes and blood and continue to 
replicate (Chartier et al., 2000). After an infection has become established, the B-
lymphocytes of the mammalian host produce anti-VSG antibodies (IgG) that lyse a large 
number of the trypanosomes and result in the development of immunes complexes. 
These are removed by phagocytes and presented to lymphoid cells. The attachment of 
antigen-antibody complexes to red blood cell membranes contribute to the damage and 
lysis of the erythrocytes. Moreover, the lysis of the trypanosomes release many harmful 
substances in the extracellular environment, such as haemolysins and enzymes 
(proteases, phospholipases and neuraminidases, etc), which directly damage the host’s 
erythrocytes membranes. The elimination of large numbers of damaged erythrocytes 
from the blood circulation occurs soon after the beginning of the parasitaemia, by cells 
of the mononuclear phagocytic system (MPS), and produces a decrease in the Packed 
Cell Volume (PCV). Some trypanotolerant cattle (e.g. Baoule) control the parasitaemia 
quite effectively (earlier and higher antibody responses to the first peak of 
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parasitaemia) when compared with similarly infected Zebu cattle (Connor and Van den 
Bossche, 2004). The PCV values of infected trypanotolerant animals are definitely higher 
than that of susceptible ones when they are well maintained (deworming, food in 
adequate quantity, absence of concomitant infection, etc). 
Anaemia is then largely attributable to an increased rate of erythrophagocytosis in the 
early phase of infection. Nevertheless, there is no single cause of the anemia in AAT. 
Indeed, as a response to the trypanosomal infections both IgM and IgG antibodies are 
produced. While the IgM appear to be directed mainly against VSG antigens, IgGs are 
oriented against both the somatic trypanosomal antigens and the host’s own cells  
(Connor and Van den Bossche, 2004). Anti-erythrocyte antibodies contribute to the 
anemia of AAT and it is likely that a similar mechanism contributes to leukopenia.  
However, anti-VSG antibodies do not clear the infection as the trypanosome produces 
many different surface-coat glycoproteins (107 Variable Antigen Types or VAT) and 
change their surface glycoprotein to evade the host immune response (Baral, 2010). 
Thus, there is a persistent fluctuating parasitaemia that results in continuing cycles of 
trypanosome replications, antibody production, immune complex development, and 
changing of surface-coat glycoproteins. Furthermore, one of the most significant and 
complicating factors in the pathogenesis of AAT is the immunosuppression that occurs 
following infection by these parasites. This marked immunosuppression lowers the 
host’s resistance to other infections and thus results in secondary diseases, which 
greatly complicate both the clinical and pathological feature of AAT. It has been 
suggested that immunosuppression is mediated by both the macrophages and the T cells 
(Tabel et al., 2008). As a result of this, antigenic variation and immunosuppression, 
conventional vaccination strategies against AAT are not effective (Baral, 2010; Magez et 
al., 2010). Recently, alternatives approaches were explored based on camelid antibodies 
(e.g. use of Nanobodies®) (Magez et al., 2010; Magez and Radwanska, 2009). Promising 
results were obtained using low molecular weight VSG-specific trypanolytic nanobodies 
that impede endocytosis (Stijlemans et al., 2011). Further research is necessary in order 
to know if this technique developed with T. brucei as model could be adapted to T. 
congolense or T. vivax. 
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Significant tissue lesions are observed in AAT and depend on the species of 
trypanosome. Considered to be mainly intravascular parasites, T. congolense and to a 
lesser extent T. vivax, cause changes in the endothelium of capillaries, and thus indirectly 
provoke damage to adjacent tissues. The severity of endothelial damages also depends 
on the host-parasite interaction. Indeed, in T. congolense infections a generalized 
dilatation of capillary beds is observed, which alters the haemodynamics. In contrast, T. 
vivax infections commonly cause disseminated intravascular coagulation (Connor and 
Van den Bossche, 2004). 
1.7. Clinical signs 
Due to the fact that simultaneous infections with more than one trypanosome species 
and/or with other haemoparasites (Babesia spp., Theileria spp., Anaplasma spp. and 
Ehrlichia spp.) are very common (Nyeko et al., 1990), it is difficult to attribute the 
clinical signs to a given parasite. Moreover, the disease may have acute, chronic or sub -
clinical forms complicating its recognition. Nonetheless, the major clinical sign observed 
in AAT is anemia, followed invariably by an intermittent fever, weight loss, roughness of 
the hair coat and whimpering (Taylor and Authié, 2004). The severity of the clinical 
response depends on the species and the breed of the affected animal but also on the 
trypanosome species (Table 1.2), the size of the inoculum and the virulence of the 
infecting trypanosomes. For example, T. brucei brucei is very well tolerated by cattle but 
is rapidly life threatening for horses and dogs (Allsopp et al., 2004). Even within a same 
species virulence might vary a lot as is the case for T. congolense (Masumu et al., 2006). 
 
Table 1.2: Susceptibility of livestock species to the pathogenic trypanosome species. Adapted 
from (Soltys, 1963) 
 
Livestock    Trypanosome species 
Species  
  T. congolense T. simiae T. vivax T. brucei   T. evansi   T. equiperdum  T. suis 
Cattle  +++  ± ++      +  +      –  – 
Sheep  ++  + ++   +++  ++      –  – 
Goat  ++  + ++   +++  ++      –  – 
Pig  +            +++  –     +     –      –            +++ 
Horse  ++  – ++   +++  ++      +  – 
Camel  ++  –  –     ++  ++      –  – 
+++: very susceptible; ++: susceptible; +: less susceptible; –: no infection 
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1.8. Diagnosis 
1.8.1. Clinical diagnosis 
Due to the absence of any pathognomonic clinical sign for AAT, the clinical diagnosis is 
somewhat difficult. Nonetheless, anemia, pyrexia, weight loss, roughness of the hair coat, 
hypertrophy of peripheral lymph nodes, abortion, reduced milk yield and, in absence of 
treatment, death are often observed in cattle affected by the acute form of the disease 
(Eisler et al., 2004). Whatever the clinical forms of evolution of AAT (acute, subacute and 
chronic forms), it is essential to confirm the presence of the parasite in blood or lymph 
node smears by using the following parasitological tests. 
1.8.2. Parasitological diagnosis 
1.8.2.1. Direct microscopic examination 
The examination of a drop of fresh blood between slide and coverslip can be of great use 
in the field to demonstrate the parasitaemia of animals under observation or treatment 
or to determine the health status of a herd throughout the seasons. Using a light 
microscope at 400x magnification, the species of trypanosomes can be determined by 
examining their size and movement patterns. T. congolense appears short (size of about 
8 to 24µm) with a poorly developed undulating membrane; the free flagellum is absent 
or very brief and the trypanosome is stuck on erythrocytes and moves slowly. In 
contrast, T. vivax quickly crosses the field of the microscope; it is a larger trypanosome 
measuring about 18 to 31µm with a free flagellum and a less developed undulating 
membrane. T. brucei has a well-developed undulating membrane and moves freely but 
slower than T. vivax and often describes little circles. Microscopic examination of fresh 
blood films is simple and inexpensive but lacks sensitivity, with a detection limit of 
about 104 trypanosomes /ml of blood (Uilenberg, 1998). 
Thin or thick blood smears fixed in methanol or acetone and colored with May-
Grünwald-Giemsa as well as stained lymph node smears (Uilenberg, 1998) are mostly 
used for accurate trypanosome identification and are found to be more sensitive than 
the fresh blood film (Kalu et al., 1986; Paris et al., 1982). However, none of these 
techniques is sensitive enough to detect the low parasitaemia usually observed in the 
field when compared to concentration techniques. 
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1.8.2.2. Concentration techniques 
The Haematocrit Centrifugation Technique (HCT) is based on the centrifugation of 
microhaematocrit capillary tubes containing the blood sample. Afterwards, the buffy 
coat/plasma junction is observed under a microscope at 250x magnification in a special 
Woo chamber, allowing the suppression of the refraction of the light on the capillary 
tube (Woo, 1970). The Buffy Coat Technique (BCT) developed by Murray et al. (1977) is 
a variant of the HCT. The capillary tubes are cut at the level of the buffy coat/plasma 
interface. The buffy coat is extruded on a slide, covered with a coverslip and examined 
under the microscope at 400x magnification with dark ground or phase contrast 
illumination. In addition to be more sensitive, these two techniques have also the 
advantage of measuring the Packed Cell Volume (PCV) or haematocrit.  
Another available method that is not commonly used for animals in field conditions is 
the miniature-Anion Exchange Centrifugation Technique (m-AECT). This technique 
using miniature anion-exchange columns for the separation of trypanosomes from 
erythrocytes prior to concentration by centrifugation (Lumsden et al., 1979), has 
recently been improved for sleeping sickness diagnosis and staging (Büscher et al., 
2009). Due to the different electric charges of the trypanosomes and the erythrocyte 
surface, the erythrocytes get captured in the column whereas the trypanosomes are 
eluted. 
1.8.3. Serological diagnosis  
Several antibody-detecting tests are used for the diagnosis of trypanosomal infection. 
These tests only confirm the contact between the host and the parasite without 
specifying whether the infection is still active or has been cleared (Uilenberg, 1998). The 
most commonly used tests in cattle are the Indirect Fluorescent Antibody Test (IFAT),  
the antibody Enzyme-Linked Immunosorbent Assay (Ab-ELISA) and the Card 
Agglutination Test for T. evansi (CATT/T. evansi). 
In the IFAT, the antigen is constituted of a blood smear containing fixed trypanosomes. 
The primary Abs are detected by commercially available secondary antibodies 
conjugated with a fluorophore (like the fluorescein isothiocyanate or FITC). Despite the 
fact that antigen production is easy, this test has the disadvantage of not being 
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sufficiently species specific. Cross reactivity between species are frequently observed. 
Moreover, the commercial conjugates are expensive and only few numbers of sera can 
be examined in a given period as the method is rather labor intensive (Uilenberg, 1998).  
The principle of the Ab-ELISA is quite similar to IFAT. However, when compared to 
IFAT, the indirect ELISA proved to be more sensitive (Eisler et al., 2004). The test is 
more useful for epidemiological purposes than for individual routine diagnosis, and in 
areas with a low AAT prevalence. When the fly challenge is high the method is of limited 
interest as serological prevalence can then reach 80 – 90% (Van den Bossche et al., 
1999; Van den Bossche et al., 2000b). The prevalence of anti-trypanosomal antibodies is 
a sensitive indicator of the impact of tsetse control operations on disease challenge and 
for confirming the disease-free status of animals in areas from which tsetse has been 
eliminated (Van den Bossche et al., 2000a). Serology can then be performed on the new 
born calves which should not have been in contact with trypanosomes if the eradication 
was successful. Nevertheless, Ab-ELISA is quite expensive and the antigens are more 
difficult to produce than for IFAT (Connor and Van den Bossche, 2004).  
The CATT/T. evansi test is a direct card agglutination test for the detection of antibodies 
to ‘surra’ i.e. T. evansi infection in blood, serum or plasma (Desquesnes et al., 2013) of 
various animals species such as, camels (Ngaira et al., 2003; Njiru et al., 2004) and water 
buffaloes (Davison et al., 2000; Hilali et al., 2004). It consists of mixing a drop of whole 
blood or serum on a plastic card with fixed and stained trypanosomes as antigen , and 
the test is positive when the antigen agglutinates. This test is easy to carry out in the 
field, although its specificity and sensitivity need to be enhanced (Uilenberg, 1998). 
More recently, a highly specific and sensitive ELISA (ELISA/rrISG75) using a 
recombinant non-variable antigen was developed for diagnosis of ‘surra’ in camels (Tran 
et al., 2009). 
Efforts were made at the International Laboratory for Research on Animal Diseases 
(ILRAD) in Nairobi (Kenya), to develop tests based on the detection of circulating 
antigens (Nantulya et al., 1987). This test is based on the use of monoclonal antibodies 
(Mabs) against invariable antigens. Antigen-detecting ELISA (Ag-ELISA) would have 
allowed the detection of circulating trypanosomal antigens and therefore confirm the 
occurrence of an active infection (Eisler et al., 2004). However, in general this test 
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appears to be less sensitive, particularly for the detection of T. vivax infection 
(Desquesnes and de La Rocque, 1995) and even false positive results and cross-
reactions occurs frequently with the Ag-ELISA for the T. congolense and T. brucei groups 
(Uilenberg, 1998). The lack of reproducibility and specificity of the Ag-ELISA has led to 
the abandon of it (Desquesnes and de La Rocque, 1995). 
1.8.4. PCR-based methods 
PCR is based on the use of an enzyme, the DNA polymerase, in presence of nucleotides in 
a buffered environment, which amplifies a specific target sequence of DNA, until 
sufficient material is produced to be detected. Generally, once the specificity of the 
primers has been established, the size of the amplicon is sufficiently characteristic for 
diagnostic purposes (Desquesnes and Davila, 2002). 
The advantages of the classical PCR include: the easier and longer conservation of the 
samples i.e. buffy coats collected on Whatman filter paper N°4 or Whatman FTA cards 
(10 years shelf life at room temperature) and the higher specificity and sensitivity 
compared to the other parasitological techniques (20 to 500 times more sensitive). 
Indeed, PCR can detect between 1 to 20 trypanosomes per ml. However, some 
drawbacks have been reported such as (1) blood containing inhibitory substances (e.g. 
haemoglobin) that can lead to false negative results; (2) extreme care is necessary to 
avoid DNA contamination, especially when considering the mode of conservation of the 
samples on filter papers and (3) for each trypanosome species a separate PCR is 
necessary using specific primers, except when using the Internal Transcribed Spacer 1 
ribosomal DNA (ITS-1 rDNA) as PCR target in a multiplex PCR (Desquesnes et al., 2001). 
Alternatively, PCR associated with Restriction Fragment Length Polymorphism (PCR-
RFLP), allows for the identification of different trypanosome (sub)-species in one test i.e. 
a “pan-trypanosome” test for all bovine trypanosomes (Geysen et al., 2003). Indeed, 
PCR-RFLP targeting the 18S ribosomal small sub-unit DNA (Ssu-rDNA) has a higher 
sensitivity than multiplex PCR using ITS-1 primers. However, the newly developed ITS-1 
“Touch Down” PCR (ITS-1 TD PCR) in addition to achieve a comparable sensitivity, is 
less-time consuming (a single amplification step and no enzymatic restriction are 
needed) and cheaper compared to the 18S-PCR-RFLP technique (Tran et al., pers. 
Comm.). 
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1.9. Control of Animal African Trypanosomosis  
The control of AAT includes the use of trypanotolerant cattle, vector control and the use 
of trypanocidal drugs or any combination of the methods according to the specific 
conditions of an area. The choice of a strategy will depend mainly on the tsetse fly 
challenge, the susceptibility of the host, the presence/absence and type of drug 
resistance (simple or multiple) and the breeding system (transhumant, sedentary not 
confined, sedentary confined, …). 
1.9.1. Use of trypanotolerant cattle 
Breeding trypanotolerant cattle (Bos taurus) is an interesting alternative for the control 
of AAT. When properly housed and fed, these cattle can maintain good productivity 
levels in tsetse infested areas. Trypanotolerant cattle can be divided into two groups: (i) 
the short-horned cattle represented by the breeds Baoulé, Sumba, Muturu of savannah, 
Lagune, bred in Côte d’Ivoire, Benin, Togo, Ghana, Nigeria, Burkina Faso and Northern 
Cameroon and (ii) the long-horned cattle living in Southern Senegal, Mali, northern Côte 
d’Ivoire, Guinea, Gambia, Liberia, Sierra Leone, Bissau Guinea, Burkina Faso. Long-
horned cattle are represented by the breed Ndama. Due to their small size, farmers are 
somewhat reluctant to breed them (Uilenberg, 1998). This has led farmers to cross 
trypanotolerant livestock with Zebu to increase the size of the animals and the milk 
yield. The obtained crossbreds are partially trypanotolerant and represented by the 
breeds Borgou in Benin and Togo, Méré in Guinea, Burkina Faso, Côte d’Ivoire, Bambara 
in Mali and Djakoré in Senegal and Gambia. 
1.9.2. Vector control 
Fly populations can be down-regulated by chemical control including the use of 
insecticides by ground application, aerial spraying, and impregnation of traps / screens 
or spraying / pour-on application on the back line of host animals, spraying the belly 
and legs of cattle. This last method is cheap and easy to implement and take advantage 
of the specific tropism of heamatophagous flies for the lower parts of the animals 
(Bouyer et al., 2009; Bouyer et al., 2007). When the tsetse fly population is decreased by 
95% or more in isolated areas that cannot be reinvaded, eradication can be achieved by 
the Sterile Insect Technique (release of sterile males). This technique is based on the fact 
that female flies only accept one single mating. If this mating is performed by a sterile 
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male, this female will never produce any offspring. Methods such as deforestation and 
elimination of the game animals that were used in early eradication campaigns, have 
been abandoned because of obvious environmental and ethical reasons (Uilenberg, 
1998). Paradoxically, encroachment has the same effect and large areas are in this way 
freed from the burden of tsetse flies allowing agriculture and cattle breeding. However, 
livestock keepers often lead their animals to less degraded environments where grass 
and trees are still available and tsetse flies as well. 
1.9.3. Trypanocidal drugs 
Currently, in West Africa, three main molecules are used to deal with AAT: diminazene 
aceturate (DA), isometamidium chloride (ISM) and homidium salts (bromide or 
chloride). 
1.9.3.1. Diminazene aceturate 
Structurally, DA is an aromatic diamidine derived from Surfen (Jensch, 1958). The 
compound, marketed as aceturate salts, consists of two amidinophenyl linked by a 
triazene bridge: p,p-diamidinodiazoaminobenzene diaceturate tetrahydrate; N-1,3-
diamidinophenyltriazene diaceturate tetrahydrate (C22H29N9O6.4H2O, mol. wt. = 587,6; 
mol. wt. base = 281,2) (Figure 1.6) (Peregrine and Mamman, 1993). 
 
Figure 1.6: Molecular structure of diminazene aceturate (Peregrine and Mamman, 1993). 
 
 
When taken up by the trypanosome, DA is mainly accumulated in the kDNA where it 
binds through specific interactions with sites rich in adenine-thymine (A-T) base pairs. 
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The compound has a higher affinity to 5’-AATT-3’ than to 5’-TTAA-3’ regions of DNA 
(Peregrine and Mamman, 1993). It has been demonstrated that DA binds to the double-
stranded DNA via the minor groove through electrostatic and hydrogen-bond forces. 
Therefore, DA interferes with the synthesis of RNA primers, resulting in the 
accumulation of replicating intermediates and subsequent inhibition of kDNA 
replication. Moreover, Shapiro and Englund (1990) have shown that DA inhibits the 
mitochondrial type II topoisomerases in trypanosomes which blocks the DNA 
replication. 
The drug is commercialized as a yellow powder than can be used in aqueous solution up 
to 10-15 days when stored at room temperature without losing its activity (Fairclough, 
1962). DA is recommended as a therapeutic drug at the dosage of 3.5mg/kg body weight 
(b.w) by intramuscular (IM) route to clear T. congolense and T. vivax infections in cattle. 
Standard therapeutic doses of DA (3.5mg/kg b.w) rarely results in signs of toxicity in 
domestic animals, since the compound is rapidly excreted via urine and feces (t1/2 < 1h) 
(Delespaux and de Koning, 2007; Mamman et al., 1993). However, the product is 
relatively toxic in dogs and a single dose of 7mg/kg b.w can be highly toxic in camels . 
Currently, DA is marketed under the trade names of Berenil®, Veriben®, Trypazène®, 
Trypan®, Ganaseg®, etc. and is widely available and commonly used by farmers in West 
Africa. Additionally to its availability and low cost, DA is also used to treat animals 
affected by various tick-borne diseases, including babesiosis (Bruning, 1996). These 
clear advantages have made of DA a first-line treatment for sick animals.  
1.9.3.2. Isometamidium chloride 
ISM is a phenanthridinium salt (Browning et al., 1938). Chemically, ISM is known as 8-
[(m-amidinophenyl-azo) amino]-3-amino-5-ethyl-6-phenylphenanthridinium chloride 
hypochloride (C28H25ClN7HCl; MW: 531.5) and differs from homidium (see later) by an 
additional moiety of m-amidinophenyl-azo-amine (Wragg et al., 1958) (Figure 1.7). In 
other words, ISM is synthesized by coupling homidium with a part of the diminazene 
molecule (Delespaux and de Koning, 2007). 
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Figure 1.7: Molecular structure of ISM (Delespaux et al., 2010) 
 
ISM is an amphiphilic cationic drug, which is commercialized as a dark reddish-brown 
powder. ISM is less soluble in pure organic solvents and labile under low and high pH 
conditions and at a high temperature. Its solubility in water is about 6% (w/v) at 20°C 
(Kinabo and Bogan, 1988). As marketed (Trypamidium®, Samorin®), ISM product 
contains 70% of ISM and 30% of a mixture of its two isomers and a small proportion of a 
bis-compound (bis designates the number of each type of ligand in the complex ion) and 
homidium (Novidium® and Ethidium®). ISM is used in aqueous solution (1 or 2%) 
mainly by deep intra muscular route at doses between 0.25 and 1 mg/kg b.w., 
depending on the risk of TDR. To clear infections with T. vivax and T. congolense in 
bovines and small ruminants, the drug is recommended at doses between 0.25 and 0.5 
mg/kg b.w.. Moreover, it protects animals that received doses of 0.5 to 1 mg/kg b.w. for 
a period between 2 to 4 months (Chartier et al., 2000). 
1.9.3.3. Homidium salts 
Chemically, homidium is a 3,8-diamino-5-ethyl-6-phenylphenanthridinium. Homidium 
is better known by its chloride salt or Novidium® (C21H20ClN3; MW: 349.86) and its 
bromide salt or ethidium bromide (Ethidium®; C21H20BrN3; MW: 394.31) (Figure 1.8). 
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Figure 1.8: Molecular structure of homidium (Delespaux et al., 2010) 
 
Used at the dose of 1 mg/kg b.w. (IM) homidium is active against T. congolense and T. 
vivax infections in cattle. The compound is essentially used as a curative drug in the field, 
even if some studies reported a prophylactic effect varying from 2 to 19 weeks (Dolan et 
al., 1990; Stevenson et al., 1995). Homidium was widely used during the 1960s but due 
to the spread of resistance and its mutagenic activity, its use has greatly decreased 
(Geerts et al., 2010; Kinabo, 1993). The guideline is actually to forbid it for treating 
animals. This is highly understandable when considering the precautions taken by 
laboratory technicians when using this compound for DNA staining (Ethidium bromide).  
Phenanthridinium drugs exhibits their antitrypanosomal activity through both the 
blockade of nucleic acid synthesis via DNA intercalation, inhibition of RNA and DNA 
polymerase and the incorporation of nucleic acid precursors into DNA and RNA (Kinabo, 
1993). However, there are others biochemical mechanisms involved in the trypanocidal 
effect of these drugs, including the modulation of glycoprotein biosynthesis lipid 
metabolism, membrane transport and selective cleavage of kDNA minicircles  (Shapiro 
and Englund, 1990). 
These trypanocidal drugs were used for more than 50 years and have been 
manufactured for decades by European drug companies. However, recently, cheaper 
generic forms of these compounds with different levels of quality have flooded all over 
the African market (Geerts et al., 2010). Unfortunately, due to the limited number of 
field veterinarians, most livestock keepers treat their sick animals themselves or via 
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more experienced farmers. They often purchase the trypanocidal drugs from the 
informal sector (Affognon et al., 2009). Several recent studies have shown that these 
farmers, besides not having enough knowledge on trypanocidal drugs usage (Delespaux 
et al., 2002), usually underestimate the body weight of the treated animals and 
consequently under-dose their animals (Machila et al., 2008). These bad practices in the 
use of ISM and DA have contributed to the development of TDR in about 17 sub-Saharan 
African countries (Delespaux et al., 2008a). 
1.10. Trypanocidal drug resistance  
1.10.1. Definition and etiology 
As previously stated, in the context of this thesis, TDR is defined as the decreased or 
absence of sensitivity of trypanosome strains to standard quality trypanocidal drugs at 
the dose recommended by the manufacturer and administered according to the good 
veterinary practice. It is still unclear if TDR is spreading from resistant genotypes 
existing in wild trypanosome populations that are selected by drug pressure or if it is 
the drug pressure that is inducing mutations having resistance as a consequence. The 
fact that it is possible to induce TDR in vitro by gradual exposure to the drug (Peregrine 
et al., 1991) tends to indicate that acquisition of TDR is a reality. However, the isolation 
of drug resistant trypanosomes from wildlife that were never in contact with the drug 
(Chitanga et al., 2011) suggests that TDR is existing without any drug pressure and was 
existing before the discovery of the drugs. A combination of both processes could be 
considered when we observe the gradation of TDR varying from a slight decrea se to a 
complete loss of sensitivity to the drug (i.e. that the host is killed by the drug before the 
parasite). This gradation could be explained by the co-existence of different mechanisms 
of TDR, which are adding their effects to achieve a certain level of resistance.  
When the trypanosome is resistant to more than one drug, it is considered as multidrug 
resistant. In this case, different resistance mechanisms are acquired / selected 
independently through exposure to different drugs (Black et al., 2001). This is the case 
for DA and ISM. Cross resistance is a resistance to a particular drug that often results in 
resistance to another drug, usually from a similar chemical class, to which the  
trypanosome may not have been exposed. Here, a single mechanism is responsible for 
resistance to more than one drug. This is the case for quinapyramine that causes 
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resistance to DA and ISM (Chartier et al., 2000; Uilenberg, 1998). For this reason it has 
been removed from the market in the seventies. Unfortunately, this drug is currently 
again available in Africa originating from Asian markets where the drug is allowed. 
Quinapyramine should be strictly restricted to the treatment of horses and camels 
infected with T. evansi. 
Many factors contribute to the development of TDR in West Africa. Indeed, since the 90s 
and the privatization of the veterinary services, the policy of veterinary medicine 
restricted the administration of trypanocides to veterinarians and their distribution by 
registered private veterinarians (Sidibé, 2003). In practice, factors like the few number 
of private field veterinarians agents associated with the porosity of African borders and 
the high cost of the formal sector have led to the proliferation of an informal sector with 
often poor drug quality (Coulibaly, 2004). There is little control on drug sale and an 
evident lack of information on the correct condition of trypanocides storage and use. All 
of these factors, associated to the change of farming systems (extensive to more 
intensive farming in peri-urban zone with increased treatments) and the absence of new 









Figure 1.9: Factors fostering TDR in West Africa (Anonymous, 2004) 
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1.10.2. Distribution 
In West Africa, TDR was first identified in 1984 and concerned T. congolense resistance 
against ISM (Authie, 1984). A few years later, multiple resistance was confirmed in the 
pastoral area of Samorogouan in Burkina Faso (Clausen et al., 1992). More recently, the 
West Africa’s cotton belt was found affected by drug resistance concerning the two main 
molecules used in this zone i.e. DA and ISM (McDermott et al., 2003; Diall, 2005; Grace, 
2005; Talaki et al., 2006; Affognon et al., 2009; Clausen et al., 2010). While, in West 
Africa, reports of the occurrence of TDR are increasing, it is not really clear whether this 
is due to a real increase of the TDR problem or just an increased interest by scientists. 
Nevertheless, a report on a five-fold increase in the prevalence of DA resistance over a 
seven year period in the Eastern Province of Zambia, suggests that there might be a 
worsening of the problem (Delespaux et al., 2008b). Currently, TDR has been officially 
reported in 17 African countries (Figure 1.10) (Delespaux et al., 2008a). 
 
 
Figure 1.10: Countries for which reports on TDR in animal trypanosomes are available. 
Adapted from Delespaux et al. (2008a). 
Drug resistance reported 
No drug resistance reported 
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However, there are probably more countries affected by TDR. This lack of information is 
related to the laborious and costly nature of traditional TDR detection tests. Hence, an 
epidemiological surveillance network for trypanosomosis and TDR (RESCAO) was 
created in 2009 in West Africa with the goal to monitor the evolution of TDR, especially 
in zones with suspected multiple drug resistance. 
1.10.3. Epidemiological monitoring network of chemoresistance to trypanocidal 
and acaricides drugs in West Africa (RESCAO) 
1.10.3.1. Objectives 
Created in April 2009 by the “Centre International de Recherche-Développement sur 
l’Elevage en zone Subhumide” (CIRDES) of Bobo-Dioulasso and the Institute of Tropical 
Medicine of Antwerp, the RESCAO is an epidemiological surveillance network with 
regional ambitions, of which the main objective is to contribute to the improvement of 
the livestock health and agriculture productivity in West Africa, through effective 
strategic control of trypanosomosis and tick-borne diseases by a rational use of the 
available therapeutic arsenal. More specifically, it aims at: (i) a better understanding of 
the epidemiology of TDR and acaricides in West Africa, (ii) proposing control strategies 
adapted to the local conditions and (iii) implementing the CIRDES as a West Africa’s 
Regional Center for the molecular diagnosis of both AAT and TDR. This network was 
funded by the Belgian Development Cooperation (Vitouley et al., 2013). 
1.10.3.2. Institutional and structural organization 
The membership in RESCAO is institutional and application can be done by sending a 
letter of commitment signed by the h ighest authority of the country’s center, which in 
turn will appoint a focal point (Table 1.3) that will remain in permanent contact 
(quarterly reports activities carried out, annual meeting, etc.) with RESCAO coordination 
based in the CIRDES. Members are governmental research institutes in animal health 
and production, universities / training schools in animal health and production, 
international organizations, etc… To date, the RESCAO includes 8 West African countries 
(Benin, Burkina Faso, Côte d’Ivoire, Ghana, Mali, Niger, Nigeria and Togo) (Figure 1.11), 
the interstate school of veterinary sciences and medicine of Dakar (EISMV) via its 
laboratory of control of the quality of veterinary drugs (LACOMEV), ITM and CIRDES. 
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Table 1.3: Focal points of RESCAO 
Identities  Email addresses  Home institution  Country 
POMALEGNI  cpomalegni@yahoo.fr  Institut National de   Bénin 
Charles      Recherche Agronomiques  
du Bénin (INRAB) 
 
OUATTARA  sielouattara@hotmail.com Direction Générale des Burkina Faso 
Lassina      Services Vétérinaires 
(DGSV)    
 
Mme KOMOIN  cl.komoin@gmail.com  Laboratoire National  Côte d’Ivoire 
Clarisse      d’Appui au Développement  
       Agricole (LANADA) 
 
Alledje-Cudjoe  emmallec@yahoo.com Central Veterinary  Ghana 
Emmanuel      Laboratory/Pong-Tamalé 
 
DIARRA Boucader diarrab@gmail.com  PATTEC   Mali 
 
GAMATIE Djibo gamatieal@hotmail.com Laboratoire Central de  Niger 
l’Elevage (LABOCEL) 
 
Mamman  mammanm@hotmail.com Nigerian Institute for   Nigeria 
Muhammad      Trypanosomiasis  
Research (NITR) 
 
DAO Balabadi  balabadidao@gmail.com Institut Togolais de   Togo 
       Recherches 
       Agronomiques (ITRA) 
 
 
Figure 1.11: West Africa’s map  
Adapted from http://www.afdb.org/fr/countries/west-africa/  
The yellow circle shows the 8 RESCAO’s member countries. 
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Furthermore, as all epidemiological surveillance networks, the modus operandi of the 
RESCAO can be summarized in four main steps (Dufour and Hendrikx, 2009): (i) data 
collection, (ii) data transmission, (iii) data management and processing, and (iv) 
dissemination of the results. Thus the network is structured as a pyramid and is headed 
by a regional steering committee followed by the regional technical committee, the 
regional animation cell and national field units. 
Based in the CIRDES, the regional steering committee is constituted by the ITM, the 
CIRDES and the focal points within the countries, universities and others member 
institutions. This committee decides on the major policies and sets objectives, validates 
results, assesses progress and settles corrective actions when necessary. The regional 
technical committee is composed of an epidemiologist in charge of the dynamism of the 
network and scientists known for their work in the RESCAO’s targeted research area. 
This committee contributes to the design of the protocols and organizes the analysis of 
collected data. Hosted at the CIRDES, the regional animal cell includes a facilitator and 
technical assistants specialized in data processing and in the dissemination of the 
results. The national animation cell is constituted by the focal point assisted by 
resources persons (veterinarians, veterinary assistants, laboratory technicians, etc.) 
from the same institution. Its role is to implement procedures and actions defined by the 
regional steering committee. Finally, field units, decentralized structures of the national 
cells, are constituted by veterinary stations, research stations, health and animal 
production schools, veterinary clinics, farmers NGOs, etc (Figure 1.12). 
Therefore, to resume Dufour and Hendrikx (2009) criteria’s, the RESCAO could be 
characterized as follow: supranational network, targeted surveillance of drug resistance, 
active data collection and autonomous from others usual activities.  
 
 














Figure 1.12: The flowchart of the RESCAO 
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1.10.4. Mechanisms of TDR 
1.10.4.1. Isometamidium chloride 
ISM is firstly seen in the cytoplasmic compartment of the trypanosome from where the 
drug is driven to its primary site of accumulation i.e. the kinetoplastic compartment 
(Wilkes et al., 1995). From the outside environment, ISM is driven down the 
concentration gradient and enters the cell via a facilitated diffusion, which therefore 
does not require an expenditure of metabolic energy. Then, ISM is actively transported 
into the kinetoplastic compartment probably due to the mitochondrial electrical 
potential (Wilkes et al., 1997) or through an as yet unidentified energy-consuming 
transmembrane transporter (Delespaux et al., 2005). When placed in an ISM free 
medium, the diffusion of ISM out of the cell does not vary between sensitive and 
resistant strains. However, under the same conditions, a large proportion of the drug 
sequestered within the mitochondrion of the sensitive strains is retained (Wilkes et al., 
1997). Therefore, ISM-resistance might probably be caused by the synergistic 
combination of reduced uptake and increased efflux of the drug at the level of the 
mitochondrion (Figure 1.13) i.e. (i) a decrease in transport through the mitochondrial 
membrane (lowered mitochondrial electrical potential), (ii) the modification of a 
possible transporter located in the inner mitochondrion membrane, (iii) an incre ased 
efflux of the drug from the cytoplasmic compartment via a – yet to be identified - 
transporter or (iv) a combination of these processes (Delespaux et al., 2008a; Sutherland 
and Holmes, 1993). 
Other authors mentioned also the role of a mutation in an ATP-binding-like-transporter 
as shown by the presence of a conserved GAA codon insertion in a gene coding for a 
putative ABC (ATP Binding Cassette) transporter in the resistant clone (Delespaux et al., 
2005). ABC transporters are ubiquitous membrane proteins that use directly the energy 
from ATP to transport substrate across biomembranes, irrespective of the concentration 
gradient (Borst and Elferink, 2002). However, more than one resistance mechanism 
could be involved since some strains characterized as resistant in the mouse test (Eisler 
et al., 2001) did not show the GAA insertion codon (Delespaux et al., 2005). 
 
38  Chapter 1 
 
 
Figure 1.13: Model of the uptake of ISM by T. congolense mitochondria. 
 
(a, b) Drug importer models: (a) Heterozygous wild-type (light grey) and mutated (black) 
importers with decreased activity. (b) Homozygous mutated importers with decreased affinity. 
Only the homozygous mutated importers will be resistant to ISM. 
(c, d) Drug exporter models: (c) Heterozygous wild-type (black) and mutated exporters with 
increased affinity (dark grey). (d) Homozygous mutated exporters leading to a resistant 
phenotype. Heterozygous and homozygous mutated exporters would both be resistant to ISM to 
different degrees (Delespaux et al., 2008a). 
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ISM resistance mechanism could also include the alteration or modification of the 
targeted site of the drug since it has been suggested that the main mode of action of ISM 
was the cleavage of kDNA-topoisomerase complexes (Shapiro and Englund, 1990). The 
silencing of the mitochondrial topoisomerase gene by RNA interference or by the use of 
specific topoisomerase II inhibitors induces the progressive shrinking and 
disappearance of the kinetoplast DNA network (Cavalcanti et al., 2003; Wang and 
Englund, 2001). This possible mechanism of resistance to ISM (i.e. modification of the 
topoisomerase II gene) was explored in T. congolense (Delespaux et al., 2007). 
Topoisomerases are a class of enzymes that alter the supercoiling of double-stranded 
DNA and then serve to maintain both the transcription and replication of DNA. 
Topoisomerase II cuts both strands of the DNA to relax coil and extend the DNA 
molecule. The two mitochondrial topoisomerase genes of 10 ISM-sensitive and 14 ISM-
resistant strains of T. congolense were screened using the single-strand conformation 
polymorphism (SSCP) technique, sequencing and polymerase chain reaction-restriction 
fragment length polymorphism (PCR-RFLP). This study revealed that both genes were 
highly conserved and that no polymorphism related to ISM-resistance could be observed 
(Delespaux et al., 2007). 
1.10.4.2. Homidium salts 
Contrary to ISM, homidium is spread much more diffuse throughout the trypanosome 
(Boibessot et al., 2002). Despite their mutagenic activity, Homidium salts (Ethidium® 
and Novidium®) are still found on the African trypanocidal drug market, less in We st 
than in East Africa (Geerts et al., 2010; Macgregor and Johnson, 1977). The resistance 
mechanism to this drug is still unknown even if some studies suggested that it is similar 
to ISM (Peregrine et al., 1997). 
1.10.4.3. Diminazene aceturate 
Given the highly charged nature of diamidine compounds, speciﬁc carriers are required 
to translocate the drugs across biomembranes. Conversely, the absence or loss of these 
transport activities would render cells insensitive to this class of drugs, and may explain 
both their selective toxicity and the probable resistance mechanism. Mediated uptake of 
DA by T. brucei was first demonstrated in vitro by Girgis-Takla and James (1974) and 
found to be lifted after depletion of glucose, indicating then an active uptake . However, it 
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was after Carter and Fairlamb’s (1993) experiment showing the uptake of melarsoprol 
by the P2 aminopurine transporter, that it emerged that the same transporter might 
mediate transport of diamidines as well. Indeed, trypanosomes import purines from 
their hosts through a variety of transporters among which, the adenosine transporters 
P1 and P2. Whereas P1 was shown to be a broad-specificity purine transporter, P2 is a 
high affinity transporter for aminopurine, adenine and adenosine (Carter and Fairlamb, 
1993; Delespaux et al., 2006). Barret et al. (1995) found that induction of DA resistance 
in T. equiperdum coincided with the loss of P2 activity. Similarly, alterations of the P2-
aminopurine transporter encoded by the TbAT1 gene resulted in DA resistance in T. b. 
brucei (Delespaux and de Koning, 2007). Alteration of P2-transporter activity may not 
be the only mechanism contributing to DA resistance. Indeed, a novel gene TeDR40, the 
encoded protein appeared to have a ubiquitous cellular localization, is shown to 
contribute to a high DA resistance in T. evansi (Witola et al., 2005). It is probable that 
such a high level of DA resistance is the result of the cumulative effect of two distinct 
resistance mechanisms (TeDR40 and P2-type purine transporter). Concerning T. 
congolense, a putative P2-type purine transporter TcoAT1 was identified by blasting the 
TbAT1 gene of T. b. brucei. A conserved Val306 to Ile306 permutation in this gene was 
observed and showed to be correlated with the DA resistance phenotype (Delespaux et 
al., 2006). Very recently it has been demonstrated that the TcoAT1 encoded protein is a 
P1-type purine transporter that is not involved in DA transport (Munday et al., 2013). 
Therefore, it was proposed to rename the gene TcoAT1 into TcoNT10. However, a 
genetic linkage between the observed mutation in the TcoAT1 gene and DA resistance 
cannot be excluded as a consistent statistical correlation has been previously 
demonstrated (Delespaux et al., 2006). A clear trend exists towards homozygosis for this 
DA-resistance marker in areas of increasing drug usage (Delespaux and de Koning, 
2013). 
1.10.5. Methods of TDR detection  
Several methods have been described to identify drug resistance in trypanosomes. 
These include field and conventional laboratory tests (in vivo, in vitro and ISM-ELISA 
methods) and more recently molecular tools. With the exception of the recently 
developed molecular tools, all laboratory tests are time-consuming, laborious and costly 
because all experimental animals (mice or ruminants) have to be examined twice a week 
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for the detection of trypanosomes in the peripheral blood. Similarly, in the field test a 
large number of cattle have to be screened every two weeks over a period of two to 
three months. 
1.10.5.1. Field tests for the detection of TDR 
ISM treatment failure can be assessed in the field, under natural Trypanosoma challenge, 
by using the “block treatment” approach (Eisler et al., 2000). It consists of two groups of 
infected cattle (30 to 80 animals) either treated with 1mg/kg ISM or untreated (control 
group). The animals are exposed to natural challenge and tested for the presence of 
trypanosomes in the blood by using the phase contrast buffy coat technique (Murray et 
al., 1977) every two weeks during two to three months. Drug resistance will be strongly 
suspected if more than 25% of ISM-treated animals become infected within eight weeks 
of exposure. A variant of the “block treatment” technique is also used to assess 
suspected DA and ISM treatments failures by treating both the two groups with DA and 
ISM respectively at the start of the experiment, and checking for the presence of 
parasites two weeks after treatment (Mamoudou et al., 2006; McDermott et al., 2003; 
Rowlands et al., 1993). 
1.10.5.2. In vivo tests 
A standardized protocol has been described to assess the susceptibility and resistance of 
trypanosomes in mice and ruminants (Eisler et al., 2001). The long duration of these 
studies (60 days in mice and up to 100 days in ruminants) is the major disadvantage. 
However, there is a good correlation between the test in mice and the one in ruminants. 
Nevertheless, the curative dose used in ruminants cannot be extrapolated from the 
results in mice (Geerts et al., 2000). Finally, the fact that T. vivax and some T. congolense 
strains do not grow in mice constitute another limit of these tests. 
1.10.5.3. In vitro tests 
In vitro tests can be used to detect resistance in T. brucei and T. congolense (Gray et al., 
1993; Hirumi et al., 1993). However, the slow adaptation of trypanosomes to the 
experimental conditions is one of the major constraints of these tests (Clausen et al., 
2000). Considering the complexity of maintaining T. congolense in vitro, two alternative 
methods have been developed in which a short in vitro incubation in the presence of 
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various drug concentrations is sufficient. The Drug Incubation Glossina Infectivity Test 
(DIGIT), which is the first approach, is limited by the availability of tsetse flies (Clausen 
et al., 1999). Briefly, it consists in feeding flies with blood containing trypanosomes and 
different concentrations of drugs. The flies are then dissected 20 days later to check 
their infection status. In the second method, the Drug Incubation Infectivity Test (DIIT), 
mice are infected by trypanosomes after drug incubation (Knoppe et al., 2006). 
1.10.5.4. ISM-ELISA and the mitochondrial electrical potential  
For the detection of TDR, several other rarely used tests include the ISM-ELISA 
technique and a test based on the measurement of the mitochondrial electrical potential 
(MEP). Wilkes et al. (1997) suggested that the variation of the MEP might be the primary 
factor determining the rate of ISM accumulation in the trypanosome kinetoplast. Indeed, 
their initial studies using T. congolense populations have shown that an increased or 
decreased MEP might be a candidate quantitative marker for ISM susceptibility or 
resistance, respectively. However, the decrease in the MEP could also be related to the 
interference of a drug extruder generating an important energetic consumption.  
Actually, the accumulation of ATP in the mitochondrion is causing a high MEP and 
inversely, a decrease in ATP linked to an important consumption of it will decrease the 
MEP.  
The ISM-ELISA technique can be used in addition to the “block treatment” or individual 
treatment of ruminants to detect resistant trypanosomes (Eisler et al., 1996). The 
presence of trypanosomes in animals with an ISM serum concentration > 0.4 ng/ml 
suggests that parasites are resistant (Eisler et al., 1997). 
1.10.5.5. Molecular tools for the detection of TDR 
Two molecular tools for the detection of ISM resistance in cattle have been developed. 
Recent studies using the AFLP technique allowed differentiating two isogenic clones of 
T. congolense, differing in their ISM-sensitivity phenotype. From these results, a PCR-
RFLP test using the restriction enzyme MboII was developed and used to diagnose T. 
congolense resistant to ISM (Delespaux et al., 2005). The test is based on the 
polymorphism observed in a 381bp fragment (sensitive strains) or 384bp fragment (in 
resistant strains) of a putative gene presenting some homologies with an ABC 
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transporter. Indeed, the gene in ISM-resistant strains of T. congolense has a conserved 
triplet insertion (GAA) coding for an extra lysine. The correlation of the MboII-PCR-RFLP 
tool with the standard mouse test was 85.7% for T. congolense isolates (N=30) collected 
from different areas of the tsetse fly belt (Delespaux et al., 2005). This number 
decreased to 60% (Delespaux et al., 2008a) and 75% (Dayo, 2005) when the same test 
was used on 20 T. congolense strains originating from Ethiopia and Burkina Faso and 9 
isolates from Zambia, respectively. In a recent study in Cameroon, the MboII-PCR-RFLP 
only identified 4 strains as resistant among 12 isolates confirmed to be resistant in the 
in vivo mouse test (Mamoudou et al., 2008). These results suggest the existence of an 
alternative mechanism to ISM resistance.  
Another test, SfaNI-PCR-RFLP, based on the polymorphism of a 677bp fragment of the 
TbAT1 gene allowed the distinction between ISM-resistant and ISM-sensitive strains of 
T. b. brucei (Afework et al., 2006). However, the authors did not use strains that were 
specifically mono-resistant to ISM. Unfortunately, from the available data none of these 
recently developed molecular tools for the detection of ISM-resistance are fully 
satisfactory. Further field and laboratory work are required. The reduction in cost of 
whole genome sequencing allows new research strategies i.e. permits to perform more 
whole genome analysis. The Veterinary Protozoology Unit of the Institute of Tropical 
Medicine of Antwerp (ITM) is now running whole genome sequencing on field strains 
(+/- 30) that were previously characterized for their sensitivity/resistance to ISM in the 
mouse model (Delespaux, pers. Comm.). 
Concerning DA-resistance diagnosis, a PCR-RFLP test using the restriction enzyme BclI 
was also developed by the ITM. Studies made on 26 resistant T. congolense strains 
coming from various geographic areas and previously characterized for their 
resistance/sensitivity to DA into mice, have concluded that the BclI-PCR-RFLP technique 
is a powerful tool for diagnosing the presence or absence of T. congolense resistance to 
DA (Delespaux et al., 2006). The test is based on a single nucleotide permutation (G to A) 
observed in the DA-resistant strains that can be easily detected via BclI restriction of the 
amplicon. This single point mutation confers a Val306 to Ile306 permutation in the 
TcoNT10 gene. As stated before, there is a statistical correlation between the presence of 
this mutation and the in vivo resistance phenotype but it is not the mutation itself that is 
affecting the transport of DA within the trypanosome. Concerning T. brucei, a conserved 
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set of six point mutations was described in the TbAT1 gene of melarsoprol-resistant 
strains (Mäser et al., 1999). Notwithstanding the crucial role of TbAT1 gene in high 
levels of resistance to melarsoprol, others factors such as action of the high-affinity 
pentamidine transporter (HAPT1), the low-affinity pentamidine transporter (LAPT), 
aquaporines or ABC transporters could be involved (Bridges et al., 2007; Delespaux and 
de Koning, 2007; Luscher et al., 2006). Finally, further field validation of the BclI-PCR-
RFLP test and the development of such molecular tools for the diagnosis of T. vivax 
resistant strains will be discussed in subsequent chapters. 
1.10.6. Strategies for combating TDR 
The treatment of livestock with trypanocidal drugs is the most important control 
strategy for AAT. The effective use of the existing drugs by smallholder crop-livestock 
farmers in the cotton zone of West Africa is threatened by the development of 
widespread resistance (Clausen et al., 2010). Therefore, the guidelines recommended by 
Geerts and Holmes (1998) for rational drug usage and for delaying the development of 
TDR are still valid (Table 1.4). These strategies include the use of the sanative pair i.e. a 
pair of curative drugs which could be alternatively used in the field when resistance  to 
either one of them has developed (Whiteside, 1958). The concept was firstly proposed 
for the DA / Homidium pair and the DA / ISM pair usually used in the field. However, the 
effectiveness of this strategy may be questioned by the increased field reports from 
many parts of West Africa of multiple resistant trypanosomes (Clausen et al., 1992; 
Talaki, 2008; Clausen et al., 2010; Mungube et al., 2012). In their study in the cotton 
zone of West Africa, Clausen et al. (2010) have suggested that in such circumstances an 
integrated approach should be applied to prevent and contain TDR: (i) rational drug use 
information given to farmers, (ii) training farmers and paravets in integrated 
trypanosomosis control and (iii) training animal care providers to a more specific 
diagnosis of trypanosomosis to avoid inappropriate treatment. Notwithstanding all the 
above strategies, it is crucial to monitor the evolution of TDR, especially in areas with 
suspected multiple drug resistance. It is then important to use molecular tools. 
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Table 1.4: Guidelines to delay the development of TDR in livestock (Geerts and Holmes, 1998) 
1. Avoid sub-therapeutic drug concentrations 
2. Use of the sanative pairs (alternation of ISM and DA) 
3. Reduce the treatment frequency 
 - Avoid exclusive reliance on trypanocidal drugs 
 - Integrated drug usage with other control measures 
  - Trypanotolerant animals 
  - Tsetse control 
  - Stimulate host immunity (good nutrition, avoid stress, etc) 
4. Avoid mass treatments 
 - Limit treatment to animal which needs it (PCV<20) 
5. Ban on use of quinapyramine in cattle 
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64  Objectives of the thesis 
This thesis aims at a better insight on the problem of TDR in West Africa by using 
molecular tools and to propose alternative methods for the management of this 
phenomenon. 
To achieve the above general objective, the study included the following specific 
objectives: 
1. To improve the molecular tools used to diagnose TDR by: 
 
 Increasing the performance of the existing molecular tool for the 
detection of DA resistance in T. congolense under field conditions using 
filter papers for sample storage; 
 Prospecting the development of a molecular diagnostic tool for T. vivax 
resistance to DA in the field. 
 
2. To evaluate the impact of TDR on the health status of T. vivax infected animals. 
3. To explore possibilities to circumvent TDR using alternative treatment i.e. 
potentiate the efficacy of ISM by combining it with two affordable veterinary 







Improved PCR-RFLP for the diagnosis of diminazene aceturate 
resistance in Trypanosoma congolense in the field using filter 





Vitouley H.S., Mungube E.O., Alledye-Cudjoe E., Diall O., Bocoum Z., Diarra B., Randolph 
T.F., Baeur B., Clausen P-H., Geysen D., Sidibé I., Bengaly Z., Van den Bossche P. and 
Delespaux V. (2011). Improved PCRF-RFLP for the Detection of Diminazene Resistance 
in Trypanosoma congolense under Field Conditions Using Filters Papers for Sample 
Storage. PLoS Negl Trop Dis 5(7): e1223. doi:10.1371/journal.pntd.0001223. 
& 
Vitouley, H.S., Bengaly, Z., Adakal, H., Sidibe, I., Van Den Abbeele, J., Delespaux, V., 2013. 
Réseau d'EpidémioSurveillance de la Chimiorésistance aux trypanocides et aux 
acaricides en Afrique de l'Ouest (RESCAO). TROPICULTURA 31, 205-212. 
. 
66  Chapter 2 
2.1. Introduction 
The different methods for the detection of TDR (Eisler et al., 2001; Eisler et al., 2000) 
and their main inconvenience (labour intensive, time-consuming, costly, etc) were 
reviewed in the first chapter of this thesis. To address these important drawbacks, the 
former Department of Animal Health (currently incorporated in the Department of 
Biomedical Sciences) of the ITM / Antwerp has developed a BclI-PCR-RFLP test for the 
molecular diagnosis of DA resistance in T. congolense (Delespaux et al., 2006). Although 
the test performs very well under laboratory conditions (Mamoudou et al., 2008), it 
required further adaptation and evaluation for use under field conditions with biological 
material that is not always collected or stored in optimal conditions. More specifically, 
the test’s ability to amplify low concentrations of parasite DNA (as a result of often low 
parasitaemia in livestock) needs to be enhanced and its specificity improved by 
preventing incomplete digestion of the amplicons by the BclI enzyme. This incomplete 
digestion creates a mixture of undigested and digested amplicons and as such, falsely 
mixed RFLP profiles (sensitive and resistant). To address those weak points, the 
following changes were made to the standard protocol: (i) the BclI restriction enzyme 
was replaced by a more effective cutter i.e. DpnII restriction enzyme and (ii) a step of 
whole genome amplification was performed on samples that were found negative in the 
PCR for species determination. 
2.2. Material and methods 
2.2.1. Material 
449 whole blood spots (40–50 µl) on filter papers were used (Figures 2.1 and 2.2). 
These were collected from parasitologically positive cattle originating from the cotton 
zone of South-East Mali where treatments failures to DA and ISM were previously 
reported (Mungube et al., 2012). The samples were stored sun-protected for 1 year at 
tropical ambient temperature without adding dehydrated silica crystals in the storage 
plastic bags (i.e., stored under sub-optimal conditions as it is often the case in rural 
environments), allowing for potential degradation of the DNA. 
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Figure 2.1: Laboratory material used for the processing of the samples.  
 
 
Figure 2.2: Dried blood spots (left) and buffy coats (right) on labelled filter papers.  
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2.2.2. Methods 
2.2.2.1. DNA extraction 
DNA extraction was performed following the PBS-Saponin technique (de Almeida et al., 
1997). In brief, filter papers discs containing the entire buffy coat or blood spot were cut 
using a scalpel blade, which was flame-heated between each sample. Each cutting was 
transferred to a 1.5 ml Eppendorf tube, containing 1ml of PBS-Saponine 0.5%. The tube 
with the disc was manually mixed and incubated for a minimum of 4h at 4°C or 
overnight. After a 1 min centrifuging at 15,000 x g, the supernatant was removed and 1 
ml of PBS was added to each tube and mixed manually. Followed 1-2 h incubation at 4°C 
and a novel 1 min centrifugation at 15,000 x g. Afterwards, the maximum of the 
supernatant were removed without disturbing the pellet. 100 µl of a 10% Chelex -100 
resin suspension (Bio-Rad, Herculex, CA) in ultrapure water was added to each tube and 
incubated for 10 min at 95°C. Thereafter, the samples were centrifuged at 14,000 rpm 
for 5 min. Finally, the maximum of the supernatant was transferred into a new 1.5  ml 
Eppendorf tube and stored at -20°C until used. 
2.2.2.2. DNA amplification for the detection of trypanosomes 
DNA amplification was performed using three primers targeting the 18S small ribosomal 
subunit gene as described by Geysen et al. (2003) for the diagnosis of trypanosome 
infections. Thus, standard PCRs were carried out in 25 µl reaction mixtures containing 5 
µl DNA sample, 50 mM KCl, 10 mM Tris -HCl (pH 8.3), 1.5 mM MgCl2, 200 µl of each 
dNTP, 20 pmol of each primer (18STnF2 and 18STnR3) and 0.5 U Taq polymerase 
enzyme (Goldstar, Eurogentec). The reaction mixture was overlaid by 50 µl fine neutral 
mineral oil (Sigma) and placed on a heating block of a programmable thermocycler 
(PTC-100 TM, M.J. Research Inc.; Techgene, Techne Duxford, Cambrigde, UK). After a 
denaturation step of 4 min at 94°C, each of the 40 cycles consisted of 30s at 92°C, 45s at 
58°C and 60s at 72°C. Semi-nested runs was performed adding 0.5 µl of amplification 
product from the first run to 24.5 µl of PCR mix at 84°C (hot start principle), containing 
the same ingredients and concentrations except for the primer pair (18ST nF2 and 18ST 
nR2). The amplification program was identical but only for 25 cycles. A positive and a 
negative control consisting of adding a reference trypanosome DNA and ultrapure water 
respectively, were included in each PCR amplification. 
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In order to observe the presence of DNA fragments within the mixtures, a 5 µl volume of 
each sample was electrophoresed in a 2% agarose gel for 20 min at 100 V and stained 
with ethidium bromide for 30 min. A 100bp DNA ladder (MBI Fermentas Lithuania) was 
included in each gel. Next, the gel was washed under running tap water and 
photographed under UV illumination.  
Sequence of the 5’-3’ primers 
First round:  18ST nF2 (CAACGATGACACCCATGAATTGGGGA)  
18ST nR3 (TGCGCGACCAATAATTGCAATAC) 
 
Semi-nested:  18ST nF2 (CAACGATGACACCCATGAATTGGGGA)  
18ST nR2 (GTGTCTTGTTCTCACTGACATTGTAGTG) 
 
After the above detection of Trypanosoma spp. infections, RFLP was used for species 
diagnosis (Geysen et al., 2003). 
2.2.2.3. RFLP for species determination 
The nested products from the previously described PCR were digested with MspI 
enzyme in NEBuffer 2 (New England BioLabs) according to the manufacturer’s 
specification (MBI Fermentas, Lithuania) using 10 U/µg DNA (0.6 U/µl PCR product) on 
6 µl of amplified DNA in 15 µl total volume. The reaction was left overnight in a water 
bath at 37°C. A volume of 4 µl of restricted sample was then mixed with 2 µl of loading 
buffer and transferred onto a 10% polyacrylamide gel together with a 100 bp DNA 
ladder (MBI Fermentas, Lithuania) for fragment size determination. DNA fragments 
were thereafter separated by horizontal electrophoresis in 0.5 x TBE buffer at 100V for 
2.5 h. The gel was stained using commercial silver staining kit (Silver staining kit DNA 
plusone, Pharmacia Biotech, Uppsala, Sweden) and mounted for storage. 
2.2.2.4. PCR-RFLP for detecting DA resistance 
For discriminating the DA sensitive and resistant T. congolense genotypes, the following 
PCR targeting the T. congolense putative gene (TcoAT1/TcoNT10) coding for a putative 
P2-like nucleoside transporter, was used as described by Delespaux et al. (2006). 
Standard PCR amplifications were carried out as described above except for the couple 
of primers used i.e. Ade2F as forward primer (ATAATCAAAGCTGCCATGGATGAAG) and 
Ade2R (GATGACTAACAATATGCGGGCAAAG) as reverse primer. The PCR products were 
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then enzymatically restricted as described above, except for the enzyme used. The BclI 
restriction enzyme (T^GATCA) was replaced by DpnII (^GATC) to avoid partial digestion 
of the amplicon. Internal negative and positive controls (sequenced resistant and 
sensitive strains) were added to ensure the absence of contamination, an effective DNA 
amplification and the complete digestion of the PCR product. For the visualization of the 
restriction fragments use was made either of a 4% agarose gel and a staining with 
ethidium bromide (figure 2.5) or a polyacrylamide gel and a silver staining as described 
for the species diagnosis (figure 2.6.). 
2.2.2.5. Whole genome amplification 
Whole genome amplification was performed on the negative samples using the QIAGEN 
REPLI-g® UltraFast Mini Kit exactly as described by the manufacturer. This kit uses the 
Multiple Displacement Amplification (MDA) technology that provides high quality and 
sufficient yield of DNA products for genomic analysis. For economical reasons, the whole 
genome amplification was not performed on all samples but only on the PCR negatives.  
2.3. Results and discussion 
2.3.1. Output of the PCR and RFLP for species determination 
A total of 68% (304) of all blood spots was found positive for the presence of 
trypanosomes using the 18S pan-PCR developed by Geysen et al. (2003) (Figure 2.3). Of 
these, 74% (225) were diagnosed as a single or mixed T. congolense savannah (Figure 
2.4). The prevalence of the other trypanosome species is not shown since the focus here 
was the diagnosis of DA-resistance in T. congolense. Otherwise, as observed in the figure 
2.4, it was impossible to differentiate T. simiae species from those of T. theileri using 
MspI as restriction enzyme. However, this has no consequences for epidemiological 
surveys in cattle since T. theileri is not pathogenic for cattle and T. simiae does usually 
not occur in these animals. It would be an important issue when dealing with AAT in 
small ruminants, which are indeed susceptible for T. simiae (Geysen et al., 2003; 
Stephen, 1986). However if needed, these two species can be differentiated by the MboII 
enzyme on the same amplicon (Geysen et al., 2003). 
 
Chapter 2  71 
 
 





Figure 2.4: Trypanosome species diagnosis using MspI-PCR-RFLP with  
lanes 1 – 3 T. congolense savannah type, 4 T. congolense riverine forest,  


















72  Chapter 2 
2.3.2 Output of the DpnII-PCR-RFLP and whole genome amplification  
Out of the 225 T. congolense–positive samples, 59 (26%) were successfully amplified 
using the DpnII-PCR-RFLP. By adding a step of whole genome amplification, an extra 42 
samples became positive, reaching a total of 101 (44.9%). The DpnII-PCR-RFLP profiles 
of the 101 amplified T. congolense samples were distributed as follows: 92% presented a 
resistant genotype, 2% a sensitive genotype and 6% presented a mixed genotype 





Figure 2.5: Output of the DpnII-PCR-RFLP with lanes 1, 6, and 10 as size markers (100-bp 
ladder), lanes 2, 3, 4, 5, and 7 as sensitive profiles (one band), lane 8 as resistant profile (two 
bands), and lane 9 as mixed profile (three bands).  
 
 
Figure 2.6 illustrates the improved performance of the DpnII-PCR-RFLP compared to the 
previous BclI-PCR-RFLP on the same set of samples. 
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(A)        (B) 
Figure 2.6: Comparison of DpnII-PCR-RFLP (A) and BclI-PCR-RFLP (B) profiles of some samples 
with a mixed profile (1-2), a resistant profile, completely restricted (3), a sensitive profile (4), a 
mixed profile (5-6), a resistant profile with incomplete restriction (7), a sensitive profile (8). 
 
 
Digestion of the PCR products was more complete with the DpnII restriction enzyme 
compared to BclI (Figure 2.6. lane 3 shows a complete restriction, figure 2.6. lane 7 
shows an incomplete restriction). The agarose gel (figure 2.5.) has the advantage to be 
easier to make and non-toxic when compared to the polyacrylamide gel (figure 2.6.). 
Therefore we can state that our objectives to improve the PCR-RFLP for identification of 
DA-resistance in T. congolense were achieved: 1) higher sensitivity as the number of 
positive PCR’s was increased by a factor 1,7 through the use of whole genome 
amplification, and 2) more complete restriction of the “resistant” amplicons by the use 
of an alternative restriction enzyme DpnII. 
The newly improved PCR-RFLP was then used to assess the current situation of TDR in 
West Africa in the framework of the RESCAO (Vitouley et al., 2013). A total of 911 
samples were collected in suspected treatment failure areas (Murray et al., 1977) of 6 
West African countries and analyzed exactly as described above. The obtained results 







1 2 3 4 5 6 7 8 
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2.3.3. Current situation of DA-resistance in West Africa using molecular tools 
Out of the 911 samples collected from 6 West African countries, approximately 21% 
(194/911) were diagnosed in the MspI-PCR-RFLP as T. congolense or mixed T. 
congolense infections. A total of 45% (88/194) of the latter samples were successfully 
amplified with the PCR Ade2. The DpnII-PCR-RFLP profiles of these samples were 
distributed as follow: 83% presented a DA-resistant genotype, 2% a DA-sensitive 
genotype, while 15% presented a mixed-DA genotype (Table 2.1). Recently, such a high 
level of the DA-resistance genotype was also observed in the Ghibe river basin 
(Ethiopia) where 94.6% of the samples successfully amplified in the DpnII-PCR-RFLP 
presented a DA-resistant genotype (Moti et al., 2012).  
Although these results suggest an alarming situation, they might not always reflect the 
real situation in the field as a resistant profile might be classified as sensitive when 
counterchecked in the mice test at the discriminating dose of 20mg/kg (Delespaux et al., 
2006). The molecular technique allows then for the identification of some resistant 
genotypes that still have sensitive phenotypes in the field. In West Africa for example, 
when using the block treatment method, the proportion of reported treatment failure to 
DA is lower with observed prevalences ranging from 8.6% (n=93) in Burkina Faso (Sow 
et al., 2012) to 42.2% (19/45) in Mali (Mungube et al., 2012).  
The molecular method appears thus to be much more sensitive than the mice test and 
the block treatment technique. Consequently, it can be argued whether or not the use of 
this molecular test is useful. In other words, does this higher sensitivity constitute an 
advantage for the establishment of adequate control strategies? What to do with the 
animals that are infected with “resistant” trypanosomes (harboring the mutation) but 
that would be cured with a normal dosage of the drug? These issues will be more 
extensively handled in the general discussion. 
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Table 2.1: PCR-RFLP outputs of the samples collected in 6 West African countries 
 
Country  Number of field  MspI-PCR-RFLP  PCR Ade2+    DpnII-PCR-RFLP 
   samples received  (Tc and mixed Tc)      R  S  M 
 
Benin   25     7   4    4  0  0 
 
Burkina Faso  350     62   28    19  0  9 
 
Côte d’Ivoire  313     100   39    33  2  4 
 
Ghana   20     11   9    9  0  0 
 
Nigeria  149     7   3    3  0  0 
 
Togo   54     7   5    5  0  0 
 
Total (%)  911    194 (21%)  88 (45%)   73 (83%)         2 (2%)    13 (15%) 
R, S, and M as T. congolense with respectively a resistant, sensitive, and mixed DpnII-PCR-RFLP profile. 
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2.4. Conclusions 
Notwithstanding the suboptimal storage procedure, it can be concluded that blood 
samples collected and stored on filter papers can be used for detecting the presence of 
trypanosomes resistant to DA in a trypanosome population. Moreover, losses due to the 
sub-optimal storage conditions can be compensated for by increasing the sample size. 
Considering the important logistical and economic advantages of filter papers, their use 
greatly facilitates the implementation of large scale surveys for TDR in trypanosomosis -
affected African countries using molecular diagnostic tools. Furthermore, the use of 
molecular tools greatly supports the functioning and sustainability of much-needed 
regional reference laboratories (25€ for species identification and DA resistance 
detection in DpnII-PCR-RFLP, compared to a test in mice -150€ all included except 
technician salary and transport - and block treatment which costs 945€ for a survey of 
treatment failure in a village herd). However, the results of the analysis performed with 
the improved RFLP-test must be interpreted with caution as some strains presenting a 
resistant genotype, were detected in the field with a sensitive phenotype. The opposite 
was never observed. There is need to better understand and characterize the link 
between the presence of the mutation and the level of drug resistance observed. 
Finally, it might be interesting to prospect the development of a similar molecular tool 
for the diagnosis of DA-resistance in T. vivax, as it is the predominant trypanosome 
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Prospecting the development of a molecular diagnostic tool for 
Trypanosoma vivax resistance to diminazene aceturate. 
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3.1. Introduction 
T. vivax infections are widespread in sub-Saharan Africa. It is the predominant parasite 
encountered in small wild vertebrates in South Cameroon (Njiokou et al., 2004), in small 
ruminants in Nigeria (Kalu et al., 2001) and in pigs and cattle in Ghana (Nakayima et al., 
2012). The control of the trypanosome infections in the animal host still heavily relies 
on the use of three trypanocidal drugs i.e. ISM, DA and homidium salts.  
The molecular tools that were recently developed permit the rapid diagnosis of TDR in 
T. congolense and in T. brucei. Those tools were used in the framework of large-scale 
epidemiological surveys in different countries of sub-Saharan Africa (de Koning et al., 
2004; Delespaux et al., 2006; Vitouley et al., 2011). Unfortunately, up to now, for T. vivax, 
the page remains blank in this domain. Therefore, the objective of the work reported in 
this chapter was to explore the possibility of the development of a similar technique for 
T. vivax. The study consisted of the systematic screening of the genes of T. vivax coding 
for nucleoside transporters. Up to now, no functional analysis has been performed on 
the nine nucleoside transporters described in the genomic databases available for T. 
vivax. At the moment of the study, it was not possible to discriminate the P1 from the P2 
type transporters. Even if in T. congolense a P1-type purine transporter (TcoNT10) was 
identified as a genetic marker associated with DA resistance, a test based on a mutation 
in a P2-type purine transporter identified as associated with the resistant phenotypes 
would bring some evidence in the scientific community (Delespaux et al., 2006; Mäser et 
al., 2003). As a first approach in our exploration, we decided to go for a systematic 
screening of the available nine T. vivax open reading frames that are predicted to code 
for putative nucleoside transporters (Jackson et al., 2013). Subsequently, SSCP and 
sequencing analysis were performed, on the four genes of T. vivax clading with the T. 
brucei genes, to detect point mutations that could possibly be linked to decreases in 
sensitivity to DA.  
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3.2. Materials and methods 
3.2.1. Materials used  
Five T. vivax samples were used for the SSCP analysis and sequencing, in which one 
(ILRAD700) was the sensitive reference strain (Andrikaye, 2008) and four were field 
isolates characterized for their sensitivity/resistance to DA in goats (Vitouley et al., 
2012; Delespaux, pers. Comm.). Table 3.1 summarizes the details about the isolates. 
3.2.2. Methods 
3.2.2.1. DNA extraction 
Four of the five the T. vivax samples used in this study were buffy coats stored in 0.5 ml 
Eppendorf tubes containing 30 µl of sterile distilled water. These buffy coats were 
homogenized after which 100µl of 1% aqueous solution of Chelex® (BIORAD) was added 
to the tubes and vortexed slowly. The tubes were then placed in a heating block for 1h at 
56°C and then 30min at 95°C. Finally, the tubes were centrifuged for 2 min at 15 000g 
and the supernatants (containing the parasite DNA) were collected in new Eppendorf 
tubes. The DNA extracts were stored at -20°C for subsequent PCR analysis (Solano et al., 
1999). For the reference sample, i.e. the mouse adapted ILRAD700, DNA extraction from 
mouse blood was performed using the QIAamp DNA Blood Mini Kit (Qiagen). 
3.2.2.2. PCR-RFLP for species diagnosis 
In order to confirm the trypanosome species, a first PCR based on the small ribosomal 
sub-unit 18S was performed on the DNA extracts using 18STnF2/18STnR3 and 
18STnF2/18STnR2 as first and second round primers, respectively. Subsequently, the 
PCR products were digested with the MspI restriction enzyme (Geysen et al., 2003; 
Vitouley et al., 2011). 
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Table 3.1: T. vivax samples used in the SSCP and cloning studies 
DNA code    Sensitivity to DA  Host  Village Country Provided by Conservation 
 
DE51Tv/Ch.D, 03/04/09 (H65)  resistant  Goat  Dèrè  Burkina Faso CIRDES Buffy coat 
 
MOU18Tv/Ch.A, 11/04/09 (H89)  resistant  Goat  Mou  Burkina Faso CIRDES Buffy coat  
 
DEB53Tv/F, 09/04/09 (H988)  sensitive  Goat  Débé  Burkina Faso CIRDES Buffy coat  
 
GH12Tv/Ch.A62, 29/05/08 (H1008)  sensitive  Goat  Kunchugu Ghana  CIRDES Buffy coat 
 
ILRAD700     sensitive  Mouse  -  Belgium ITM  Stock solution* 
* For the reference sample, the mouse adapted ILRAD700, DNA extraction from mouse blood was performed using the QIAamp DNA Blood 
Mini Kit (Qiagen). 
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3.2.2.3. Single Strand Conformation Polymorphism (SSCP) analysis 
Sets of primers (Table 3.2) were designed using the Primer3 (Rozen and Skaletsy, 2000) 
computer program (http://frodo.wi.mit.edu/). PCR and subsequent SSCP analysis were 
then performed on the 1395bp, 1419bp, 1413bp, 1122bp nucleoside transporter genes 
with their respective predicted sequences Chr6Tviv400 (TvY486_0043680), 
Chr2Tviv585 (TvY486_0202110), ChrUnknownTviv1924 (TvY486_1112030), 
ChrUnknownTviv275 (TvY486_0014570) (GeneDB-Welcome Trust Sanger Institute, 
http://www.genedb.org). To detect sequence differences (point mutations) that could 
possibly be linked to a decreased sensitivity to DA, we firstly used Single Strand 
Conformation Polymorphism (SSCP) on the 4 genes of T. vivax clading with the purine 
transporters of T. brucei (Figure 3.1). Subsequently, sequencing was then used to 
compare the open reading frame sequences. 
Standard PCR amplifications were carried out (40 cycles) as described in the second 
chapter, except for the T. vivax specific primer-sets that were used (see Table 3.2). 
Electrophoresis was performed in a 1% agarose gel for 20min (100V) and stained with 
ethidium bromide for 30min. Next, the obtained PCR products were digested using two 
restriction enzymes per amplicon. The two restriction sites were located at least 50bp 
from each other to ensure that - at least on one of the amplicons - the restriction did not 
happen too close of a potential mutation rendering its detection impossible. To allow 
optimal SSCP analysis, restriction enzymes were chosen to cut the amplicons in 
fragments of an adequate size i.e. between 100 and 300bp. Digestions were then 
performed with the restriction enzymes mentioned in table 3.2 in the appropriate 
NEBuffer (New England BioLabs) according to the manufacturer’s specifications, using 
10 units µg DNA (0.6 U/µl PCR product) on 6 µl of amplified DNA in 15 µl total volume. 
The reaction was incubated overnight at the specified temperature. The electrophoresis 
and staining for the SSCP analysis was performed as follow: 8 µl of D2 buffer (95% 
formamide, 10 mM NaOH, 0.05% bromophenol blue, 0.05% xylene cyanol) was mixed 
with 4 µl of digested PCR product. The mixture was then heated for 5 min at 95°C, cooled 
on ice and left for at least 10 min at -18°C. Thereafter, 6µl of this mixture was loaded in 
the wells of a polyacrylamide gel (PAGE gel) and the electrophoresis was run at 100V for 
2h30 min. 
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Table 3.2: T. vivax nucleoside transporters explored in the SSCP, cloning and sequencing analysis  
 
Amplicons  Size (bp) Restriction enzymes  Forward primer    Reverse primer 
TvY486_0043680 (1 ) 625  AgsI-BamHI   AGGTGCGCTCTCAACTGAAT   CCAGAAAGTGGGAGTCCAAA 
TvY486_0043680 (2 ) 606  AarI-PflFI   CCGGTGCAAAGACGTTATTC   AGAAGAGGAGCGTTGAGCAG 
TvY486_0043680 (3 ) 703  RleAI-EaeI   TGATCAGGTCGAAAACACCA   TTCATTTTGCTTTGCACCAC 
TvY486_0202110 (1 ) 596  BamHI-Cac8I   GCAAACATGATTCTTTCTCTTTGAT  ATAATATACCGGTGATGACTCCAGA 
TvY486_0202110 (2 ) 596  BseRI-Hin4I   CAATGGAATTGAAAAATCTCTCTGT  GGAAAAACAAAACTGTTGTGAAATA 
TvY486_0202110 (3 ) 536  DrdIV-BseRI   CTATTTCACAACAGTTTTGTTTTTCC   ACAAACACTTATTTACCACACAGGTT 
TvY486_1112030 (1 ) 517  BamHI-RsaI   CCACCGGCTCTATATATTCCTTATAC  GCGATGGAAAAATATATGTATGACTG 
TvY486_1112030 (2 ) 642  DpnII-RsaI   TCCATCAGTCATACATATATTTTTCCA CATTACCTTCTATTATACGACGTTGG 
TvY486_1112030 (3 ) 608  AlwI-MboII   CGTCTACTTCTCAACATTTGTGTTTT  TCACGAATTGATGAATAACTTCTTTC 
TvY486_0014570 (1 ) 656  BamHI-SfaNI   TCCTGTCTTCACACTATTAGACAAGC  GAGAAGTATATGTACGACTGGGTCAA 
TvY486_0014570 (2 ) 631  BstNI-AlwI   CTCTTGACCCAGTCGTACATATACTT  GTTGTCCTTTATCACCTTCTGTTGAC 
TvY486_1103740 (1 ) 585   -   TGTTGTCCAGCTGCTTTCCTA   TTCTCCATCGACCCCTTGAT 
TvY486_1103740 (2 ) 565   -   ACATATGGAGGCCACCACTTAC  ATCACCAAAGTTGTAGCACAGAATC 
TvY486_1103740 (3 ) 501   -   TTCCTTCTTTGTCACGCTCTTTAT  CAGTAAACGCTGCTACGTCTTAAA 
TvY486_0041960 (1 ) 586   -   TGCTGAAGTGACATCGAAGG   ACGACACCAGCGTGTAAGTG 
TvY486_0041960 (2 ) 596   -   CACTTACACGCTGGTGTCGT   AGGGCCATATGCACTTGAAC  
TvY486_0041960 (3 ) 415   -   TCTTGTCCTTCCCATTGACC   AAGGTACTGTTAGGGCAAAGC 
TvY486_0011610 (1 ) 631   -   CAAATATGCTCCTGGGCTTCT   ATGACAAGTGAGGCGGCTAT 
TvY486_0011610 (2 ) 439   -   CACTTACACGCTGGTGTCGT   CGTTCTCCTGTGTCAGGTGT 
TvY486_1103750 (1 ) 595   -   TGCTGAAGTGACATCGAAGG   GATAACGGCGCAGGTTCG 
TvY486_1103760 (1 )*  666   -   AGGGGGATCCTCTAGAGTCG   TTCATCATGCGGTACTCAGC 
TvY486_1103760 (2 )*  688   -   CGCTACATTTCCTACGCACA   ATGCCAATGGGCAGTCTTAG 
TvY486_…(x) as the x amplicon of the gene TvY486_… 
TvY486_… without indication of restriction enzymes as the additional T. vivax nucleoside transporters genes explored only in the sequencing analysis 
(i.e. TvY486_1103740, TvY486_0041960, TvY486_0011610, TvY486_1103750, TvY486_1103760) 
* Gene fragment, no complete open reading frame 
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Figure 3.1: The phylogenetic tree of the nucleoside transporters in T. congolense, T. brucei and T. 
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3.2.2.4. Cloning and sequencing 
The nine nucleoside transporters genes described in T. vivax (Figure 3.1) (Jackson et al., 
2013) were explored by amplification and sequencing of two DA-resistant and two DA-
sensitive samples (Table 3.1). ILRAD 700 was used as a T. vivax reference sensitive 
strain (Andrikaye, 2008). These samples were amplified as described above for the 
amplicons of the SSCP analysis except of the additional use of 5 new primers (see Table 
3.2) for the transporters cladding with the T. congolense nucleoside transporters (Figure 
3.1). For the sequencing of the targeting genes, the PCR products were cloned using the 
Topo-cloning® kit (Invitrogen, Carlsbad, CA, USA), exactly as described by the 
manufacturer. The recombinant plasmids containing the desired inserts were purified 
and then sequenced (one clone per isolate for each PCR) using the Model 377-XL 
Sequencer (PE-Applied Biosystems, Eurogentec®, Belgium). Afterwards, the obtained 
fragments were aligned using ClustalX 2.0.12 software in order to detect any conserved 
polymorphism between sensitive and resistant strains. 
3.3. Results and discussion 
3.3.1. Species diagnosis 
All the five samples analyzed in 18S-PCR-RFLP using restriction enzyme MspI were 
confirmed as T. vivax (see Figure 3.2). 
 
 
Figure 3.2: PCR-RFLP-MspI profile of T. vivax infections 
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3.3.2. Determination of polymorphism related to diminazene aceturate resistance 
in T. vivax 
When considering both techniques (SSCP and sequencing), the results showed the 
conserved character of the explored genes and did not reveal any polymorphism related 
to DA resistance. Some polymorphism was observed but was not linked to the 
sensitivity/resistance phenotypes. When considering for example the nucleoside 
transporter TvY486_1112030, the results of SSCP performed on the first amplicon using 
sensitive and resistant T. vivax strains (Table 3.1) are shown in the figure 3.3 below. 
 
               
Gel A (BamHI)     Gel B (RsaI) 
 
Figure 3.3: SSCP analysis performed on the first amplicon of TvY486_1112030 using 5  
T. vivax samples with BamHI and RsaI as restriction enzymes. 
R for resistant samples (R1: H65, R2: H89); S (S1: H988, S2: H1008) for sensitive samples and RS 
for the reference sensitive sample. 
 
As can be observed in the above figure 3.3, sensitive and resistant strains have the same 
SSCP profile for the two restriction enzymes used. Concerning the sequence analysis of 
this amplicon, the obtained results after alignment with Clustal X 2.0.12 are shown 
hereafter. No conserved polymorphism was observed between sensitive and resistance 
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>TvY486_1112030F1  CCACCGGCTCTATATATTCCTTATAC 
>TvY486_1112030R1  GCGATGGAAAAATATATGTATGACTG 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           CCACCGGCTCTATATATTCCTTATACAGCTACTCCACAGAATTTTACAAAATGGCTCAGG 
H89_resistant           CCACCGGCTCTATATATTCCTTATACAGCTACTCCACAGAATTTTACAAAATGGCTCAGG 
H988_sensitive          CCACCGGCTCTATATATTCCTTATACAGCTACTCCACAGAATTTTACAAAATGGCTCAGG 
H1008_sensitive         CCACCGGCTCTATATATTCCTTATACAGCTACTCCACAGAATTTTACAAAATGGCTCAGG 
ILRAD700_sensitive      CCACCGGCTCTATATATTCCTTATACAGCTACTCCACAGAATTTTACAAAATGGCTCAGG 
                        ************************************************************ 
 
H65_resistant           GCGACCCGAATGCCACAACCAGCGACCCTGACTTCTGGAAGAATATCTACACGTATTACA 
H89_resistant           GCGACCCGAATGCCACAACCAGCGACCCTGACTTCTGGAAGAATATCTACACGTATTATA 
H988_sensitive          GCGACCCGAATGCCACAACCAGCGACCCTGACTTCTGGAAGAATATCTACACGTATTATA 
H1008_sensitive         GCGACCCGAATGCCACAACCAGCGACCCTGACTTCTGGAAGAATATCTACACGTATTATA 
ILRAD700_sensitive      GCGACCCGAATGCCACAACCAGCGACCCTGACTTCTGGAAGAATATCTACACGTATTATA 
                        ********************************************************** * 
 
H65_resistant           ACGTGGTTATCTTTTCAACAGAAATCGTTTTTGAATTGTTCATGCTGACGTCGCTTGGCA 
H89_resistant           ACGTGGTTATCTTTTCAACAGAAATCGTTTTTGAATTGTTCATGCTGACGTCGCTTGGCA 
H988_sensitive          ACGTGGTTATCTTTTCAACAGAAATCGTTTTTGAATTGTTCATGCTGACGTCGCTTGGCA 
H1008_sensitive         ACGTGGTTATCTTTTCAACAGAAATCGTTTTTGAATTGTTCATGCTGACGTCGCTTGGCA 
ILRAD700_sensitive      ACGTGGTTATCTTTTCAACAGAAATCGTTTTTGAATTGTTCATGCTGACGTCGCTTGGCA 
                        ************************************************************ 
 
H65_resistant           GAAGGATCCCATTGCGACTGAGGTTGGCGCTAGGCTTCTTCCTTTCGCTTGCACAACTCC 
H89_resistant           GAAGGATCCCATTGCGACTGAGGTTGGCGCTAGGCTTCTTCCTTTCGCTTGCACAACTCC 
H988_sensitive          GAAGGATCCCATTGCGACTGAGGTTGGCGCTAGGCTTCTTCCTTTCGCTTGCACAACTCC 
H1008_sensitive         GAAGGATCCCATTGCGACTGAGGTTGGCGCTAGGCTTCTTCCTTTCGCTTGCACAACTCC 
ILRAD700_sensitive      GAAGGATCCCATTGCGACTGAGGTTGGCGCTAGGCTTCTTCCTTTCGCTTGCACAACTCC 
                        ************************************************************ 
 
H65_resistant           TTTCGTACATGATGGTCACCACATTCCATACAAGCGAATCCGGCGCAAAGTGTATATTTT 
H89_resistant           TTTCGTGCATGATGGTCACCACATTCCATACAAGCGAATCCGGCGCAAAGTGTATATTTT 
H988_sensitive          TTTCGTACATGATGGTCACCACATTCCATACAAGCGAATCCGGCGCAAAGTGTATATTTT 
H1008_sensitive         TTTCGTACATGATGGTCACCACATTCCATACAAGCGAATCCGGCGCAAAGTGTATATTTT 
ILRAD700_sensitive      TTTCGTACATGATGGTCACCACATTCCATACAAGCGAATCCGGCGCAAAGTGTATATTTT 
                        ****** ***************************************************** 
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H65_resistant           TGCTTTTTGGCGTTGTCAATGGCGTGGCAAAGACTTTCTGTGCGTCCAGCACTGTGGCAC 
H89_resistant           TGCTTTTTGGCGTTGTCAATGGCGTGGCAGAGACTTTCTGTGCGTCCAGCACTGTGGCAC 
H988_sensitive          TGCTTTTTGGCGTTGTCAATGGCGTGGCAAAGACTTTCTGTGCGTCCAGCACTGTGGCAC 
H1008_sensitive         TGCTTTTTGGCGTTGTCAATGGCGTGGCAAAGACTTTCTGTGCGTCCAGCACTGTGGCAC 
ILRAD700_sensitive      TGCTTTTTGGCGTTGTCAATGGCGTGGCAAAGACTTTCTGTGCGTCCAGCACTGTGGCAC 
                        ***************************** ****************************** 
 
H65_resistant           TTGCAGGTCCATTTCCTACAAAAATTTTTAGTGCGTATGTCCTTGGAATCCCATTTGCTG 
H89_resistant           TTGCAGGTCCATTTCCTACAAAAATTTTTAGTGCGTATGTCCTTGGAATCCCATTTGCTG 
H988_sensitive          TTGCAGGTCCATTTCCTACAAAAATTTTTAGTGCGTATGTCCTTGGAATCCCATTTGCTG 
H1008_sensitive         TTGCAGGTCCATTTCCTACAAAAATTTTTAGTGCGTATGTCCTTGGAATCCCATTTGCTG 
ILRAD700_sensitive      TTGCAGGTCCATTTCCTACAAAAATTTTTAGTGCGTATGTCCTTGGAATCCCATTTGCTG 
                        ************************************************************ 
 
H65_resistant           GAGTAATCGCTGGCGTGCTATCGGTAACAATCAAGGCGTCGATGAATGGTGACTTTCACG 
H89_resistant           GAGTAATCGCTGGCGTGCTATCGGTAACAATCAAGGCGTCGATGAATGGTGACTTTCACG 
H988_sensitive          GAGTAATCGCTGGCGTGCTATCGGTAACAATCAAGGCGTCGATGAATGGTGACTTTCACG 
H1008_sensitive         GAGTAATCGCTGGCGTGCTATCGGTAACAATCAAGGCGTCGATGAATGGTGACTTTCACG 
ILRAD700_sensitive      GAGTAATCGCTGGCGTGCTATCGGTAACAATCAAGGCGTCGATGAATGGTGACTTTCACG 
                        ************************************************************ 
 
H65_resistant           GCTTGCTCCATCAGTCATACATATATTTTTCCATCGC 
H89_resistant           GCTTGCTCCATCAGTCATACATATATTTTTCCATCGC 
H988_sensitive          GCTTGCTCCATCAGTCATACATATATTTTTCCATCGC 
H1008_sensitive         GCTTGCTCCATCAGTCATACATATATTTTTCCATCGC 
ILRAD700_sensitive      GCTTGCTCCATCAGTCATACATATATTTTTCCATCGC 
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A similar result was observed with the second amplicon of TvY486_1112030 in SSCP 
analysis as is shown in Fig. 3.4. 
 
     
Gel C (DpnII)       Gel D (RsaI) 
Figure 3.4: SSCP analysis performed on the second amplicon of TvY486_1112030 using  
5 T. vivax samples with DpnII and RsaI as restriction enzymes. 




For the sequencing results of the second amplicon of TvY486_1112030, some 
polymorphism was observed, but this was not linked to the sensitivity / resistance 
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>TvY486_1112030F2  TCCATCAGTCATACATATATTTTTCCA 
>TvY486_1112030R2  CATTACCTTCTATTATACGACGTTGG  
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           TCCATCAGTCATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCC 
H89_resistant           TCCATCAGTCATACATATATTTTTCCATCGCTATGGTTTTTCACTCGGTGACCTGCGTCC 
H988_sensitive          TCCATCAGTCATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCC 
H1008_sensitive         TCCATCAGTCATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCC 
ILRAD700_sensitive      TCCATCAGTCATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCC 
                        ******************************************* **************** 
 
H65_resistant           TTTTGTATTTGCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTTGGTACG 
H89_resistant           TTTTGTATTTGCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAGTTTAGGTACG 
H988_sensitive          TTTTGTATTTGCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACG 
H1008_sensitive         TTTTGTATTTGCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACG 
ILRAD700_sensitive      TTTTGTATTTGCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACG 
                        ************************************************* *** ****** 
 
H65_resistant           CGGCGAGGGGTAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTG 
H89_resistant           CGGCGAGGGGTAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTG 
H988_sensitive          CGGCGAGGGGTAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTG 
H1008_sensitive         CGGCGAGGGGTAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTG 
ILRAD700_sensitive      CGGCGAGGGGTAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTG 
                        ************************************************************ 
 
H65_resistant           CACCTGATTCGCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGT 
H89_resistant           CACCTGATTCGCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGT 
H988_sensitive          CACCTGATTCGCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGT 
H1008_sensitive         CACCTGATTCGCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGT 
ILRAD700_sensitive      CACCTGATTCGCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGT 
                        ************************************************************ 
 
H65_resistant           ACAACACTGCAAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTG 
H89_resistant           ACAACACTGCAAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTG 
H988_sensitive          ACAACACTGCAAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTG 
H1008_sensitive         ACAACACTGCAAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTG 
ILRAD700_sensitive      ACAACACTGCAAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTG 
                        ************************************************************ 
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H65_resistant           ACCAGGTGGAGAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCA 
H89_resistant           ACCAGGTGGAGAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCA 
H988_sensitive          ACCAGGTGGAGAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCA 
H1008_sensitive         ACCAGGTGGAGAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCA 
ILRAD700_sensitive      ACCAGGTGGAGAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCA 
                        ************************************************************ 
 
H65_resistant           TCAAGCGCATATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGT 
H89_resistant           TCAAGCGCATATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGT 
H988_sensitive          TCAAGCGCATATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGT 
H1008_sensitive         TCAAGCGCATATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGT 
ILRAD700_sensitive      TCAAGCGCATATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGT 
                        ************************************************************ 
 
H65_resistant           TTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTGGAATCACTGGTACGGCACTG 
H89_resistant           TTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTGGAATCACTGGTACGGCACTG 
H988_sensitive          TTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTGGAATCACTGGTACGGCACTG 
H1008_sensitive         TTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTGGAATCACTGGTACGGCACTG 
ILRAD700_sensitive      TTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTGGAATCACTGGTACGGCACTG 
                        ************************************************************ 
 
H65_resistant           CGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTGTATGTTTCTTCAGTTCAAGA 
H89_resistant           CGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTGTATGTTTCTTCAGTTCAAGA 
H988_sensitive          CGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTGTATGTTTCTTCAGTTCAAGA 
H1008_sensitive         CGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTGTATGTTTCTTCAGTTCAAGA 
ILRAD700_sensitive      CGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTGTATGTTTCTTCAGTTCAAGA 
                        ************************************************************ 
 
H65_resistant           GAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATTCGCTCGCCTACTGATTGCAG 
H89_resistant           GAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATTCGCTCGCCTACTGATTGCAG 
H988_sensitive          GAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATTCGCTCGCCTACTGATTGCAG 
H1008_sensitive         GAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATTCGCTCGCCTACTGATTGCAG 
ILRAD700_sensitive      GAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATTCGCTCGCCTACTGATTGCAG 
                        ************************************************************ 
 
H65_resistant           TACCGCTTTTCCTTTGCCAACGTCGTATAATAGAAGGTAATG 
H89_resistant           TACCGCTTTTCCTTTGCCAACGTCGTATAATAGAAGGTAATG 
H988_sensitive          TACCGCTTTTCCTTTGCCAACGTCGTATAATAGAAGGTAATG 
H1008_sensitive         TACCGCTTTTCCTTTGCCAACGTCGTATAATAGAAGGTAATG 
ILRAD700_sensitive      TACCGCTTTTCCTTTGCCAACGTCGTATAATAGAAGGTAATG 
                        ****************************************** 
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Concerning the third amplicon of TvY486_1112030, resistant and sensitive T. vivax 
strains present the same SSCP profile as is observed in the Figure 3.5. 
 
 
    
Gel E (AlI)       Gel F (MboII) 
 
Figure 3.5: SSCP analysis performed on the third amplicon of TvY486_1112030 using  
5 T. vivax samples with AlI and MboII as restriction enzymes 






For the sequencing of the third amplicon of TvY486_1112030, some polymorphism was 
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>TvY486_1112030F3  CGTCTACTTCTCAACATTTGTGTTTT 
>TvY486_1112030R3  TCACGAATTGATGAATAACTTCTTTC 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           CGTCTACTTCTCAACATTTGTGTTTTTCCCTGGAGTTTTTACCTCGGTGGATTACAAGGG 
H89_resistant           CGTCTACTTCTCAACATTTGTGTTTTTCCCTGGAGTTTTTACCTCGGTGGATTACAAGGG 
H988_sensitive          CGTCTACTTCTCAACATTTGTGTTTTTCCCTGGAGTTTTTACCTCGGTGGATTACAAGGG 
H1008_sensitive         CGTCTACTTCTCAACATTTGTGTTTTTCCCTGGAGTTTTTACCTCGGTGGATTACAAGGG 
ILRAD700_sensitive      CGTCTACTTCTCAACATTTGTGTTTTTCCCTGGAGTTTTTACCTCGGTGGATTACAAGGG 
                        ************************************************************ 
 
H65_resistant           TTGGAATCACTGGTACGGCACTATTGTAATAGTTCTGTTCAATTTCGGGGATTTTTTTTC 
H89_resistant           TTGGAATCACTGGTACGGCACTATTGTAATAGTTCTGTTCAATTTCGGGGATTTTTTTTC 
H988_sensitive          TTGGAATCACTGGTACGGCACTATTGTAATAGTTCTGTTCAATTTCGGGGATTTTTTTTC 
H1008_sensitive         TTGGAATCACTGGTACGGCACTATTGTAATAGTTCTGTTCAATTTCGGGGATTTTTTTTC 
ILRAD700_sensitive      TTGGAATCACTGGTACGGCACTATTGTAATAGTTCTGTTCAATTTCGGGGATTTTTTTTC 
                        ************************************************************ 
 
H65_resistant           GGGTGTTCTGCTTCAATTCAAAAAGTTTCACCTATCACCGAAGGCAGCGATCATAGGGTC 
H89_resistant           GGGTGTTCTGCTTCAATTCAAAAAGTTTCACCTATCACCGAAGGCAGTGATCATAGGGTC 
H988_sensitive          GGGTGTTCTGCTTCAATTCAAAAAGTTTCACCTATCACCGAAGGCAGTGATCATAGGGTC 
H1008_sensitive         GGGTGTTCTGCTTCAATTCAAAAAGTTTCACCTATCACCGAAGGCAGTGATCATAGGGTC 
ILRAD700_sensitive      GGGTGTTCTGCTTCAATTCAAAAAGTTTCACCTATCACCGAAGGCAGTGATCATAGGGTC 
                        *********************************************** ************ 
 
H65_resistant           GTTTGGCCGTCTACTGATCGCTGTCCCGCTAGTGGTATGCCAACGTCGTATAATAGAAGG 
H89_resistant           GTTTGGCCGTCTACTGATCGCTGTCCCGCTAGTGGTATGCCAACGTCGTATAATAGAAGG 
H988_sensitive          GTTTGGCCGTCTACTGATCGCTGTCCCGCTAGTGGTATGCCAACGTCGTATAATAGAAGG 
H1008_sensitive         GTTTGGCCGTCTACTGATCGCTGTCCCGCTAGTGGTATGCCAACGTCGTATAATAGAAGG 
ILRAD700_sensitive      GTTTGGCCGTCTACTGATCGCTGTCCCGCTAGTGGTATGCCAACGTCGTATAATAGAAGG 
                        ************************************************************ 
 
H65_resistant           TAATGCCGCCAAAGCGTTGTCCTGTGTTCTCTCACTCCTCTGGGGTATCACAAACGGTTT 
H89_resistant           TAATGCCGCCAAAGCGTTGTCCTGTGTTCTCTCACTCCTCTGGGGTATCACAAACGGTTT 
H988_sensitive          TAATGCCGCCAAAGCGTTGTCCTGTGTTCTCTCACTCCTCTGGGGTATCACAAACGGTTT 
H1008_sensitive         TAATGCCGCCAAAGCGTTGTCCTGTGTTCTCTCACTCCTCTGGGGTATCACAAACGGTTT 
ILRAD700_sensitive      TAATGCCGCCAAAGCGTTGTCCTGTGTTCTCTCACTCCTCTGGGGTATCACAAACGGTTT 
                        ************************************************************ 
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H65_resistant           TTGCGGCGGCATGATGCTTATTTACGGATCGAGGACTGCATCATTGACAACGGCAGGCCA 
H89_resistant           TTGCGGCGGCATGATGCTTATTTACGGATCGAGGACTGCATCATTGACAACGGCAGGCCA 
H988_sensitive          TTGCGGCGGCATGATGCTTATTTACGGATCGAGGACTGCATCATTGACAACGGCAGGCCA 
H1008_sensitive         TTGCGGCGGCATGATGCTTATTTACGGATCGAGGACTGCATCATTGACAACGGCAGGCCA 
ILRAD700_sensitive      TTGCGGCGGCATGATGCTTATTTACGGATCGAGGACTGCATCATTGACAACGGCAGGCCA 
                        ************************************************************ 
 
H65_resistant           GCGTCCTCTTGCAGGGATATGCAACAATGTGTCAGTACTGTCGGGTCTTTTTGCAGGTTC 
H89_resistant           GCGTTCTCTTGCAGGGATATGCAACAATGTGTCAGTACTATCGGGTCTTTTTGCAGGTTC 
H988_sensitive          GCGTTCTCTTGCAGGGATATGCAACAATGTGTCAGTACTATCGGGTCTTTTTGCAGGTTC 
H1008_sensitive         GCGTTCTCTTGCAGGGATATGCAACAATGTGTCAGTACTATCGGGTCTTTTTGCAGGTTC 
ILRAD700_sensitive      GCGTTCTCTTGCAGGGATATGCAACAATGTGTCAGTACTATCGGGTCTTTTTGCAGGTTC 
                        **** ********************************** ******************** 
 
H65_resistant           GGCGGCGGCAATAGGACTGAGCAAGTTGCTTTAATGTGAGTGAGTTCAAGGTTTGTGAAG 
H89_resistant           GGCGGCGGCAATAGGACTGAGCAAGTTGCTTTAATGTGAGTGAGTTCAAGGTTTGTGAAG 
H988_sensitive          GGCGGCGGCAATAGGACTGAGCAAGTTGCTTTAATGTGAGTGAGTTCAAGGTTTGTGATG 
H1008_sensitive         GGCGGCGGCAATAGGACTGAGCAAGTTGCTTTAATGTGAGTGAGTTCAAGGTTTGTGAAG 
ILRAD700_sensitive      GGCGGCGGCAATAGGACTGAGCAAGTTGCTTTAATGTGAGTGAGTTCAAGGTTTGTGAAG 
                        ********************************************************** * 
 
H65_resistant           ACTAAACACTTGTTGTTATTATTTTGCCCATGTGATAAAGTGGGTGTTTTGCGGTTGAAC 
H89_resistant           ACTAAACACTTGTTGTTATTATTTTGCCCATGTGATAAAGTGGGTGTTTTGCGGTTGAAC 
H988_sensitive          ACTAAACACTTGTTGTTATTATTTTGCCCATGTGATAAAGTGGGTGTTTTGCGGTTGAAC 
H1008_sensitive         ACTAAACACTTGTTGTTATTATTTTGCCCATGTGATAAAGTGGGTGTTTTGCGGTTGAAC 
ILRAD700_sensitive      ACTAAACACTTGTTGTTATTATTTTGCCCATGTGATAAAGTGGGTGTTTTGCGGTTGAAC 
                        ************************************************************ 
 
H65_resistant           CACTCATGCTTTTGGTGCACAATTACGTAGCAATGCGTGGCTGAAAGAAGTTATTCATCA 
H89_resistant           CACTCATGCTTTTGGTGCACAATTACGTAGCAATGCGTGGCTGAAAGAAGTTATTCATCA 
H988_sensitive          CACTCATGCTTTTGGTGCACAATTACGTAGCAATGCGTGGCTGAAAGAAGTTATTCATCA 
H1008_sensitive         CACTCATGCTTTTGGTGCACAATTACGTAGCAATGCGTGGCTGAAAGAAGTTATTCATCA 
ILRAD700_sensitive      CACTCATGCTTTTGGTGCACAATTACGTAGCAATGCGTGGCTGAAAGAAGTTATTCATCA 
                        ************************************************************ 
 
H65_resistant           ATTCGTGA 
H89_resistant           ATTCGTGA 
H988_sensitive          ATTCGTGA 
H1008_sensitive         ATTCGTGA 
ILRAD700_sensitive      ATTCGTGA 
                        ******** 
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The fact that some polymorphisms were observed in sequencing and not in SSCP could 
be explained by the higher resolution of the former technique. However, as stated 
previously, no conserved polymorphism was observed between sensitive and resistant 
strains. 
The results of the sequencing performed on the other nucleoside transporters of T. vivax 
are shown in the Annex 1 of the thesis.  
 
3.4. Conclusion 
Despite using highly sensitive methods for the screening of T. vivax samples previously 
characterized for their sensitivity/resistance to DA in goats, our results might suggest 
that the observed DA-resistance phenotype in two T. vivax field samples is not linked to 
sequence alterations in the nine T. vivax genes that are predicted to encode for 
nucleoside transporters. Our results are based on a limited set of sequencing data and 
would advantageously be completed by whole genome sequencing on more than 4 
strains. Further work is undoubtedly needed to better understand the mechanism of DA-
resistance in T. vivax. The lack of DNA of high purity did not allow us to use gene walking 
methods for the gene fragment TvY486_1103760, as this could have permitted to 
complete the partial sequence to a complete open reading frame for further cloning and 
analysis. 
After improving the performance of an existing molecular tool for DA-resistance 
diagnosis in T. congolense and prospecting without success so far the development of 
such of tool for T. vivax, it would be interesting to explore the current impact of TDR on 
the health status of trypanosome-infected animals. Indeed, some studies suggest that 
even in the presence of proven drug resistance, the impact of the parasite on the health 
of infected cattle could be very limited when the animal is treated with PCV values 
remaining in a physiological range (Chitanga et al., 2011; Delespaux et al., 2010). This 
will be the topic of the next chapter of this thesis. 
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4.1. Introduction 
The diagnosis of relapses after treatment is mainly done by microscopic examination, 
which seriously underestimates the effective relapsing rate, and more seldom by 
existing molecular tools (Gall et al., 2004). A noticeable difference in sensitivity between 
the two techniques for the detection of relapses after treatment was already described 
in a mice model (Chitanga et al., 2011). Furthermore, it was shown that the ﬂuctuating 
low parasitaemia following the treatment of cattle with ISM after inoculation with ISM-
resistant strains of T. congolense (Delespaux et al., 2010) had also limited impact on the 
PCV of the parasitaemic animals. From those observations, the hypothesis was made 
that latent low parasitaemia infections caused by drug resistant trypanosomes were 
actually compatible with the survival and an acceptable productivity of their host. 
The objectives of this study were thus (i) to evaluate the sensitivity of local T. vivax 
strains to the two main trypanocidal drugs used in the ﬁeld i.e. ISM and DA, and (ii) to 
compare the effects of the treatments on the haematocrit and the body weight in 
animals relapsing after diagnosis by microscopical examination or diagnosis with a 
trypanosome speciﬁc 18S-PCR and in animals completely cleared from parasites. 
4.2. Materials and methods 
4.2.1. Experimental animals 
60 female goats aged between 1 and 3 years, belonging to the Sahelian breed were 
selected from the North-Eastern region of Burkina Faso (Dori), an area free of tsetse flies 
(Bengaly et al., 2001; Courtin et al., 2010). The goats were housed in fly-proof facilities. 
Before the experiment, they were treated with DA at the blanking dose of 7 mg/kg b.w. 
(i.e. the double of the dose recommended by the manufacturer) and dewormed with 
oxfendazole (4.5 mg/kg b.w.). Due to endemic pasteurellosis in the area, the animals 
were vaccinated against this disease and then quarantined for a month. They were fed 
with fresh or dry straw, supplemented with cotton seed and watered ad libitum with tap 
water during the quarantine and the experiment. A trypanosome specific 18S-PCR-RFLP 
(Delespaux et al., 2003; Geysen et al., 2003) was performed on buffy coats sampled from 
each goat to verify the absence of trypanosomes at the moment of inoculation. 
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4.2.2. Trypanosome isolates 
Twelve isolates were sampled in 6 villages located in the vicinity of Bobo Dioulasso, 
Burkina Faso (see GIS coordinates in Table 4.1). Species diagnosis was performed using 
a trypanosome specific 18S-PCR-RFLP (Delespaux et al., 2003; Geysen et al., 2003). 
Trypanosome-infected blood samples were cryopreserved in a 5% final concentration of 
DMSO and stored in liquid nitrogen until characterization. Details on those strains are 
provided in table 4.2. 
 
Table 4.1: GIS coordinates of the sampling sites 
 
Village    X coordinate     Y coordinate 
Dafinso   −4.22493     11.28616 
Débé    −4.47417     12.03837 
Dèrè    −4.28566     11.15875 
Kadomba   −4.00108     11.50257 





Table 4.2: T. vivax isolates used in the in vivo goat sensitivity test 
 
Group  Codea     Host    Village 
1  KAD 41 Tv/F, 10/11/10  Bovin    Kadomba 
2  D 39 Tv/F, 13/11/10   Bovin    Dafinso 
3  D 42 Tv/F, 13/11/10   Bovin    Dafinso 
4  K 56 Tv/F, 12/11/10   Bovin    Koumbia 
5  K 30 Tv/F, 8/11/10   Bovin    Koumbia 
6  K 4 Tv/F, 8/11/10   Bovin    Koumbia 
7  D 32 Tv/F, 13/11/10   Bovin    Dafinso 
8  K 28 Tv/F, 8/11/10   Bovin    Koumbia 
9  DE 35 Tv/Ch.T3, 02/11/09  Caprin    Dèrè 
10  DEB 53 Tv/F, 09/04/09  Bovin    Débé 
11  KA 1 Tv/F, 08/04/09   Bovin    Kangotenga 
12  DE 57 Tv/F, 03/04/09  Bovin    Dèrè 
a All strains collected for the Centre International de Recherche-Développement sur l’Elevage en 
zone Subhumide (CIRDES) 
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4.2.3. Experimental infection 
Each of the twelve T. vivax cryostabilates was thawed at 37°C and reactivated through a 
passage in a goat. Parasitaemia was monitored by microscopical examination of the 
buffy coat as described by Murray et al. (1977). At the first peak of the parasitaemia, 
blood was collected and diluted with PBS/Glucose (5%) to a final concentration of 10 5 
trypanosomes / ml. 
For each isolate, five goats were ear-tagged and inoculated intravenously with 105 
reactivated trypanosomes. At the first observation of parasites in the blood of one of the 
five animals of a group, two were treated with 3.5 mg/kg b.w. DA, two with 0.5 mg/kg 
b.w. ISM and one left untreated as control. A dose of 7 mg/kg  b.w. DA, i.e. the double of 
the dose recommended by the manufacturer to clear T. vivax infection in domestic 
animals was used for goats showing a life-threatening PCV (below 15%) during the 
observation period. For these animals, observations were stopped at that moment.  
4.2.4. Monitoring 
After inoculation, the goats were parasitologically monitored every 5 days by sampling 
blood from the jugular vein with heparinized Vacutainer® tubes (BD Medical). From 
those tubes, blood was collected into glass capillary tubes without anti-clotting agent 
and stopped at an extremity with Cristaseal® (Hawxley). After centrifugation at 9000 
rpm for 5 min, the values of the hematocrit were recorded. Buffy coats were examined 
using a microscope (x400) for the detection of trypanosomes. A slide was considered as 
negative if no trypanosome was observed in 50 fields. For each animal, one buffy coat 
was placed on a filter paper (Whatman N°4, Whatman®), dried protected from UV light, 
stored in individual envelopes that were placed in plastic bags containing silica gels and 
conserved at -20°C for subsequent molecular analysis with the trypanosome specific 
18S-PCR-RFLP (Delespaux et al., 2003; Geysen et al., 2003). The RFLP step necessary for 
the trypanosome species determination was conserved, even if the species that was 
inoculated was known, to confirm the specificity of the PCR reaction. The DNA stored on 
the filter papers was extracted using the routine PBS-Saponin technique (de Almeida et 
al., 1997). The parasitaemia, the haematocrit and the body weight of the goats wer e 
controlled every 5 days after treatment with the trypanocides for a period of 100 days. 
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4.2.5. Statistical analysis 
PCV data were analyzed using cross-sectional time-series linear regressions in Stata 10, 
separately for DA and ISM treatments. Categorical explanatory variables were the goat 
status (no relapse, relapse at microscopy or relapse at PCR), the period of observation 
(<15, 15-44 or ≥45 days post-infection) and the interactions between the two. Individual 
goats were considered as random effects. Finally, relative PCV differences between 
periods (using period 1 as denominator) were calculated using the non-linear 
combination of estimators (delta method). The difference of relative differences was 
calculated using the following equations: 
 
Where DRD is the difference of relative differences; PCV the packed cell volume; W the 
weight; NR the non-relapsing goats; R the relapsing goats; 1 the Period 1 or day 1 and x 
is the period 2 or 3 or day 2, 3, or 4. Furthermore, weight data were analyzed in similar 
models, except that explanatory variables were the goat’s status, time of observation 
(days 0, 30, 60 and 90 post-infection) and the interaction between the two. 
4.3. Results 
4.3.1. Health condition 
Control and treated goats presenting severe clinical signs or a PCV below 15 were 
treated with DA 7 mg/kg b.w. which caused in all cases an increase of the PCV back to 
physiological values or at least values higher than 20%. Nine goats from 6 ISM groups (1, 
2, 5, 9, 10 and 11) and the 2 goats from DA group 2 had to be treated with a high dose of 
DA to rescue them from certain death. This corresponds to all relapses diagnosed by 
microscopic examination (see Table 4.3). 
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4.3.2. Sensitivity tests of the T. vivax strains 
Among the 12 groups of four goats (control not included) that were screened by 
microscopical examination, six were completely cured after treatment, 5 showed 
relapses in at least one goat treated with ISM and 1 showed relapses in all treated goats. 
The data are summarized in table 4.3. 
 
 
Table 4.3: Results of the microscopic examination of the 60 goats  
 
  DA1  DA2  ISM1  ISM2   C 
Group 1 -    +  -   + 
Group 2 +  +  +  +   + 
Group 3 -  -  -  -   + 
Group 4 -  -  -  -   + 
Group 5 -  -  +  -   + 
Group 6 -  -  -  -   + 
Group 7 -  -  -  -   + 
Group 8 -  -  -  -   + 
Group 9 -  -  -  +   + 
Group 10 -  -  +  +   + 
Group 11 -  -  +  +   + 
Group 12 -  -  -  -   + 
With + as animal found microscopically positive during the examination period, DAx goat 
treated with DA, ISMx goat treated with ISM and C as control. 
 
 
For the 6 groups that were randomly selected and additionally screened with the 
trypanosome specific 18S-PCR-RFLP, the following results were observed: for the 
groups treated with DA no relapses by microscopic examination, and 83.3% (10/12) 
using the 18S-PCR-RFLP. For the groups treated with ISM, 25% (3/12) relapses by 
microscopic examination and 83.3% (10/12) with the 18S-PCR. The data are 
summarized in table 4.4. 
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Table 4.4: Comparison of the results of the microscopic examination and the 18S-PCR for goats 
 
  Microscope      PCR 
 
  DA1 DA2 ISM1 ISM2    DA1 DA2 ISM1 ISM2 
Group 1 N N 6x N    3x 3x 6x 4x 
Group 3 N N N N    4x N 3x N 
Group 4 N N N N    2x 3x 1x N 
Group 5 N N N 8x    3x 3x 3x 8x 
Group 6 N N N N    3x 5x 3x 3x 
Group 9 N N N 8x    2x N 1x 8x 
Total relapses 0/6 0/6 1/6 2/6    6/6 4/6 6/6 4/6 
With N as negative, XX as number of times that an animal was observed positive during the 100  
days observation period (every 5 days), DAx goat treated with DA and ISMx goat treated with 
ISM. 
 
4.3.3. PCV and weight evolution of DA relapsing goats compared to DA non-
relapsing goats 
The relative average PCV in goats that relapsed microscopically, decreased significantly 
more than in non-relapsing goats. The difference between the relative average PCV 
reduction between period 1 (day 0–14) and period 2 (day 15–44) in relapsing and non-
relapsing goats was estimated at 24.9% (95% CI 17.9-31.9%). This difference was not 
significant when relapses were detected using the trypanosome specific 18S-PCR-RFLP 
and this when comparing period 1 to period 2 or period 1 to period 3 (≥45 days). No 
difference was observed in the weight evolution between relapsing or non-relapsing 
goats and this for all comparisons in time i.e. time 1 versus 2, 1 versus 3 and 1 versus 4. 
The results for the weight evolution are summarized in table 4.5. 
4.3.4. PCV and weight evolution of ISM relapsing goats compared to ISM non-
relapsing goats 
The relative average PCV in goats that relapsed microscopically, decreased significantly 
more than in non-relapsing goats. The difference between the relative average PCV 
reduction period 1 and period 2 in relapsing and non-relapsing goats was estimated at 
10.1% (95% CI 4.8-15.4%). This difference was also significant when relapses were 
detected using the trypanosome specific 18S-PCR-RFLP (difference of average PCV 
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reduction between period 1 and period 2 in relapsing and non-relapsing goats: 8.4-95% 
CI 14.4-2.4% and difference of average PCV reduction between period 1 and period 3: 
12.5-95% CI 7.2-17.7%). The goats that relapsed microscopically presented significantly 
higher relative weight losses for all the three recording times compared to day 0. 
Relapses goats at 18S-PCR-RFLP did not present significantly higher relative weight loss 
than non-relapsing goats and this for the three recording times. The results are 
summarized in table 4.6 below. 
 
 
Table 4.5: Weight evolutions of relapsing goats compared to non-relapsing after treatment with 
DA with probabilities and 95% confidence intervals  
 
Comparison Observed reduction  Probability  95% low 95% up  
Micro 1-2 3.73%    0.44   -5.70%  13.16% 
Micro 1-3 -6.05%    0.21   -15.51% 3.40% 
Micro 1-4 -7.58%    0.12   -17.08% 1.91% 
PCR 1-2 2.27%    0.46   -3.80%  8.33% 
PCR 1-3 1.97%    0.53   -4.11%  8.05% 
PCR 1-4 0.75%    0.81   -5.33%  6.83% 
Difference of the relative weight reduction (using weight at time 1 as denominator) in relapsing 
and non-relapsing goats. With Micro x-x as the comparison of the relative weight loss of animals 
relapsing microscopically between period x and x; PCR x-x as comparison of the relative weight 




Table 4.6: Weight evolutions of relapsing goats compared to non-relapsing after treatment with 
ISM with probabilities and 95% confidence intervals  
 
Comparison Observed reduction  Probability  95% low  95% up  
Micro 1-2 -9.38%    0.01   -16.35% -2.40% 
Micro 1-3 -14.96%   0.00   -22.00% -7.92% 
Micro 1-4 -17.14%   0.00   -24.22% -10.06% 
PCR 1-2 -2.43%    0.53   -10.03%     5.17% 
PCR 1-3 -2.98%    0.45   -10.67%     4.70% 
PCR 1-4 -2.60%    0.51   -10.37%     5.17% 
Difference of the relative weight reduction (using weight at time 1 as denominator) in relapsing 
and non-relapsing goats. With Micro x-x as the comparison of the relative weight loss of animals 
relapsing microscopically between period x and x; PCR x-x as comparison of the relative weight 
loss of animals relapsing when examined by PCR between period x and x.  
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4.4. Discussion 
Animal health and production in zones that are endemic for trypanosomosis ha ve 
always be challenging from an economic perspective. Decreasing the impact of the 
disease on the health status of their animals is often the only possible strategy for 
farmers with scarce financial resources. Some farmers act strategically by preferring 
trypanotolerant animals in net-protected units (Bauer et al., 2006). Yet, in most cases, 
farmers rely on trypanocidal drugs that are administered with different levels of know-
how (Grace et al., 2009) but also often without any parasitological diagnosis or even 
clinical examination (Van den Bossche et al., 2000). The sole trypanocides available for 
animal use have been marketed for more than half a century. Considering the nearly 
blind and routine administration of those products, it is not astonishing that drug 
resistance prevails in many regions of Africa (Delespaux et al., 2008). Even if 
constructive initiatives were implemented for promoting a rational use of trypanocides 
(Liebenehm et al., 2011), the prevailing situation is described by many authors as very 
alarming (Chaka and Abebe, 2003; Mamoudou et al., 2008). However, an experimental 
study in a mice model where ISM-resistant trypanosomes were inoculated into ISM-
treated and untreated animals suggests that even when TDR is evident, it might be 
relevant to threat the infected animals (Delespaux et al., 2010).  
From this study on the sensitivity of different T. vivax isolates to the two main 
trypanocidal drugs used in the field i.e. ISM and DA, we can conclude that drug 
resistance for these parasites is present but still manageable in the region around Bobo 
Dioulasso as only 1/12 isolate was found resistant to both drugs and 5/12 resistant to 
ISM only allowing in most instances the use of the sanative pair. The multi-resistant 
isolate albeit highly virulent was cleared microscopically with 7mg/kg b.w. of DA, i.e. the 
double of the dose recommended by the manufacturer to clear T. vivax infection in 
domestic animals. The presence of drug resistance in T. vivax in Burkina Faso being 
confirmed, the second aim of this study was to evaluate the effects of the treatment in 
animals inoculated and treated at the first observation of parasites and to compare the 
evolution of the weight and PCV in (i) microscopically relapsing animals, (ii) animals 
relapsing when diagnosed by the trypanosome specific 18S-PCR-RFLP and finally (iii) 
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animals completely cured and this in controlled conditions but the closest possible to 
field conditions. 
As reasonably expected, the relative PCV reductions were significantly higher in animals 
relapsing microscopically i.e. in animals showing the highest parasitaemia. F or the 
relapsing animals diagnosed using the trypanosome specific 18S-PCR-RFLP i.e. animals 
with the lowest parasitaemia, the fact that the relative PCV reductions were only 
significant after treatment with ISM, suggests a higher degree of ISM-resistance 
compared to DA. A lower level of resistance against DA would allow the host immunity 
together with the temporary toxic effect of the drug to keep the parasite under control. 
This might not be the case with ISM for which higher degree of resistance would not 
allow animals to control the parasite as efficiently as with DA in spite of the fact that the 
elimination of ISM from the host is far slower (approximately 2 months compared to two 
weeks for DA). Yet, the absence of significant effect in DA treated animals could be 
attributed to the low number of relapses with DA. Interestingly, the animals showing a 
relapse with a high parasitaemia (microscopic diagnosis) presented the highest relative 
PCV reductions (24.9% and 10.1% after treatment with DA and ISM respectively). It can 
be reasonably assumed that, as it was observed in T. congolense (Masumu et al., 2006), 
the virulence of different strains of T. vivax might vary and, among the drug resistant 
parasites, the most virulent only will cause visible deleterious effects on the health of the 
relapsing animals. Furthermore, self-cure appears to be relatively common in T. vivax 
infections (Gardiner, 1989) and it was observed that animals that recovered 
spontaneously from an acute infection developed chronic and asymptomatic infections 
(Batista et al., 2009). The treatment with trypanocide combined with the immune 
system of the host could increase this recovery rate by allowing a better control of the 
parasite and resulting in very low oscillating parasitaemia with no or little impact on the 
host’s health. Furthermore, as hypothesized above for PCV, the significantly higher 
weight losses in ISM relapsing animals (diagnosed using microscopy i.e. with the highest 
parasitaemia) might be explained by a higher resistance against this particular drug 
compared to DA. 
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4.5. Conclusion 
This study showed that TDR might probably have limited impact on the PCV and body 
weight losses of experimental goats infected with T. vivax, except for a few highly 
virulent strains. However, this still needs to be confirmed in cattle under natural tsetse 
and Trypanosoma challenge. Nevertheless, it would be crucial to find an alternative in 
order to contain or reverse the TDR phenomenon in West Africa. 
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5.1. Introduction 
Considering the wide distribution of TDR previously mentioned, strategic alternatives 
are urgently needed to circumvent this plague. Reversal of drug resistance or 
chemosensitization was successfully achieved, among others, in yeast (Knorre et al., 
2009), Plasmodium (Bhattacharjee et al., 2001; Masseno et al., 2009), cancer cells (Tao et 
al., 2009) and Leishmania (Wong et al., 2009). Such strategies could bring a much 
needed relief to African livestock breeders if they could be implemented at a reasonable 
price by shortcutting the development of new compounds, toxicity studies and long 
clinical trials. Many bacterial secondary multidrug resistance transporters belonging to 
the two major families, i.e. the Major Facilitator Superfamily (MFS) and the Multi 
Antimicrobial Extrusion Family (MatE) are described as having affinity for ethidium 
bromide (Homidium) as well as for many different compounds such as plant alkaloids, 
noxious metabolic products (such as fatty acids or bile salts), organic solvents and 
diverse antibiotics (Mazurkiewicz et al., 2005). At least eight representatives of those 
transporter families are present in the genome of T. congolense. Homidium is part of the 
ISM molecule, the structural relatedness of both molecules being thus obvious (Figure 
5.1). Furthermore, in the field, cross-resistance is observed between ethidium bromide 
and ISM (Olila et al., 2002) suggesting that uptake and extrusion of the drug within and 
from the trypanosome are mediated by the same mechanisms for both compounds. 
In a preliminary experiment, a number of antibiotics were selected and screened in a 
mouse model consisting of the inoculation of ISM-resistant trypanosomes into ISM-
treated and untreated animals (Table 5.1) (Delespaux et al., 2010). The working 
hypothesis was that chemical compounds could interfere (compete) with the extrusion 
of ISM from the drug resistant trypanosome allowing a prolonged trypanocidal action. 
The criterion for inclusion in this study was the affinity of the medications for bacterial 
efflux systems as described for ß-lactams (Li et al., 1994; Pages et al., 2009), tetracycline 
(TC), oxytetracycline (OTC) (Roberts, 2005), nalidixic acid (quinolone) (Bailey et al., 
2008) and the fluoroquinolone enrofloxacine (FQE) (Usui et al., 2009). After this 
preliminary screening, TC was chosen as the easiest and cheapest commercial 
preparation for oral administration to mice by dilution in drinking water. Despite the 
unusual high degree of resistance of the T. congolense strain used in this study, the 
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survival times were significantly higher after treatment with the association of ISM and 
TC. When considering the efficacy of the compounds against the trypanosomes, the 
complete ineffectiveness of TC alone and the increased efficacy of ISM in the presence of 
TC, provides strong arguments in favor of the hypothesis that the two compounds 
compete for the same efflux system.  
The objective of the work presented in this chapter was to study the effect of some 
antibiotics on the efficacy of ISM in cattle infected with ISM-resistant T. congolense 
resistant infected animals. From the preliminary experiment in mice, OTC was selected 
for the experiment in cattle as it is available as an injectable long acting form allowing 
for a reduction of the number of injections. Enrofloxacin was not pre-tested in 
combination with ISM in mice but immediately used in cattle. 
 
Table 5.1: Initial screening of antibiotics in a mouse model (T. congolense strain IL3343) 
 
Treatment    Cured   Median PP  95%  
        (days)   confidence 
           intervals 
Untreated control   0/6   5,41   4,10-7,16 
Penicilline G (100mg/kg)  0/6   5,79   4,38-7,77 
Nalidixic acid (175mg/kg)  0/6   6,29   4,76-8,32 
Tetracycline (125mg/kg)  0/6   6,80   5,14-8,99 
Oxytetracycline (125mg/kg)  0/6   5,06   3,83-6,69 
Enrofloxacine (40mg/kg)  0/6   5,22   3,95-6,90 
ISM (1mg/kg)    0/6   16,29   12,32-21,53 
ISM/Penicilline G (*)   0/6   12,27   9,28-16,22 
ISM/Nalidixic acid   0/6   16,73   12,66-22,13 
ISM/Tetracycline   4/6   51,96   38,01-71,05 
ISM/Oxytetracycline   3/6   39,1   29,16-52,43 
ISM/Enrofloxacine   N.T.   -   - 
(*) ISM at 1mg/kg combined to the antibiotic at the dose under used alone; N.T.: Not Tested 
 




Figure 5.1: Structural relatedness between ISM and ethidium salts  
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5.2. Materials and methods 
5.2.1. Trypanosome strains 
The cloned T. congolense savannah type strain IL3343 used to infect cattle was identified 
as resistant to ISM when tested in mice (CD50 = 1.7 mg/kg) (Peregrine et al., 1997). The 
CD50 is defined as the curative dose that gives complete cure in 50% of the animals .  
5.2.2. Cattle inoculation and treatment 
Three groups of 6 adult crossbred zebus weighing on average 158 kg each (extremes 
140 and 201kg) were inoculated with 5 x 105 trypanosomes (cloned isolate IL3343) 
each by intra-jugular injection 30 days after treatment with DA (7mg/kg) to clear all 
trypanosomal infections and deworming. One non-treated control group of 2 cattle was 
inoculated in the same way. The 20 cattle were housed in fly-proof facilities. From day 7 
after the inoculation, all animals were monitored 2 times a week during 95 days. Their 
PCV was measured and jugular blood was examined for the presence of parasites by 
microscopic examination of the buffy coats and by PCR (Geysen et al., 2003) performed 
on buffy coats collected on Whatman 4 filter paper (Whatman). The DNA was obtained 
using a routine chelex-based extraction method (Sambrook et al., 1989). 
At the first parasitaemia, group A was treated with one single administration of 
0.5mg/kg ISM by intramuscular (IM) injection, group B with one single administration of 
0.5mg/kg ISM and with 20mg/kg OTC (Terramycin LA) IM every 3 days for 30 days and 
group C with one single administration of 0.5mg/kg ISM and with 5mg/kg FQE (Baytril 
100) IM every 2 days for 30 days. For each animal, the injection sites of the drugs were 
alternatively selected in forehand and hindquarters, shaved and colored with methylene 
blue and picric acid for OTC and FQE respectively. A minimal distance of 6 cm between 
injection sites was respected. 
5.2.3. Statistical analysis 
The cattle’s PCV values were analyzed using a cross-sectional linear regression, 
accounting for repeated measures from individual animals in Stata 10 (Copyright 1996–
2009 StataCorp LP). Explanatory variables were the animal groups, post-treatment 
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periods and the interactions between them. Three post-treatment periods, each 
containing the same number of samplings, were defined as follows: day 1–21, day 22–54 
and day 55–95. The interaction term between the groups and the third period (using the 
first period as a baseline) was used as indicator of the impact of the disease on the PCV. 
5.3. Results and discussion 
The two untreated control animals became parasitaemic 11 days after inoculation and 
were treated with DA (7 mg/kg) on day 30 because their PCV reached the critical value 
of 25. All 6 animals of group A (ISM) became positive between days 24 and 46 post-
inoculation. The data are summarized in table 5.2. When ISM was used in combination 
with either OTC (group B) or FQE (group C), the relapse period was significantly longer 
(p<0.001; Figure 5.2). Fifty percent of the cattle became infected (between days 46 and 
82) and 50% completely cleared the infection. In the groups B (ISM-OTC) and C (ISM-
FQE), the parasitaemia remained very low, below the detection level of the microscopic 
examination, i.e. 450 trypanosomes / ml (Ancelle et al., 1997). The PCR results were 
fluctuating with animals being detected parasitaemic every 2 to 3 weeks, indicating a 
parasitaemia oscillating just above and below the detection limit of the PCR test, i.e. 25 
trypanosomes/ml blood (Geysen et al., 2003). 
The impact of the infection on the PCV was not very pronounced in the ISM-treated 
groups, even in group A (average PCV reduction 8 to 14 weeks after treatment: 5.9%; 
95% CI: 4.5–7.3). However, this impact was lower in groups B (ISM-OTC) and C (ISM-
FQE) compared to group A (ISM) (p<0.01). These observations indicate that even in the 
case of ISM-resistant trypanosomes, farmers still seem to benefit from the use of the 
trypanocide because of the significant decrease of the effect of the infection on the 
health status of the animals as represented in the PCV values. 
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Table 5.2: Summarized data of the output of the treatments in cattle 
 
    Group A (ISM) Group B (ISM-OTC) Group C (ISM-FQE) 
Number of animals  6   6   6 
Median prepatent period 35 (26-47)  84 (61-117)  91 (66-127) 
(days) 
 
Mean PCV drop from period 5.9 (4.5-7.3)  1.8 (0.3-3.2)  3.3 (1.9-4.7) 
1 to period 3 
 




Figure 5.2: Kaplan-Meier survival estimates in cattle infected with the resistant strain IL3343. 
With ISM: group A; ISM-OTC: group B; ISM-FQE: group C. 
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5.4. Prospects and impact 
Although resistance to DA and ISM is developing quickly (Delespaux and de Koning, 
2007; Delespaux et al., 2008; Geerts et al., 2001), controlling the parasite in livestock 
using drugs remains the control method of choice for small-scale livestock breeders. 
Localized tsetse control is usually not effective (Vale, 2009) and a vaccine is not yet 
available, leaving little choice to control the disease. Animal trypanosomosis not only 
affects livestock production (milk, meat) but also impacts greatly on crop production 
through the inability to keep draft animals in tsetse-infested areas (Shaw, 2004). 
Notwithstanding the alarming levels of TDR that have been reported in the cotton belt of 
West Africa (McDermott et al., 2003) and in some regions of southern Africa (including 
Zambia) (Delespaux et al., 2008; Mamoudou et al., 2008), new trypanocidal drugs for 
animal use are not expected to become available in the near future. Hence, potentiating 
the available trypanocidal drugs may represent a powerful alternative to the current 
problems associated with the control of trypanosomes in livestock. Research in the field 
of non-competitive inhibitors of efflux pumps in bacteria is being conducted (Markham, 
1999; Sangwan et al., 2008) and may ultimately represent an immense hope for future 
control of trypanosomosis using drugs. In the meantime, TC and some derivatives are 
cheap drugs, registered for use in livestock, widely available on the African market and 
with an expired patent, now in the public domain. More importantly, TC is commonly 
used by African farmers and will not require elaborate new chemistry and safety tests. 
Hence, assuming that further trials confirm the effectiveness of the antibiotics in 
potentiating the activity of trypanocidal drugs in cattle under natural tsetse challenge, 
the new control approach can be implemented rapidly. It is likely that the combination 
ISM–TC/OTC can also be made more cost effective after adjusting dosage and the 
duration of the treatment. Furthermore, several analogues of TC/OTC and FQE are 
available albeit somewhat more expensive as patents are still in force. These compounds 
are currently being screened with the aim of optimizing the delivery system to increase 
the specificity of the treatment, to boost the intracellular concentration of the 
chemosensitizer within the trypanosome and to reduce the dose. Obviously, the current 
treatment schedule cannot be used under field conditions. The repeated administration 
of a high dose of antibiotics is far too expensive for the rural communities and would 
certainly render the treated animals unsuitable for human consumption. Further 
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research is thus ongoing to identify the best galenic solution, the optimal combination of 
chemosensitizer with ISM (qualitative and quantitative) and to test this combination in 
livestock under controlled and field conditions in areas with high tsetse challenge and 
high TDR. An effective combination of ISM and chemosensitizer(s) should result in (i) a 
decrease in the proportion of circulating strains resistant to ISM and (ii) a decrease in 
the impact of the disease on the health status of the cattle. Strategic use of this approach 
may result in an increased efficacy of currently available trypanocidal drugs in extensive 
areas of sub-Saharan Africa where their use is severely curtailed as a result of the 
development of TDR. 
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6.1. Introduction 
The development, the spread and the control of TDR have been the subject of various 
researches in West Africa (Authie, 1984; McDermott et al., 2003; Grace, 2005; Talaki, 
2008; Clausen et al., 2010). In this chapter, we will discuss about the management of 
TDR in West Africa in a broader context of animal trypanosomosis by taking into 
account (i) the current distribution and impact of TDR on livestock health and 
productivity and (ii) the role of molecular tools in the proactive management of TDR. 
6.2. Distribution and impact of TDR in West Africa 
The establishment of an updated low-resolution data set on the distribution of TDR in 
West Africa was made possible by the creation of the RESCAO, the monitoring 
epidemiological network including eight West African countries. Even if the quality of 
the action was unequal between countries, the harmonization of the protocols and 
further training of the administrative and technical stakeholders will allow for more 
comparable results in the future. The structure and the technical staff being in place, all 
procedures have to be exposed to quality insurance assessments with regular audits to 
create positive retroactive improvements of the system. Recommendations to the 
Ministry of Agriculture will be made to integrate this network into the National Research 
Centers Program to ensure a long-term financial sustainability. This continuity in the 
TDR monitoring is necessary to follow the evolution of the situation and to give to the 
farmers some guidelines for disease control that are provided as feedback from the 
samplings of their animals. The general conclusion that can be drawn from the first cycle 
of activity of the RESCAO (financed by the ITM/DGD framework agreement FAIII) is that 
in the RESCAO-area, TDR is widespread in T. vivax (most abundant trypanosome 
species) as well as in T. congolense.  
After confirmation of the widespread presence of TDR in the field, the question was 
raised whether this was posing a significant problem for livestock breeding in that area. 
In other words, does a treatment failure unequivocally lead to a decrease in meat and 
milk production, to a poor body condition and even to the death of the animals as it 
would be logically expected? 
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Different factors should be here first reminded: (i) parasitaemia is commonly low in the 
field and might be under the sensitivity level of microscopy, (ii) trypanosome strains 
vary greatly in virulence, (iii) different levels of TDR are encountered and for some of 
the trypanosomes, trypanocidal drugs remain toxic even if not lethal. Therefore, the 
combination of classic microscopy and more sensitive molecular tools allowed to 
partially answering the above raised question. Indeed, when considering a positive 
microscopical diagnosis after a treatment with trypanocidal drugs, the relapsing animal 
is normally dying. This was the general observation of many field workers but like the 
invisible part of the iceberg many “hidden” things are happening that a microscope 
cannot detect. After treatment with trypanocidal drugs, some of the animals still present 
an active infection but at a microscopically undetectable parasite level (negative 
microscopic examination – sometimes PCR positive) that is compatible with an 
acceptable health status. Those low parasite levels probably allow the animals to control 
the less virulent trypanosomes even if they are drug resistant. Actually, some studies 
suggests that even in the presence of drug resistance, the continuing use of trypanocides 
(to a limited extent and in combination with other control measures) would allow the 
host to control the parasite and the corresponding disease at an acceptable physiological 
level (Rowlands et al., 1994; Geerts et al., 2001; Delespaux et al., 2010; Chitanga et al., 
2011). In this case, TDR might be more a slight decrease in the sensitivity of 
trypanosome than a complete resistance against the toxic effects of the drug. In this 
context of low level of TDR (slight decrease of sensitivity to the drug), the deleterious 
effect of the disease might be less visible, especially in cattle infected by the less virulent 
trypanosome strains. Moreover, Gardiner (1989) showed that self-cure is relatively 
common in T. vivax infections and animals that recovered spontaneously from an acute 
infection developed chronic and asymptomatic infections (Batista et al., 2009). 
Therefore, the treatment with a trypanocide combined with the immune system of the 
host could increase this recovery rate. The cumulative effect of the drug and the 
immunity of the host might allow a better control of the parasites. This is resulting in 
very low oscillating parasitaemia with no or little impact on the host’s health.  The real 
concerns would thus be the highly virulent, highly resistant trypanosomes. Fortunately, 
those trypanosomes do not constitute at present the majority of the population, as 
demonstrated in the chapter 4 of this thesis. The evolution of the virulence in parallel 
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with drug resistance under continuous drug pressure constitutes an excellent and 
challenging subject for further research. 
6.3. Molecular tools used to diagnose TDR in West Africa  
Assessing the impact of TDR in livestock health and production, and analyzing the 
distribution of TDR in West Africa have been made easier by using molecular tools  for 
the diagnosis of trypanosome infection and of DA resistance (for T. congolense). The 
newly improved molecular tool for the diagnosis of T. congolense DA-resistance is now 
an expertise of CIRDES, which is the sole West African Research Center, using routinely 
the PCR-RFLP-MspI and PCR-RFLP-DpnII tests for the diagnosis of AAT and DA 
resistance, respectively. However, further validation of the DA resistance test  will be 
necessary after the recent observation that the target gene in T. congolense on which the 
test is based (TcoAT1 / TcoNT10) is not responsible for the transport of the drug 
(Munday et al., 2013). From a diagnostic point of view, this should not be a major issue 
in the case the detected mutation in the TcoAT1 / TcoNT10 gene is linked to the genetic 
determinant responsible for the resistance phenotype elsewhere on the same 
chromosome. The data available so far strongly suggest this type of linkage for the 
TcoAT1 / TcoNT10 gene (Delespaux and de Koning, 2013). 
Another issue might be more problematic. We have seen that the mutation linked to DA 
resistance might be present in trypanosomes that disappear from the host 
(microscopical examination) following DA treatment but are not killed by the 
administration of 10 or even 20mg/kg DA in a mice test (Chitanga et al., 2011). When 
PCR is applied on the blood of such animals, low fluctuating parasitaemia are observed 
that are not detectable with the microscopical examination. In the mouse model, 
Chitanga et al. (2011) observed an increased relapse rate (detected by PCR) from 39% 
to 66.7% for 20 mg/kg simply by increasing the observation frequency from a single 
PCR-based detection at the end of the observation period (day 60) to weekly PCR-based 
parasite detections (8 in total), although all mice remained microscopically negative 
during the entire observation period. Exactly the same trend was observed in the goat 
experiment that we presented in the fourth chapter. These observations were the basis 
of our definition of TDR as “the decreased or absence of sensitivity of trypanosome 
strains to standard quality trypanocidal drugs at the dose recommended by the  
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manufacturer and administered according to good veterinary practices”. We included in 
this definition those very low parasitaemia that are not affecting the health status of the 
animals. For a routine AAT diagnosis, the microscopic examination might be more 
appropriate and the molecular tool will be more useful for epidemiological surveys. The 
molecular tool will permit to have an overview of the situation of TDR in wide areas (e.g. 
West Africa region in the framework of the RESCAO), or to undertake TDR study in areas 
and/or in animals difficult to access (e.g. wild animals).  
The situation with T. vivax is even more complex as no nucleoside transporter identified 
so far seems to be involved in DA resistance. After screening of all the nucleoside 
transporters available in the genomic database (www.genedb.org) by sequencing, no 
conserved polymorphism was observed between sensitive and resistant strains. 
Unfortunately, the sequence of one gene (TvY486_1103760) is incomplete and we 
cannot rule out that a conserved mutation linked to DA resistance might be located on 
this last unsequenced fragment. However, our study was based on a limited set of 
sequencing data and would advantageously be completed by whole genome sequencing 
on more than 4 characterized strains. 
6.4. Managing animal trypanosomosis in West Africa 
Africa faces the vital problem of feeding its people and one of the major challenge is to 
reduce the constraints on agriculture that constitute cross-border epizootics diseases 
such as animal trypanosomosis (Swallow, 1998; Shaw, 2003; Ilemobade, 2009). Indeed, 
African’s traditional livestock owners are still considering animal trypanosomosis as the 
most significant threat to their cattle (Kone et al., 2012). Strategies for reducing the 
impact of trypanosomosis on animal health strongly depend on local factors such as f ly 
pressure, infection rate of the flies, virulence of the trypanosomes, cattle breed, breeding 
conditions, availability of veterinary services, food for the cattle, drugs of good quality 
and of course the drug resistance situation (absence, presence, simp le or multiple,…). 
Trypanocidal drugs are thus essential in the management of the disease but are not the 
sole factor. A “scale perspective” should be considered. Programs like the PATTEC aim at 
the complete eradication of the tsetse fly vector (Bouyer et al., 2013; Shaw et al., 2013). 
This is one possible option but is logistically heavy, very expensive and absolutely not 
proved to be possible at the continental scale. While waiting for this ‘hypothetical’ total 
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eradication of tsetse flies, farmers have to cope with the disease and drugs are one of the 
weapons at their disposition and mostly their first reflex. In most of the cases, farmers 
prefer treating their most productive animals (draft oxen, dairy cow, etc) and therefore 
do not hesitate to reduce the quantity of drugs provided to the other animals of the herd. 
Moreover, prevention is less obvious for farmers as most of them are breeding for many 
reasons (banking system, a bit of milk and manure, draught power, social significance, 
…) but not really for making a ‘business’ out of it (Affognon et al., 2009; Grace et al., 
2009). They consider low or no input in the system. The lack of knowledge/education is 
focusing the management of the disease on drugs albeit many other options are possible 
when the relationship between the disease and the biology of the vector is understood. 
Common sense measures such as strategic watering of the cattle either by avoiding the 
early or late watering or by providing water at places where the flies are not present can 
already constitute an excellent prevention method. Other options are available such as 
restricted grazing, insecticide impregnated nets, localized spraying (belly and legs). 
However, these measures demand knowledge (Bouyer et al., 2007; Bouyer et al., 2009). 
Even the nature of the traditional breeding system by itself constitutes a major pitfall. 
What is the aim of maintaining animals for more than 10 years as it is often the case? 
The period of exposition to the vector is extremely long and meanwhile the cattle are fed 
with poor or no production in exchange. This constitutes a major threat to the 
environment and may represent an economic non-sense. A first priority in an “ideal 
world” would be to limit the breeding to the productive phase and to grab the  benefits 
when present i.e. to transform the meat in currency and bank it. This demand political 
and financial stability. The use of drugs in this scenario would be drastically decreased. 
However as traditions are very difficult to change, farmers will still have to cope with 
drugs and drug resistance. Knowing that and the fact that TDR is a reality, concentrating 
efforts on the development of new drugs remains a realistic issue. It is still too often 
stated that pharmaceutical companies are not keen on developing new drugs because of 
the “limited” African market (Sones, 2001; Affognon, 2007). This is a kind of dogmatic 
assertion as the disease also affect large parts of South America (Batista et al., 2007; 
Batista et al., 2009), China (Lun et al., 1993; Tang et al., 2012) and the Indian 
subcontinent (Ravindran et al., 2008; Desquesnes et al., 2013). What could thus be an 
ideal drug in such a context? The following characteristics should be considered: (i) 
efficient against all the pathogenic trypanosome species to allow for a “global market”,  
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(ii) good quality (good stability when diluted, etc), (iii) single dose packaging to avoid 
under dosage, (iv) different from sleeping sickness drugs to prevent the development of 
cross-resistance, (v) widely available and (vi) at a reasonable price. In the framework of 
the GALVmed project (Global Alliance for Livestock Veterinary Medicine - 
http://www.galvmed.org), new medications were tested against drug resistant, highly 
virulent trypanosome isolates originating from Cameroon. Cattle inoculated with those 
strains and treated with those new compounds were effectively cured and completely 
cleared of the parasites. Further toxicological studies are ongoing. This brings hope for 
some hot spots of drug resistance (Delespaux, pers. Comm.).  
In the Chapter 5 of this PhD thesis, we discussed about an alternative consisting in 
potentiating the efficacy of ISM by associating it to two veterinary affordable antibiotics 
drugs, i.e. oxytetracycline and enrofloxacin. Our results were encouraging even if some 
factors should have been further explored like the best galenic formula, the optimal 
combination of potentiator with ISM and the linking of the potentiator to nanobodies 
directed against the trypanosomes for a rapid internalization of the compound. Different 
attempts were made to find some pharmaceutical companies willing to contribute 
financially to the research but without success so far. While waiting for new products on 
the market, the Rational Drug Use method described by Clausen et al. (2010) is currently 
the coherent approach to adopt. It permits to better control all the chain of drug 
administration, from purchasing to injecting the drug (Clausen et al., 2010; Mungube et 
al., 2012). 
Considering existing and potential new drugs, the reinforcement and the harmonization 
of veterinary legislation and proper quality control of the trypanocidal drugs is the 
corner stone of the effective treatments of the animals. This reinforcement started in 
2006 in the “Union Economique et Monétaire Ouest-Africaine” (UEMOA) zone with the 
deliverance of a unique marketing authorization (MA) to any pharmaceutical company 
that commercialize its products. This will certainly contribute to reduce the problem of 
TDR (Daré, 2007). However, more focused actions are necessary for the control of 
veterinary drugs sold at the local markets (Figure 6.1). In the framework of a 
collaboration FAO – GALVmed – TRYRAC (Trypanosomosis Rational Chemotherapy - 
http://www.trypanocide.eu/), it is now possible for any private person or institution to 
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check the quality of different medications including trypanocides for a cost of 
300€/molecule (LACOMEV – Dakar – Senegal -http://www.eismv.org/Jumelage-entre-l-
Agence-Nationale.html). This is a great step forward as the threat is now present for 





Figure 6.1: Veterinary drugs in a West African market (Affognon et al., 2009). 
 
6.5. Conclusion 
This thesis should be considered as a small piece being part of a much larger edifice , 
which is the impact of trypanosomosis on the livelihood of farmers. I tried to bring a bit 
of light in the comprehension of this problematic by considering (i) the diagnosis of drug 
resistance, paramount parameter in the management of drug resistance, (ii) the human 
adventure of coordinating the activities of eight African countries in a same ideal , which 
will be necessary for the resolution of the problem in a mid or long term perspective, 
(iii) the real impact of drug resistance on the health status of infected animals , which 
will be of uttermost importance in the future (whether it’s a new fine-tuned balance 
between host and parasite with compromises from both parts or not) and (iv) the use of 
low-cost old means that combined together can bring new insights on handling the 
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disease. This thesis work caused in my brain the widest admiration for a small fly and a 
microscopic parasite that are challenging a large population of international researchers 
for more than a century. However, I was really pleased to humbly participate to some 
minor moves of this gigantic chess game. 
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SUMMARY 
For more than half a century, livestock trypanosomosis in West Africa has been the 
subject of various research papers published in the scientific literature. Since the 
discovery of the first T. congolense resistant strain in 1984, several studies have alerted 
on the increasing phenomenon of trypanocidal drug resistance (TDR) in the cotton belt 
of West Africa against the two commonly molecules used in this area i.e. diminazene 
aceturate and isometamidium chloride. The recently developed molecular tools for the 
diagnosis of TDR allowed gaining better information on the spread of TDR. The work 
that is presented in this thesis aimed at (i) improving the performance of the PCR-RFLP 
tool used for the diagnosis of diminazene aceturate resistance in T. congolense under 
field conditions, (ii) prospect the development of a similar molecular tool for the 
diagnosis of T. vivax resistance to diminazene aceturate, and using these molecular tools 
to monitor TDR in West Africa through the epidemiosurveillance network of 
chemoresistance to trypanocidal and acaricides drugs in West Africa called RESCAO, (iii) 
determining the impact of TDR on livestock health and production in endemic areas of 
West Africa and (iv) proposing an alternative to contain or reduce the TDR 
phenomenon. 
The first chapter of this thesis gives general information on the disease and its 
components (parasite and vector). Moreover, it reviews our current knowledge on the 
pharmacology of diminazene aceturate, isometamidium chloride and homidium salts 
and on the phenomenon of trypanocidal drug resistance. 
Chapter 2 describes the work for the improvement of the performance of a PCR-RFLP 
for the detection of diminazene resistance in T. congolense under field conditions. We 
used blood spots on filters papers collected from parasitologically positive cattle in 
South-east Mali. This study permitted to increase the specificity of the PCR-RFLP test 
and to enhance its sensitivity in determining a low parasitaemia observed in the field.  
This molecular tool was used to update the current situation of T. congolense resistance 
to diminazene aceturate in the countries that are members of RESCAO - the West 
African’s epidemiosurveillance network of chemoresistance to trypanocidal and 
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acaricides drugs. From this study we can learn that TDR in widely distributed West 
Africa. 
In chapter 3, an exhaustive exploration of the genes predicted to code for nucleoside 
transporters in T. vivax was performed. For this analysis, T. vivax samples used were 
already characterized in goats for their sensitivity and/or resistance against diminazene 
aceturate. SSCP analysis and sequencing shows that the P2-type putative adenosine 
transporters genes seem not to been involved in diminazene resistance in this 
trypanosome species. More studies are therefore needed to understand this mechanism 
of resistance or alternatively to find a trustable genetic marker. 
Chapter 4 aimed at studying the impact of TDR in livestock health and production in 
endemic areas of West Africa. We used 60 female goats infected with T. vivax strains 
collected in the vicinity of Bobo-Dioulasso (Burkina Faso). This study showed that drug 
resistant T. vivax strains inoculated to goats might probably had no significant impact on 
the PCV and body weight losses except for a few highly virulent strains. This still needs 
to be confirmed in cattle under natural tsetse and Trypanosoma challenge. 
Chapter 5 aimed at finding an alternative to contain and/or reduce TDR by potentiating 
the efficacy of isometamidium chloride by associating it to two veterinary affordable 
antibiotics i.e. tetracyclines and enrofloxacin. The obtained results are encouraging even 
if more studies are still needed to determine the best galenic solution, the optimal 
combination of the chemosensitizer with isometamidium and to test this combination in 
livestock under controlled and field conditions in areas with high tsetse challenge and 
high trypanocidal drug resistance. 
In the last chapter (Chapter 6), the major findings of the thesis are discussed in the wide 
context of the management of animal trypanosomosis in West Africa. 
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SAMENVATTING 
Reeds meer dan een halve eeuw, is trypanosomose bij het vee in West-Afrika het 
onderwerp van verschillende onderzoeken gepubliceerd in de wetenschappelijke 
literatuur. Sinds de ontdekking van de eerste T. congolense trypanocide resistente stam 
in 1984, toonden verschillende studies een toename van het probleem van trypanocide 
resistentie (TDR) –tegen diminazene en isometamidium - in de “Cotton belt” van West 
Afrika. De recent ontwikkelde moleculaire methoden voor de diagnose van TDR hebben 
bijgedragen tot een beter inzicht van de epidemiologie. 
Het onderzoek dat deel uitmaakt van dit proefschrift is gericht op (i) het verbeteren van 
de PCR-RFLP methode voor de diagnose van diminazene resistentie van T. congolense in 
veldomstandigheden, (ii) het ontwikkelen van een soortgelijke moleculaire methode 
voor de diagnose van T. vivax resistentie tegen diminazene, (iii) het bestuderen, met de 
hierboven moleculaire methoden, van TDR in West-Afrika door middel van het 
epidemiologische netwerk van chemoresistentie tegen trypanocide en acaricide 
middelen in West Afrika, genaamd RESCAO, (iv) het bepalen van de impact van TDR 
voor de dierlijke gezondheid en productie in endemische gebieden van West Afrika en 
tenslotte (v), het uittesten van alternatieve behandelingsmethoden om TDR te beperken. 
Het eerste hoofdstuk vat onze huidige kennis samen over de dierlijke trypanosomen en 
hun vectoren, de pathogenese van trypanosomosis, de diagnose, behandeling en 
controle; en gaat dieper in op de farmacologie van diminazene aceturate, 
isometamidium chloride en homidium zouten en trypanocide resistentie. 
In hoofdstuk 2 wordt een studie beschreven naar de verbetering van de gevoeligheid en 
de specificiteit van een PCR-RFLP onder veldomstandigheden voor de detectie van 
resistentie bij T. congolense tegen diminazene. Er werd gebruik gemaakt van de 
verbeterde moleculaire methode om T. congolense resistentie tegen diminazene op te 
volgen in de landen leden van RESCAO, de west Afrikaanse netwerk van epidemio -
bewaking van trypanocide en acaricide resistentie. Dit onderzoek toonde een 
uitgebreide verspreiding aan van TDR in West Afrikaanse landen die lid zijn van de 
RESCAO. 
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In hoofdstuk 3 wordt een uitgebreide screening van nucleoside transporters beschreven 
bij T. vivax. Er werd gezocht naar geconserveerde sequentie veranderingen in resistente 
fenotypes. Daarvoor werd gebruik gemaakt van T. vivax monsters die reeds 
gekarakteriseerd waren voor hun gevoeligheid en / of resistentie tegen diminazene. Uit 
de SSCP analyse en sequentiebepaling bleek dat de P2-type adenosine transporter genen 
geen rol spelen in diminazene resistentie bij T. vivax zoals het waarschijnlijk wel het 
geval is voor T. congolense. Uitgebreider onderzoek is daarom noodzakelijk om dit 
mechanisme van resistentie te begrijpen of om een betrouwbaar genetisch merker van 
diminazene resistente te vinden bij T. vivax. 
Hoofdstuk 4 was gericht op het bestuderen van de impact van TDR op de gezondheid en 
productie van geiten in endemische gebieden van West-Afrika. Zestig vrouwelijke geiten 
werden experimenteel besmet met T. vivax stammen verzameld in de omgeving van 
Bobo-Dioulasso (Burkina Faso). Deze studie toonde aan dat resistente T. vivax stammen 
geënt in geiten geen significante invloed hadden op de PCV en het lichaamsgewicht, 
behalve voor een paar zeer virulente stammen. Dit is in tegenspraak met de algemene 
opinie dat de ontwikkeling van resistentie tegen trypanociden aan de boeren geen 
uitkomst zou laten. 
In hoofdstuk 5 werd gezocht naar een alternatieve behandeling voor het beperken van 
TDR door het samen gebruiken van isometamidium met twee in de diergeneeskunde 
courant gebruikte en betaalbare antibiotica: tetracyclines en enrofloxacine. De 
preliminaire resultaten waren bemoedigend. Toch is uitgebreider onderzoek 
noodzakelijk om de beste galenische oplossing uit te werken, de optimale combinatie 
van de antibiotica met isometamidium te bepalen en deze combinatie te testen op dieren 
onder gecontroleerde omstandigheden en in veldcondities, in gebieden met hoge tsetse 
druk en met belangrijke trypanocide resistentie. 
In het laatste hoofdstuk (hoofdstuk 6), werden de belangrijkste bevindingen van dit 
proefschrift besproken in het brede kader van de epidemiologie van trypanocide 
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The exploration of the nucleoside transporter TvY486_0014570 in sequencing show no conserved polymorphism between the sensitive 




CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           TCCTGTCTTCACACTATTAGACAAGCTAGAATCTTAACAACATCAAGTTCATTCCGCGGC 
H89_resistant           TCCTGTCTTCACACTATTAGACAAGCTAGAATCTTAACAACATCAAGTTCATTCCGCGGC 
H988_sensitive          TCCTGTCTTCACACTATTAGACAAGCTAGAATCTTAACAACATCAAGTTCATTCCGCGGC 
H1008_sensitive         TCCTGTCTTCACACTATTAGACAAGCTAGAATCTTAACAACATCAAGTTCATTCCGCGGC 
ILRAD700_sensitive      TCCTGTCTTCACACTATTAGACAAGCTAGAATCTTAACAACATCAAGTTCATTCCGCGGC 
                        ************************************************************ 
 
H65_resistant           GAGATGGGGTTGCTGGGTTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTC 
H89_resistant           GAGATGGGGTTGCTGGGTTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTC 
H988_sensitive          GAGATGGGGTTGCTGGGTTTTGAGTCGCCAGCGGCCTTTGTCGTCTATTTGAGCTTCCTC 
H1008_sensitive         GAGATGGGGTTGCTGGGTTTTGAGTCGCCAGCGGCCTTTGTCGTCTATTTGAGCTTCCTC 
ILRAD700_sensitive      GAGATGGGGTTGCTGGGTTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTC 
                        *********************************** ************************ 
 
H65_resistant           TCGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTATTGCTTGTATGAATATTTT 
H89_resistant           TCGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTATTGCTTGTATGAATATTTT 
H988_sensitive          TCGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTATTGCTTATATGAATACTTT 
H1008_sensitive         TCGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTATTGCTTATATGAATACTTT 
ILRAD700_sensitive      TCGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTATTGCTTGTATGAATATTTT 
                        *********************************************** ******** *** 
 
H65_resistant           ACACAGTTCTTCAAACTTGCCCAGGGAAAGTCGGACGTCGACCCTGCGGACGCCGCGTTC 
H89_resistant           ACACAGTTCTTCAAACTTGCCCAGGGAAAGTCGGACGTCGACCCTGCGGACGCCGCGTTC 
H988_sensitive          ACACAGTTCTTCAAACTTGCCCAGGGAAAGTCGGACGTCGACCCTGCGGACGCCGCGTTC 
H1008_sensitive         ACACAGTTCTTCAAACTTGCCCAGGGAAAGTCGGACGTCGACCCTGCGGACGCCGCGTTC 
ILRAD700_sensitive      ACACAGTTCTTCAAACTTGCCCAGGGAAAGTCGGACGTCGACCCTGCGGACGCCGCGTTC 
                        ************************************************************ 
Annex         145 
H65_resistant           TGGACGAACATTCACACGTACTACAACGTGACTGTCTTTTCAACGCAGGTTGTTGCCGAG 
H89_resistant           TGGACGAACATTCACACGTACTACAACGTGACTGTCTTTTCAACGCAGGTTGTTGCCGAG 
H988_sensitive          TGGACGAACATTCACACGTACTACAACGTGACTGTCTTTTCAACGCAGGTTGTTGCCGAG 
H1008_sensitive         TGGACGAACATTCACACGTACTACAACGTGACTGTCTTTTCAACGCAGGTTGTTGCCGAG 
ILRAD700_sensitive      TGGACGAACATTCACACGTACTACAACGTGACTGTCTTTTCAACGCAGGTTGTTGCCGAG 
                        ************************************************************ 
 
H65_resistant           ATATTCATGCTGACGCCACTTGGTAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGCT 
H89_resistant           ATATTCATGCTGACGCCACTTGGTAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGCT 
H988_sensitive          ATATTCATGCTGACGCCACTTGGTAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGCT 
H1008_sensitive         ATATTCATGCTGACGCCACTTGGTAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGCT 
ILRAD700_sensitive      ATATTCATGCTGACGCCACTTGGTAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGCT 
                        ************************************************************ 
 
H65_resistant           TTTGCCCTGCCGTTTTTGCAACTCTCTTCGTACATGCTGACCACCACGTTCCATACAACG 
H89_resistant           TTTGCCCTGCCGTTTTTGCAACTCTCTTCGTACATGCTGACCACCACGTTCCATACAACG 
H988_sensitive          TTTGCCCTGCCGTTTTTGCAACTCTCTTCGTACATGCTGACCACCACGTTTCATACAACG 
H1008_sensitive         TTTGCCCTGCCGTTTTTGCAACTCTCTTCGTACATGCTGACCACCACGTTCCATACAACG 
ILRAD700_sensitive      TTTGCCCTGCCGTTTTTGCAACTCTCTTCGTACATGCTGACCACCACGTTCCATACAACG 
                        ************************************************** ********* 
 
H65_resistant           GAAAACGGTGCAAAAGCCTTATTCCTGGTCATGGCATTTGTGAACGGCCTGTCAAAGTCA 
H89_resistant           GAAAACGGTGCAAAAGCCTTATTCCTGGTCATGGCATTTGTGAACGGCCTGTCAAAGTCA 
H988_sensitive          GAAAACGGTGCAAAAGCCTTATTCCTGGTCATGGCATTTGTGAACGGCCTGTCAAAGTCA 
H1008_sensitive         GAAAACGGTGCAAAAGCCTTATTCCTGGTCATGGCATTTGTGAACGGCCTGTCAAAGTCA 
ILRAD700_sensitive      GAAAACGGTGCAAAAGCCTTATTCCTGGTCATGGCATTTGTGAACGGCCTGTCAAAGTCA 
                        ************************************************************ 
 
H65_resistant           TTCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCA 
H89_resistant           TTCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCA 
H988_sensitive          TTCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCA 
H1008_sensitive         TTCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCA 
ILRAD700_sensitive      TTCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCA 
                        ************************************************************ 
 
H65_resistant           TACGTCTTTGGTCTTCCACTTTCTGGCGTCATCACTGCCATTCTGTCCTTGGTGATCAAG 
H89_resistant           TACGTCTTTGGTCTTCCACTTTCTGGCGTCATCACTGCCATTCTGTCCTTGGTGATCAAG 
H988_sensitive          TACGTCTTTGGACTCCCACTTTCTGGCGTCATCACTGCCATTCTGTCCTTGGTGATCAAG 
H1008_sensitive         TACGTCTTTGGACTCCCACTTTCTGGCGTCATCACTGCCATTCTGTCCTTGGTGATCAAG 
ILRAD700_sensitive      TACGTCTTTGGTCTTCCACTTTCTGGCGTCATCACTGCCATTCTGTCCTTGGTGATCAAG 
                        *********** ** *********************************************
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H65_resistant           GGGTCAATGAACAACGACTTTGACAATCTCTTGACCCAGTCGTACATATACTTCTC 
H89_resistant           GGGTCAATGAACAACGACTTTGACAATCTCTTGACCCAGTCGTACATATACTTCTC 
H988_sensitive          GGGTCAATGAACAACGACTTTGACAATCTCTTGACCCAGTCGTACATATACTTCTC 
H1008_sensitive         GGGTCAATGAACAACGACTTTGACAATCTCTTGACCCAGTCGTACATATACTTCTC 
ILRAD700_sensitive      GGGTCAATGAACAACGACTTTGACAATCTCTTGACCCAGTCGTACATATACTTCTC 
                        ******************************************************** 
 
 
>TvY486_14570F2  CTCTTGACCCAGTCGTACATATACTT 
>TvY486_14570R2  GTTGTCCTTTATCACCTTCTGTTGAC 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           CTCTTGACCCAGTCGTACATATACTTCTCCACGACAATGGCTTTTCAGGCCATCGCATGC 
H89_resistant           CTCTTGACCCAGTCGTACATATACTTCTCCACGACAATGGCTTTTCAGGCCATCGCATGC 
H988_sensitive          CTCTTGACCCAGTCGTACATATACTTCTCCACGACAATGGCTTTTCAGGCCATCGCATGC 
H1008_sensitive         CTCTTGACCCAGTCGTACATATACTTCTCCACGACAATGGCTTTTCAGGCCATCGCATGC 
ILRAD700_sensitive      CTCTTGACCCAGTCGTACATATACTTCTCCACGACAATGGCTTTTCAGGCCATCGCATGC 
                        ************************************************************ 
 
H65_resistant           GTTTTGTTGTACCTGCTCCCCAAGAATCCGTACGCCCTGCGGTACGCGGCGGAGCTCAGG 
H89_resistant           GTTTTGTTGTACCTGCTCCCCAAGAATCCGTACGCCCTGCGGTACGCGGCGGAGCTCAGG 
H988_sensitive          GTTTTGTTGTACCTGCTCCCCAAGAATCCGTACGCCCTGCGGTACGCGGCGGAGCTCAGG 
H1008_sensitive         GTTTTGTTGTACCTGCTCCCCAAGAATCCGTACGCCCTGCGGTACGCGGCGGAGCTCAGG 
ILRAD700_sensitive      GTTTTGTTGTACCTGCTCCCCAAGAATCCGTACGCCCTGCGGTACGCGGCGGAGCTCAGG 
                        ************************************************************ 
 
H65_resistant           TACGCTATGAGGAAGAACAGCGCAGGTGGGAATGGAGGACACAGCACAAGAGACACAGAC 
H89_resistant           TACGCTGTGAGGAAGAACAGCGCAGGTGGGAATGGAGGACACAACACAAGAGACACAGAC 
H988_sensitive          TACGCTATGAGGAAGAACAGCGCAGGTGGGAATGGAGGACACAGCACAAGAGACACAGAC 
H1008_sensitive         TACGCTATGAGGAAGAACAGCGCAGGTGGGAATGGAGGACACAGCACAAGAGACACAGAC 
ILRAD700_sensitive      TACGCTATGAGGAAGAACAGCGCAGGTGGGAATGGAGGACACAGCACAAGAGACACAGAC 
                        ****** ************************************ **************** 
 
H65_resistant           AGACCCGAATCCCTCCTAACAGGCGAGCCTGTGAATGACGGTGACCAAGCACAGCCGGTG 
H89_resistant           AGACCCGAATCCCTCCTAACAGGCGAGCCTGTGAATGACGGTGACCAAGCACAGCCGGTG 
H988_sensitive          AGACCCGAATCCCTCCTAACAGGCGAGCCTGTGAATGACGGTGACCAAGCACAGCCGGTG 
H1008_sensitive         AGACCCGAATCCCTCCTAACAGGCGAGCCTGTGAATGACGGTGACCAAGCACAGCCGGTG 
ILRAD700_sensitive      AGACCCGAATCCCTCCTAACAGGCGAGCCTGTGAATGACGGTGACCAAGCACAGCCGGTG 
                        ************************************************************ 
Annex         147 
H65_resistant           GTGAGGAGCGTCCTGGACACGACAGTTGATCCGGATACGATGAAGGACACTGATCAGGTG 
H89_resistant           GTGAGGAGCGTCCTGGACACGACAGTTGATCCGGATACGATGAAGGACACTGATCAGGTG 
H988_sensitive          GTGAGGAGCGTCCTGGACACGACAGTTGATCCGGATACGATGAAGGACACTGATCAGGTG 
H1008_sensitive         GTGAGGAGCGTCCTGGACACGACAGTTGATCCGGATACGATGAAGGACACTGATCAGGTG 
ILRAD700_sensitive      GTGAGGAGCGTCCTGGACACGACAGTTGATCCGGATACGATGAAGGACACTGATCAGGTG 
                        ************************************************************ 
 
H65_resistant           GAGGACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGTCGCCAAACGC 
H89_resistant           GAGGACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGTCGCCAAACGC 
H988_sensitive          GAGGACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGTCGCCAAACGC 
H1008_sensitive         GAGGACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGTCGCCAAACGC 
ILRAD700_sensitive      GAGGACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGTCGCCAAACGC 
                        ************************************************************ 
 
H65_resistant           ATATACCCGATCCTCGCCACGTGCTTTTTCATCTACTTCTCAACGCTCCTCTTCTGGCCC 
H89_resistant           ATATACCCGATCCTCGCCACGTGCTTTTTCATCTACTTCTCAACGCTCCTCTTCTGGCCC 
H988_sensitive          ATATACCCGATCCTCGCCACGTGCTTTTTCATCTACTTCTCAACGCTCCTCTTCTGGCCC 
H1008_sensitive         ATATACCCGATCCTCGCCACGTGCTTTTTCATCTACTTCTCAACGCTCCTCTTCTGGCCC 
ILRAD700_sensitive      ATATACCCGATCCTCGCCACGTGCTTTTTCATCTACTTCTCAACGCTCCTCTTCTGGCCC 
                        ************************************************************ 
 
H65_resistant           GGCGTCTTCATTGCTGTGGACTCACAAGGGTGGAACTTCTGGTACGGCACGATCGTGATG 
H89_resistant           GGCGTCTTCATTGCTGTGGACTCACAAGGGTGGAACTTCTGGTACGGCACGATCGTGATG 
H988_sensitive          GGCGTCTTCATTGCTGCGGACTCACAAGGGTGGAACTTCTGGTACGGCACGATCGTGATG 
H1008_sensitive         GGCGTCTTCATTGCTGTGGACTCACAAGGGTGGAACTTCTGGTACGGCACGATCGTGATG 
ILRAD700_sensitive      GGCGTCTTCATTGCTGTGGACTCACAAGGGTGGAACTTCTGGTACGGCACGATCGTGATG 
                        **************** ******************************************* 
 
H65_resistant           GCTATGTTCAACTTTGGTGACTTCTTCTCGCGCTTGCAGCTTCAGTTCAAGAACCTCCAC 
H89_resistant           GCTATGTTCAACTTTGGTGACTTCTTCTCGCGCTTGCAGCTTCAGTTCAAGAACCTCCAC 
H988_sensitive          GCTATGTTCAACTTTGGTGACTTCTTCTCGCGCTTGCAGCTTCAGTTCAAGAACCTCCAC 
H1008_sensitive         GCTATGTTCAACTTTGGTGACTTCTTCTCGCGCTTGCAGCTTCAGTTCAAGAACCTCCAC 
ILRAD700_sensitive      GCTATGTTCAACTTTGGTGACTTCTTCTCGCGCTTGCAGCTTCAGTTCAAGAACCTCCAC 
                        ************************************************************ 
 
H65_resistant           CCATCCCCGCGGACGGTGATCATCGCCGCGTTCGCTCGCCTGCTGATCATCGTGCCGCTC 
H89_resistant           CCATCCCCGCGGACGGTGATCATCGCCGCGTTCGCTCGCCTGCTGATCATCGTGCCGCTC 
H988_sensitive          CCATCCCCGCGGACGGTGATCATCGCCGCGTTCGCTCGCCTGCTGATCATCGTGCCGCTC 
H1008_sensitive         CCATCCCCGCGGACGGTGATCATCGCCGCGTTCGCTCGCCTGCTGATCATCGTGCCGCTC 
ILRAD700_sensitive      CCATCCCCGCGGACGGTGATCATCGCCGCGTTCGCTCGCCTGCTGATCATCGTGCCGCTC 
                        ************************************************************ 
148        Annex 
 
H65_resistant           TTCCTCTGTCAACAGAAGGTGATAAAGGACAAC 
H89_resistant           TTCCTCTGTCAACAGAAGGTGATAAAGGACAAC 
H988_sensitive          TTCCTCTGTCAACAGAAGGTGATAAAGGACAAC 
H1008_sensitive         TTCCTCTGTCAACAGAAGGTGATAAAGGACAAC 
ILRAD700_sensitive      TTCCTCTGTCAACAGAAGGTGATAAAGGACAAC 
                        ********************************* 
 
 
Annex         149 
Sequencing performed on TvY486_0043680 using 2 resistant and 3 sensitive T. vivax strains 
 
 
>TvY486_0043680F1  aggtgcgctctcaactgaat 




CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           AGGTGCGCTCTCAACTGAATTCCCCCATTTGATATCACCACGTGTACCAACCACTGTCCA 
H89_resistant           AGGTGCGCTCTCAACTGAATTCCCCCATTTGATATCACCACGTGTACCAACCACTGTCCA 
H988_sensitive          AGGTGCGCTCTCAACTGAATTCCCCCATTTGATATCACCACGTGTACCAACCACTGTCCA 
H1008_sensitive         AGGTGCGCTCTCAACTGAATTCCCCCATTTGATATCACCACGTGTACCAACCACTGTCCA 
ILRAD700_sensitive      AGGTGCGCTCTCAACTGAATTCCCCCATTTGATATCACCACGTGTACCAACCACTGTCCA 
                        ************************************************************ 
 
H65_resistant           CTCTGTTTCACATTGTTAGAAAAGGAGCGATTTCGGCATCACTAAGTTCGTTCTACAGCA 
H89_resistant           CTCTGTTTCACATTGTTAGAAAAGGAGCGATTTCGGCATCACTAAGTTCGTTCTACAGCA 
H988_sensitive          CTCTGTTTCACATTGTTAGAAAAGGAGCGATTTCGGCATCACTAAGTTCGTTCTACAGCA 
H1008_sensitive         CTCTGTTTCACATTGTTAGAAAAGGAGCGATTTCGGCATCACTAAGTTCGTTCTACAGCA 
ILRAD700_sensitive      CTCTGTTTCACATTGTTAGAAAAGGAGCGATTTCGGCATCACTAAGTTCGTTCTACAGCA 
                        ************************************************************ 
 
H65_resistant           AAATGGGGTTACTGGGGTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTCT 
H89_resistant           AAATGGGGTTACTGGGGTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTCT 
H988_sensitive          AAATGGGGTTACTGGGGTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTCT 
H1008_sensitive         AAATGGGGTTACTGGGGTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTCT 
ILRAD700_sensitive      AAATGGGGTTACTGGGGTTTGAGTCGCCAGCGGCGTTTGTCGTCTATTTGAGCTTCCTCT 
                        ************************************************************ 
 
H65_resistant           CGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTACTGTTTGTATAAGTACTTTA 
H89_resistant           CGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTACTGTTTGTATAAGTACTTTA 
H988_sensitive          CGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTACTGTTTGTATAAGTACTTTA 
H1008_sensitive         CGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTACTGTTTGTATAAGTACTTTA 
ILRAD700_sensitive      CGTTTGGCATGTCTTTGATGCTCTCCGCCAACGCTGTGTACTGTTTGTATAAGTACTTTA 
                        ************************************************************ 
150        Annex 
H65_resistant           CACATTTCTACAAGCTTGTGCAGGGCGACCCGGAAGCTAAGCCTGAGGATGAAAGATTCT 
H89_resistant           CACATTTCTACAAGCTTGTGCAGGGCGACCCGGAAGCTAAGCCTGAGGATGAAAGATTCT 
H988_sensitive          CACATTTCTACAAGCTTGTGCAGGGCGACCCGGAAGCTAAGCCTGAGGATGAAAGATTCT 
H1008_sensitive         CACATTTCTACAAGCTTGTGCAGGGCGACCCGGAAGCTAAGCCTGAGGATGAAAGATTCT 
ILRAD700_sensitive      CACATTTCTACAAGCTTGTGCAGGGCGACCCGGAAGCTAAGCCTGAGGATGAAAGATTCT 
                        ************************************************************ 
 
H65_resistant           GGACGAACATTTACACGTACTACAACGTGATCATCTTTTCAACGCAGGTTGTTGCCGAGA 
H89_resistant           GGACGAACATTTACACGTACTACAACGTGATCATCTTTTCAACGCAGGTTGTTGCCGAGA 
H988_sensitive          GGACGAACATTTACACGTACTACAACGTGATCATCTTTTCAACGCAGGTTGTTGCCGAGA 
H1008_sensitive         GGACGAACATTTACACGTACTACAACGTGATCATCTTTTCAACGCAGGTTGTTGCCGAGA 
ILRAD700_sensitive      GGACGAACATTTACACGTACTACAACGTGATCATCTTTTCAACGCAGGTTGTTGCCGAGA 
                        ************************************************************ 
 
H65_resistant           TATTCATGCTGACGCCAGTTGGCAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGGCT 
H89_resistant           TATTCATGCTGACGCCAGTTGGCAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGGCT 
H988_sensitive          TATTCATGCTGACGCCAGTTGGCAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGGCT 
H1008_sensitive         TATTCATGCTGACGCCAGTTGGCAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGGCT 
ILRAD700_sensitive      TATTCATGCTGACGCCAGTTGGCAGGAGGATCCCTCTGCACCCGAGGCTGTGCGTTGGCT 
                        ************************************************************ 
 
H65_resistant           TCGCCCTCCCATTTTTTCAGCTGCTTTCGTATATGATGGCCACTACGTTCCACACGACGG 
H89_resistant           TCGCCCTCCCATTTTTTCAGCTGCTTTCGTATATGATGGCCACTACGTTCCACACGACGG 
H988_sensitive          TCGCCCTCCCATTTTTTCAGCTGCTTTCGTATATGATGGCCACTACGTTCCACACGACGG 
H1008_sensitive         TCGCCCTCCCATTTTTTCAGCTGCTTTCGTATATGATGGCCACTACGTTCCACACGACGG 
ILRAD700_sensitive      TCGCCCTCCCATTTTTTCAGCTGCTTTCGTATATGATGGCCACTACGTTCCACACGACGG 
                        ************************************************************ 
 
H65_resistant           AGGCCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCAT 
H89_resistant           AGGCCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCAT 
H988_sensitive          AGGCCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCAT 
H1008_sensitive         AGGCCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCAT 
ILRAD700_sensitive      AGGCCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCAT 
                        ************************************************************ 
H65_resistant           TCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCAT 
H89_resistant           TCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCAT 
H988_sensitive          TCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCAT 
H1008_sensitive         TCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCAT 
ILRAD700_sensitive      TCTGCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCAT 
                        ************************************************************
Annex         151 
H65_resistant           ACGTCTTTGGACTCCCACTTTCTGG 
H89_resistant           ACGTCTTTGGACTCCCACTTTCTGG 
H988_sensitive          ACGTCTTTGGACTCCCACTTTCTGG 
H1008_sensitive         ACGTCTTTGGACTCCCACTTTCTGG 
ILRAD700_sensitive      ACGTCTTTGGACTCCCACTTTCTGG 
                        ************************* 
 
 
>TvY486_0043680F2  ccggtgcaaagacgttattc 
>TvY486_0043680R2  CTGCTCAACGCTCCTCTTCT 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           CCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCATTCT 
H89_resistant           CCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCATTCT 
H988_sensitive          CCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCATTCT 
H1008_sensitive         CCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCATTCT 
ILRAD700_sensitive      CCGGTGCAAAGACGTTATTCCTTGCCATGGCATTTGTGAACGGCCTGTCAAAGTCATTCT 
                        ************************************************************ 
 
H65_resistant           GCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCATACG 
H89_resistant           GCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCATACG 
H988_sensitive          GCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCATACG 
H1008_sensitive         GCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCATACG 
ILRAD700_sensitive      GCGGGTCCAGCACCGTGGCTCTCGCGGGCCCGTTTCCCACCCGGTTCATTGGAGCATACG 
                        ************************************************************ 
 
H65_resistant           TCTTTGGACTCCCACTTTCTGGCGTGATCACTTCCATCCTGTCCATGTCGATCCAGGGGT 
H89_resistant           TCTTTGGACTCCCACTTTCTGGCGTGATCACTTCCATCCTGTCCATGTCGATCCAGGGGT 
H988_sensitive          TCTTTGGACTCCCACTTTCTGGCGTGATCACTTCCATCCTGTCCATGTCGATCCAGGGGT 
H1008_sensitive         TCTTTGGACTCCCACTTTCTGGCGTGATCACTTCCATCCTGTCCATGTCGATCCAGGGGT 
ILRAD700_sensitive      TCTTTGGACTCCCACTTTCTGGCGTGATCACTTCCATCCTGTCCATGTCGATCCAGGGGT 
                        ************************************************************ 
H65_resistant           CAATGAGCAACGACTTCAACAGTCTCTTGACTCAGTCGTACATATATTTCTCCACGACAT 
H89_resistant           CAATGAGCAACGACTTCAACAGTCTCTTGACTCAGTCGTACATATATTTCTCCACGACAT 
H988_sensitive          CAATGAGCAACGACTTCAACAGTCTCTTGACTCAGTCGTACATATATTTCTCCACGACAT 
H1008_sensitive         CAATGAGCAACGACTTCAACAGTCTCTTGACTCAGTCGTACATATATTTCTCCACGACAT 
ILRAD700_sensitive      CAATGAGCAACGACTTCAACAGTCTCTTGACTCAGTCGTACATATATTTCTCCACGACAT 
                        ************************************************************ 
152        Annex 
H65_resistant           TGGCTTTTCAAGTCATCGCATGCGTTCTGCTGTTCCTGCTCCCCAAGAATCCGTACGCCC 
H89_resistant           TGGCTTTTCAAGTCATCGCATGCGTTCTGCTGTTCCTGCTCCCCAAGAATCCGTACGCCC 
H988_sensitive          TGGCTTTTCAAGTCATCGCATGCGTTCTGCTGTTCCTGCTCCCCAAGAATCCGTACGCCC 
H1008_sensitive         TGGCTTTTCAAGTCATCGCATGCGTTCTGCTGTTCCTGCTCCCCAAGAATCCGTACGCCC 
ILRAD700_sensitive      TGGCTTTTCAAGTCATCGCATGCGTTCTGCTGTTCCTGCTCCCCAAGAATCCGTACGCCC 
                        ************************************************************ 
 
H65_resistant           TGCGCTATGCGGCGGAGCTCAGGTACGCTGTGAGGAAGAACAATGCAGGTGGCGACGCGG 
H89_resistant           TGCGCTATGCGGCGGAGCTCAGGTACGCTGTGAGGAAGAACAATGCAGGTGGCGACGCGG 
H988_sensitive          TGCGCTATGCGGCGGAGCTCAGGTACGCTGTGAGGAAGAACAATGCAGGTGGCGACGCGG 
H1008_sensitive         TGCGCTATGCGGCGGAGCTCAGGTACGCTGTGAGGAAGAACAATGCAGGTGGCGACGCGG 
ILRAD700_sensitive      TGCGCTATGCGGCGGAGCTCAGGTACGCTGTGAGGAAGAACAATGCAGGTGGCGACGCGG 
                        ************************************************************ 
 
H65_resistant           GAGACAAGGACGGGCTCGAACCCCTCCCAACAAGCGAGCCCGTGAATGACGGTGACCAAG 
H89_resistant           GAGACAAGGACGGGCTCGAACCCCTCCCAACAAGCGAGCCCGTGAATGACGGTGACCAAG 
H988_sensitive          GAGACAAGGACGGGCTCGAACCCCTCCCAACAAGCGAGCCCGTGAATGACGGTGACCAAG 
H1008_sensitive         GAGACAAGGACGGGCTCGAACCCCTCCCAACAAGCGAGCCCGTGAATGACGGTGACCAAG 
ILRAD700_sensitive      GAGACAAGGACGGGCTCGAACCCCTCCCAACAAGCGAGCCCGTGAATGACGGTGACCAAG 
                        ************************************************************ 
 
H65_resistant           CACAGCCGGTGGTGAGGAGCGTCCTGGACACGACGGTCGACCCGGATACGATGAAGGACA 
H89_resistant           CACAGCCGGTGGTGAGGAGCGTCCTGGACACGACGGTCGACCCGGATACGATGAAGGACA 
H988_sensitive          CACAGCCGGTGGTGAGGAGCGTCCTGGACACGACGGTCGACCCGGATACGATGAAGGACA 
H1008_sensitive         CACAGCCGGTGGTGAGGAGCGTCCTGGACACGACGGTCGACCCGGATACGATGAAGGACA 
ILRAD700_sensitive      CACAGCCGGTGGTGAGGAGCGTCCTGGACACGACGGTCGACCCGGATACGATGAAGGACA 
                        ************************************************************ 
 
H65_resistant           CTGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCG 
H89_resistant           CTGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCG 
H988_sensitive          CTGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCG 
H1008_sensitive         CTGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCG 
ILRAD700_sensitive      CTGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCG 
                        ************************************************************ 
H65_resistant           TCGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCC 
H89_resistant           TCGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCC 
H988_sensitive          TCGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCC 
H1008_sensitive         TCGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCC 
ILRAD700_sensitive      TCGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCC 
                        ************************************************************
Annex         153 
H65_resistant           TCTTCT 
H89_resistant           TCTTCT 
H988_sensitive          TCTTCT 
H1008_sensitive         TCTTCT 
ILRAD700_sensitive      TCTTCT 
                        ****** 
 
 
>TvY486_0043680F3  tgatcaggtcgaaaacacca 
>TvY486_0043680R3  GTGGTGCAAAGCAAAATGAA 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           TGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGT 
H89_resistant           TGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGT 
H988_sensitive          TGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGT 
H1008_sensitive         TGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGT 
ILRAD700_sensitive      TGATCAGGTCGAAAACACCACCAACGCAGAACAGATGTTGAAGGCGGAGATCTGGGTCGT 
                        ************************************************************ 
 
H65_resistant           CGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCCT 
H89_resistant           CGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCCT 
H988_sensitive          CGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCCT 
H1008_sensitive         CGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCCT 
ILRAD700_sensitive      CGTCAAGCGCATATACCCAATCCTCGCCACGTGCTTTTTAGTCTACTGCTCAACGCTCCT 
                        ************************************************************ 
 
H65_resistant           CTTCTGGCCCGGCGTCTTCATTGCTGTGGACCCAAAGGGGTGGAATTTTTGGTACACCAC 
H89_resistant           CTTCTGGCCCGGCGTCTTCATTGCTGTGGACCCAAAGGGGTGGAATTTTTGGTACACCAC 
H988_sensitive          CTTCTGGCCCGGCGTCTTCATTGCTGTGGACCCAAAGGGGTGGAATTTTTGGTACACCAC 
H1008_sensitive         CTTCTGGCCCGGCGTCTTCATTGCTGTGGACCCAAAGGGGTGGAATTTTTGGTACACCAC 
ILRAD700_sensitive      CTTCTGGCCCGGCGTCTTCATTGCTGTGGACCCAAAGGGGTGGAATTTTTGGTACACCAC 
                        ************************************************************ 
H65_resistant           GATCATGATGGCTATGTTCAACTTTGGTGACTTCTTCTCGCGCCTGCAGCTTCAGTTCAA 
H89_resistant           GATCATGATGGCTATGTTCAACTTTGGTGACTTCTTCTCGCGCCTGCAGCTTCAGTTCAA 
H988_sensitive          GATCATGATGGCTATGTTCAACTTTGGTGACTTCTTCTCGCGCCTGCAGCTTCAGTTCAA 
H1008_sensitive         GATCATGATGGCTATGTTCAACTTTGGTGACTTCTTCTCGCGCCTGCAGCTTCAGTTCAA 
ILRAD700_sensitive      GATCATGATGGCTATGTTCAACTTTGGTGACTTCTTCTCGCGCCTGCAGCTTCAGTTCAA 
                        ************************************************************ 
154        Annex 
H65_resistant           GAACCTCCACCCGTCCCCGCGGACGGTGATCATCGGCGCGTTCGCTCGCCTGCTGATCAT 
H89_resistant           GAACCTCCACCCGTCCCCGCGGACGGTGATCATCGGCGCGTTCGCTCGCCTGCTGATCAT 
H988_sensitive          GAACCTCCACCCGTCCCCGCGGACGGTGATCATCGGCGCGTTCGCTCGCCTGCTGATCAT 
H1008_sensitive         GAACCTCCACCCGTCCCCGCGGACGGTGATCATCGGCGCGTTCGCTCGCCTGCTGATCAT 
ILRAD700_sensitive      GAACCTCCACCCGTCCCCGCGGACGGTGATCATCGGCGCGTTCGCTCGCCTGCTGATCAT 
                        ************************************************************ 
 
H65_resistant           CGTGCCGCTCTTCCTCTGTCAGAAGAAGGTGATAGAGGGCAACTCGGCCAAGGTGCTGTG 
H89_resistant           CGTGCCGCTCTTCCTCTGTCAGAAGAAGGTGATAGAGGGCAACTCGGCCAAGGTGCTGTG 
H988_sensitive          CGTGCCGCTCTTCCTCTGTCAGAAGAAGGTGATAGAGGGCAACTCGGCCAAGGTGCTGTG 
H1008_sensitive         CGTGCCGCTCTTCCTCTGTCAGAAGAAGGTGATAGAGGGCAACTCGGCCAAGGTGCTGTG 
ILRAD700_sensitive      CGTGCCGCTCTTCCTCTGTCAGAAGAAGGTGATAGAGGGCAACTCGGCCAAGGTGCTGTG 
                        ************************************************************ 
 
H65_resistant           CTTGTTCCTGTCCCTCTTCTGGGGCCTCTCGAACGGTGTCTGTGGGGGTATGATGATCAT 
H89_resistant           CTTGTTCCTGTCCCTCTTCTGGGGCCTCTCGAACGGTGTCTGTGGGGGTATGATGATCAT 
H988_sensitive          CTTGTTCCTGTCCCTCTTCTGGGGCCTCTCGAACGGTGTCTGTGGGGGTATGATGATCAT 
H1008_sensitive         CTTGTTCCTGTCCCTCTTCTGGGGCCTCTCGAACGGTGTCTGTGGGGGTATGATGATCAT 
ILRAD700_sensitive      CTTGTTCCTGTCCCTCTTCTGGGGCCTCTCGAACGGTGTCTGTGGGGGTATGATGATCAT 
                        ************************************************************ 
 
H65_resistant           TTACGGGCCGAGAACTGCATCCCTGACAACAGCCGGGCAGCGCTCGATCGCCGGCATATG 
H89_resistant           TTACGGGCCGAGAACTGCATCCCTGACAACAGCCGGGCAGCGCTCGATCGCCGGCATATG 
H988_sensitive          TTACGGGCCGAGAACTGCATCCCTGACAACAGCCGGGCAGCGCTCGATCGCCGGCATATG 
H1008_sensitive         TTACGGGCCGAGAACTGCATCCCTGACAACAGCCGGGCAGCGCTCGATCGCCGGCATATG 
ILRAD700_sensitive      TTACGGGCCGAGAACTGCATCCCTGACAACAGCCGGGCAGCGCTCGATCGCCGGCATATG 
                        ************************************************************ 
 
H65_resistant           CAACAACGTGTCACTGCTAATGGGCCTCTTCTTGGGGTCGGCGGGGGCACTGGGTTTGGA 
H89_resistant           CAACAACGTGTCACTGCTAATGGGCCTCTTCTTGGGGTCGGCGGGGGCACTGGGTTTGGA 
H988_sensitive          CAACAACGTGTCACTGCTAATGGGCCTCTTCTTGGGGTCGGCGGGGGCACTGGGTTTGGA 
H1008_sensitive         CAACAACGTGTCACTGCTAATGGGCCTCTTCTTGGGGTCGGCGGGGGCACTGGGTTTGGA 
ILRAD700_sensitive      CAACAACGTGTCACTGCTAATGGGCCTCTTCTTGGGGTCGGCGGGGGCACTGGGTTTGGA 
                        ************************************************************ 
H65_resistant           GAAGCACTTGTGATATCACTAGGATCTAAGGTAGATGCTAATCTTCATTGAGTAAAGCGT 
H89_resistant           GAAGCACTTGTGATATCACTAGGATCTAAGGTAGATGCTAATCTTCATTGAGTAAAGCGT 
H988_sensitive          GAAGCACTTGTGATATCACTAGGATCTAAGGTAGATGCTAATCTTCATTGAGTAAAGCGT 
H1008_sensitive         GAAGCACTTGTGATATCACTAGGATCTAAGGTAGATGCTAATCTTCATTGAGTAAAGCGT 
ILRAD700_sensitive      GAAGCACTTGTGATATCACTAGGATCTAAGGTAGATGCTAATCTTCATTGAGTAAAGCGT 
                        ************************************************************
Annex         155 
H65_resistant           TAAGAGGTCTAAACAGAAAAAACGGGCAAAAAACTACACCTCCCCACTTTCCCCCTCTGT 
H89_resistant           TAAGAGGTCTAAACAGAAAAAACGGGCAAAAAACTACACCTCCCCACTTTCCCCCTCTGT 
H988_sensitive          TAAGAGGTCTAAACAGAAAAAACGGGCAAAAAACTACACCTCCCCACTTTCCCCCTCTGT 
H1008_sensitive         TAAGAGGTCTAAACAGAAAAAACGGGCAAAAAACTACACCTCCCCACTTTCCCCCTCTGT 
ILRAD700_sensitive      TAAGAGGTCTAAACAGAAAAAACGGGCAAAAAACTACACCTCCCCACTTTCCCCCTCTGT 
                        ************************************************************ 
 
H65_resistant           TTTCTCCACATATGTAAACGCATGTGGTGCAAAGCAAAATGAA 
H89_resistant           TTTCTCCACATATGTAAACGCATGTGGTGCAAAGCAAAATGAA 
H988_sensitive          TTTCTCCACATATGTAAACGCATGTGGTGCAAAGCAAAATGAA 
H1008_sensitive         TTTCTCCACATATGTAAACGCATGTGGTGCAAAGCAAAATGAA 
ILRAD700_sensitive      TTTCTCCACATATGTAAACGCATGTGGTGCAAAGCAAAATGAA 




156        Annex 
Sequencing performed on TvY486_0202110 using 2 resistant and 3 sensitive T. vivax strains 
 
 
>TvY486_0202110F1  GCAAACATGATTCTTTCTCTTTGAT 
>TvY486_0202110R1  ataatataccggtgatgactccaga  
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           GCAAACATGATTCTTTCTCTTTGATCTAGTCAAGGGACACGCACCCTCCACTGCCAAATA 
H988_sensitive          GCAAACATGATTCTTTCTCTTTGATCTAGTCAAGGGACACGCACCCTCCACTGCCAAATA 
H1008_sensitive         GCAAACATGATTCTTTCTCTTTGATCTAGTCAAGGGACACGCACCCTCCACTGCCAAATA 
ILRAD700_sensitive      GCAAACATGATTCTTTCTCTTTGATCTAGTCAAGGGACACGCACCCTCCACTGCCAAATA 
                        ************************************************************ 
 
H65_resistant           GATTTTCCAGAAAATGGCAGTGTTAGGGTTTGAGTCCACCTCGGCCCTGCTTGTTTACGT 
H988_sensitive          GATTTTCCAGAAAATGGCAGTGTTAGGGTTTGAGTCCACCTCGGCCCTGCTTGTTTACGT 
H1008_sensitive         GATTTTCCAGAAAATGGCAGTGTTAGGGTTTGAGTCCACCTCGGCCCTGCTTGTTTACGT 
ILRAD700_sensitive      GATTTTCCAGAAAATGGCAGTGTTAGGGTTTGAGTCCACCTCGGCCCTGCTTGTTTACGT 
                        ************************************************************ 
 
H65_resistant           GAGCTTCCTGTTCTTTGGGATGTCGCTGATGCTGACCGCCAACTCTATATATTCCTTATA 
H988_sensitive          GAGCTTCCTGTTCTTTGGGATGTCGCTGATGCTGACCGCCAACTCTATATATTCCTTATA 
H1008_sensitive         GAGCTTCCTGTTCTTTGGGATGTCGCTGATGCTGACCGCCAACTCTATATATTCCTTATA 
ILRAD700_sensitive      GAGCTTCCTGTTCTTTGGGATGTCGCTGATGCTGACCGCCAACTCTATATATTCCTTATA 
                        ************************************************************ 
 
H65_resistant           CGGCTACTCCACAGAGTTTTACAGATTGGCACAGGGCGACCCGAATGCCACAACCAGCGA 
H988_sensitive          CGGCTACTCCACAGAGTTTTACAGATTGGCACAGGGCGACCCGAATGCCACAACCAGCGA 
H1008_sensitive         CGGCTACTCCACAGAGTTTTACAGATTGGCACAGGGCGACCCGAATGCCACAACCAGCGA 
ILRAD700_sensitive      CGGCTACTCCACAGAGTTTTACAGATTGGCACAGGGCGACCCGAATGCCACAACCAGCGA 
                        ************************************************************ 
 
H65_resistant           CCCCGACTTCTGGAAGAATATCTACACATATTATAACGTGGTGTTGTTTAGCCTGCAACT 
H988_sensitive          CCCCGACTTCTGGAAGAATATCTACACATATTATAACGTGGTGTTGTTTAGCCTGCAACT 
H1008_sensitive         CCCCGACTTCTGGAAGAATATCTACACATATTATAACGTGGTGTTGTTTAGCCTGCAACT 
ILRAD700_sensitive      CCCCGACTTCTGGAAGAATATCTACACATATTATAACGTGGTGTTGTTTAGCCTGCAACT 
                        ************************************************************ 
Annex         157 
H65_resistant           TTCTACAGAGCTATTCATGCTGACTCCGCTCGGAAGAAGGATCCCATTGCGGCTGAGGTT 
H988_sensitive          TTCTACAGAGCTATTCATGCTGACTCCGCTCGGAAGAAGGATCCCATTGCGGCTGAGGTT 
H1008_sensitive         TTCTACAGAGCTATTCATGCTGACTCCGCTCGGAAGAAGGATCCCATTGCGGCTGAGGTT 
ILRAD700_sensitive      TTCTACAGAGCTATTCATGCTGACTCCGCTCGGAAGAAGGATCCCATTGCGGCTGAGGTT 
                        ************************************************************ 
 
H65_resistant           GGCGCTAGGCTTCTCCCTTTCGTTCGTGCAGCTCCTTTCGTACATGATGGTCACCACATT 
H988_sensitive          GGCGCTAGGCTTCTCCCTTTCGTTCGTGCAGCTCCTTTCGTACATGATGGTCACCACATT 
H1008_sensitive         GGCGCTAGGCTTCTCCCTTTCGTTCGTGCAGCTCCTTTCGTACATGATGGTCACCACATT 
ILRAD700_sensitive      GGCGCTAGGCTTCTCCCTTTCGTTCGTGCAGCTCCTTTCGTACATGATGGTCACCACATT 
                        ************************************************************ 
 
H65_resistant           CCATACAAGCGAATCCGGCGCAAAGTGTGTATTTTTGTTCAGTGCTTTTGTCAATGGAAT 
H988_sensitive          CCATACAAGCGAATCCGGCGCAAAGTGTGTATTTTTGTTCAGTGCTTTTGTCAATGGAAT 
H1008_sensitive         CCATACAAGCGAATCCGGCGCAAAGTGTGTATTTTTGTTCAGTGCTTTTGTCAATGGAAT 
ILRAD700_sensitive      CCATACAAGCGAATCCGGCGCAAAGTGTGTATTTTTGTTCAGTGCTTTTGTCAATGGAAT 
                        ************************************************************ 
 
H65_resistant           TGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCCAACAAAATT 
H988_sensitive          TGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCCAACAAAATT 
H1008_sensitive         TGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCCAACAAAATT 
ILRAD700_sensitive      TGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCCAACAAAATT 
                        ************************************************************ 
 
H65_resistant           TTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTATATTAT 
H988_sensitive          TTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTATATTAT 
H1008_sensitive         TTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTATATTAT 
ILRAD700_sensitive      TTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTATATTAT 
                      *************************************************** 
 
158        Annex 
>TvY486_0202110F2  caatggaattgaaaaatctctctgt 
>TvY486_0202110R2  ggaaaaacaaaactgttgtgaaata  
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           CAATGGAATTGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCC 
H988_resistant          CAATGGAATTGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCC 
H1008_sensitive         CAATGGAATTGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCC 
ILRAD700_sensitive      CAATGGAATTGAAAAATCTCTCTGTGGCTCCAGCACTGTGGCACTTGCAGGTCCCTTTCC 
                        ************************************************************ 
 
H65_resistant           AACAAAATTTTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTAT 
H988_resistant          AACAAAATTTTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTAT 
H1008_sensitive         AACAAAATTTTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTAT 
ILRAD700_sensitive      AACAAAATTTTTTGCGGCTGTCATCCTTGGTATCCCATTTTCTGGAGTCATCACCGGTAT 
                        ************************************************************ 
 
H65_resistant           ATTATCCGTGACGGTTAAGGCATCGATGGATGGGGACTTTCACAGTTTGCTCCATCAGTC 
H988_resistant          ATTATCCGTGACGGTTAAGGCATCGATGGATGGGGACTTTCACAGTTTGCTCCATCAGTC 
H1008_sensitive         ATTATCCGTGACGGTTAAGGCATCGATGGATGGGGACTTTCACAGTTTGCTCCATCAGTC 
ILRAD700_sensitive      ATTATCCGTGACGGTTAAGGCATCGATGGATGGGGACTTTCACAGTTTGCTCCATCAGTC 
                        ************************************************************ 
 
H65_resistant           ATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCCTTTTGTATTT 
H988_resistant          ATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCCTTTTGTATTT 
H1008_sensitive         ATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCCTTTTGTATTT 
ILRAD700_sensitive      ATACATATATTTTTCCATCGCTATGGTTTTTCAGTCGGTGACCTGCGTCCTTTTGTATTT 
                        ************************************************************ 
 
H65_resistant           GCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACGCGGCGAGGGG 
H988_resistant          GCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACGCGGCGAGGGG 
H1008_sensitive         GCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACGCGGCGAGGGG 
ILRAD700_sensitive      GCTTCCGCGAAATCCGTATGCTTTACGCTATGCTGCAGAATTTAGGTACGCGGCGAGGGG 
                        ************************************************************ 
 
H65_resistant           TAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTGCACCTGATTC 
H988_resistant          TAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTGCACCTGATTC 
H1008_sensitive         TAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTGCACCTGATTC 
ILRAD700_sensitive      TAATCCTGTTGAGTGTGAGGAGCAGACGGAAAAGAAGGAAGCAAATGGTGCACCTGATTC 
                        ************************************************************ 
Annex         159 
H65_resistant           GCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGTACAACACTGC 
H988_resistant          GCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGTACAACACTGC 
H1008_sensitive         GCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGTACAACACTGC 
ILRAD700_sensitive      GCGTCCAGCGAAAGGACCGGCAGATGACTATTGTGACGATGCGCAGCCGTACAACACTGC 
                        ************************************************************ 
 
H65_resistant           AAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTGACCAGGTGGA 
H988_resistant          AAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTGACCAGGTGGA 
H1008_sensitive         AAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTGACCAGGTGGA 
ILRAD700_sensitive      AAAAAACGTCTTGGATACATCGATTGATCCGGACACGATGAAGGATACTGACCAGGTGGA 
                        ************************************************************ 
 
H65_resistant           GAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCATCAAGCGCAT 
H988_resistant          GAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCATCAAGCGCAT 
H1008_sensitive         GAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCATCAAGCGCAT 
ILRAD700_sensitive      GAACACCACTAGTGCTGAGCAGATGCTGAAGGCAGAAGTGTGGGTTGTCATCAAGCGCAT 
                        ************************************************************ 
 
H65_resistant           ATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGTTTTTCC 
H988_resistant          ATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGTTTTTCC 
H1008_sensitive         ATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGTTTTTCC 
ILRAD700_sensitive      ATACCCGGTCCTTTCTACGTGCTTTTTTGTCTATTTCACAACAGTTTTGTTTTTCC 




>TvY486_0202110F3  ctatttcacaacagttttgtttttcc  
>TvY486_0202110R3  acaaacacttatttaccacacaggtt  
 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           CTATTTCACAACAGTTTTGTTTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTG 
H89_resistant           CTATTTCACAACAGTTTTGTTTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTG 
H988_sensitive          CTATTTCACAACAGTTTTGTTTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTG 
H1008_sensitive         CTATTTCACAACAGTTTTGTTTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTG 
ILRAD700_sensitive      CTATTTCACAACAGTTTTGTTTTTCCCTGGTGTTTTTATCTCGGTGGATTACAAGGGCTG 
                        ************************************************************ 
160        Annex 
H65_resistant           GAATCACTGGTACGGCACTGCGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTG 
H89_resistant           GAATCACTGGTACGGCACTGCGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTG 
H988_sensitive          GAATCACTGGTACGGCACTGCGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTG 
H1008_sensitive         GAATCACTGGTACGGCACTGCGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTG 
ILRAD700_sensitive      GAATCACTGGTACGGCACTGCGGTGATGGTTGTGTTCAATTTGGGTGATTTTGTTTCGTG 
                        ************************************************************ 
 
H65_resistant           TATGTTTCTTCAGTTCAAGAGAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATT 
H89_resistant           TATGTTTCTTCAGTTCAAGAGAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATT 
H988_sensitive          TATGTTTCTTCAGTTCAAGAGAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATT 
H1008_sensitive         TATGTTTCTTCAGTTCAAGAGAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATT 
ILRAD700_sensitive      TATGTTTCTTCAGTTCAAGAGAAATCACCCATCACCGAAGGCAGTGATTATAGGGTCATT 
                        ************************************************************ 
 
H65_resistant           CGCTCGCCTACTGATTGCAGTACCGCTTTTCCTTTGCCAACGTCGTATAATAGAGGGCCA 
H89_resistant           CGCTCGCCTACTGATTGCAGTACCGCTTTTCCTTTGCCAACGTCGTATAATAGAGGGCCA 
H988_sensitive          CGCTCGCCTACTGATTGCAGTACCGCTTTTCCTTTGCCAACGTCGTATAATAGAGGGCCA 
H1008_sensitive         CGCTCGCCTACTGATTGCAGTACCGCTTTTCCTTTGCCAACGTCGTATAATAGAGGGCCA 
ILRAD700_sensitive      CGCTCGCCTACTGATTGCAGTACCGCTTTTCCTTTGCCAACGTCGTATAATAGAGGGCCA 
                        ************************************************************ 
 
H65_resistant           TGCCGCCAAAGCGTTGTCCTGTGTTCTTTCACTCCTCTGGGGTATGACCAACGGTTTTTG 
H89_resistant           TGCCGCCAAAGCGTTGTCCTGTGTTCTTTCACTCCTCTGGGGTATGACCAACGGTTTTTG 
H988_sensitive          TGCCGCCAAAGCGTTGTCCTGTGTTCTTTCACTCCTCTGGGGTATGACCAACGGTTTTTG 
H1008_sensitive         TGCCGCCAAAGCGTTGTCCTGTGTTCTTTCACTCCTCTGGGGTATGACCAACGGTTTTTG 
ILRAD700_sensitive      TGCCGCCAAAGCGTTGTCCTGTGTTCTTTCACTCCTCTGGGGTATGACCAACGGTTTTTG 
                        ************************************************************ 
 
H65_resistant           TGGCGGTATGATGCTTATTTACGGACCAAGGACCGCGTCGCTTACAACGGCAGGCCAGCG 
H89_resistant           TGGCGGTATGATGCTTATTTACGGACCAAGGACCGCGTCGCTTACAACGGCAGGCCAGCG 
H988_sensitive          TGGCGGTATGATGCTTATTTACGGACCAAGGACCGCGTCGCTTACAACGGCAGGCCAGCG 
H1008_sensitive         TGGCGGTATGATGCTTATTTACGGACCAAGGACCGCGTCGCTTACAACGGCAGGCCAGCG 
ILRAD700_sensitive      TGGCGGTATGATGCTTATTTACGGACCAAGGACCGCGTCGCTTACAACGGCAGGCCAGCG 
                        ************************************************************ 
 
H65_resistant           TTCTCTTGCCGGGATATGCAACAATGTGTCACTACTGGTGGGCCTTTTTGCAGGTTCGGC 
H89_resistant           TTCTCTTGCCGGGATATGCAACAATGTGTCACTACTGGTGGGCCTTTTTGCAGGTTCGGC 
H988_sensitive          TTCTCTTGCCGGGATATGCAACAATGTGTCACTACTGGTGGGCCTTTTTGCAGGTTCGGC 
H1008_sensitive         TTCTCTTGCCGGGATATGCAACAATGTGTCACTACTGGTGGGCCTTTTTGCAGGTTCGGC 
ILRAD700_sensitive      TTCTCTTGCCGGGATATGCAACAATGTGTCACTACTGGTGGGCCTTTTTGCAGGTTCGGC 
                        ************************************************************ 
Annex         161 
 
H65_resistant           AGCGGCAATAGGACTGAGCAAGACGCTGTAATGTGAGTGGGTTCCAGAAAAGGTTTAAGA 
H89_resistant           AGCGGCAATAGGACTGAGCAAGACGCTGTAATGTGAGTGGGTTCCAGAAAAGGTTTAAGA 
H988_sensitive          AGCGGCAATAGGACTGAGCAAGACGCTGTAACGTGAGTGGGTTCCAGAAAAGGTTTAAGA 
H1008_sensitive         AGCGGCAATAGGACTGAGCAAGACGCTGTAACGTGAGTGGGTTCCAGAAAAGGTTTAAGA 
ILRAD700_sensitive      AGCGGCAATAGGACTGAGCAAGACGCTGTAACGTGAGTGGGTTCCAGAAAAGGTTTAAGA 
                        ******************************* **************************** 
 
H65_resistant           GTATACTTATTGTTATTTTTTTCTATTTTTAACCTGTGTGGTAAATAAGTGTTTAA 
H89_resistant           GTATACTTATTGTTATTTTTTTCTATTTTTAACCTGTGTGGTAAATAAGTGTTTGT 
H988_sensitive          GTATACTTATTGTTATTTTTTTCTATTTTTAACCTGTGTGGTAAATAAGTGTTTGT 
H1008_sensitive         GTATACTTATTGTTATTTTTTTCTATTTTTAACCTGTGTGGTAAATAAGTGTTTGT 
ILRAD700_sensitive      GTATACTTATTGTTATTTTTTTCTATTTTTAACCTGTGTGGTAAATAAGTGTTTGT 
                        ******************************************************   
 
 
162        Annex 
Sequencing performed on TvY486_1103740 using 2 resistant and 3 sensitive T. vivax strains 
 
>TvY486_1103740F1  TGTTGTCCAGCTGCTTTCCTA 
>TvY486_1103740R1  TTCTCCATCGACCCCTTGAT  
 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           TGTTGTCCAGCTGCTTTCCTAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGC 
H89_resistant           TGTTGTCCAGCTGCTTTCCTAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGC 
H988_sensitive          TGTTGTCCAGCTGCTTTCCTAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGC 
H1008_sensitive         TGTTGTCCAGCTGCTTTCCTAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGC 
ILRAD700_sensitive      TGTTGTCCAGCTGCTTTCCTAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGC 
                        ************************************************************ 
 
H65_resistant           TTCGGAGGTCTACGTGTATGTGACCTGCGTTATCCTTGGCATTGCGATTCTCACGCCCCT 
H89_resistant           TTCGGAGGTCTACGTGTATGTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCT 
H988_sensitive          TTCGGAGGTCTACGTGTATGTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCT 
H1008_sensitive         TTCGGAGGTCTACGTGTATGTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCT 
ILRAD700_sensitive      TTCGGAGGTCTACGTGTATGTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCT 
                        **************************** ******************************* 
 
H65_resistant           CAAGTGCCTGGTGTCTGCACCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGA 
H89_resistant           CAAGTGCCTGGTGTCTGCACCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGA 
H988_sensitive          CAAGTGCCTGGTGTCTGCACCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGA 
H1008_sensitive         CAAGTGCCTGGTGTCTGCACCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGA 
ILRAD700_sensitive      CAAGTGCCTGGTGTCTGCACCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGA 
                        ************************************************************ 
 
H65_resistant           TCCGGACGCCAAGCCAACCCCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGTGC 
H89_resistant           TCCGGACGCCAAGCCAACTCCCCCCATCTTCTGGGCTAACATTCTCACATTCTAAAGTGC 
H988_sensitive          TCCGGACGCCAAGCCAACCCCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGCGC 
H1008_sensitive         TCCGGACGCCAAGCCAACCCCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGTGC 
ILRAD700_sensitive      TCCGGACGCCAAGCCAACCCCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGTGC 
                        ****************** *********************************** ** ** 
Annex         163 
H65_resistant           AGTGTCATTGGTGACGCAGATACTTTTTGGACCCACAGTTCTCACTCGCACGGTCAGGCG 
H89_resistant           AGTGTCATTGGTGACACAAATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCG 
H988_sensitive          AGTGTCATTGGTGACACAAATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCG 
H1008_sensitive         AGTGTCATTGGTGACGCAGATACTTTTTGGACCCACAGTTCTCACTCGCACGGTCAGGCG 
ILRAD700_sensitive      AGTGTCATTGGTGACGCAAATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCG 
                        *************** ** ***** ** *  ***************************** 
 
H65_resistant           CCTCTCCTTGAGTACGCGCTTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGC 
H89_resistant           CCTCTCCTTGAGTACGCGCTTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGC 
H988_sensitive          CCTCTCCTTGAGTACGCGCTTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGC 
H1008_sensitive         CCTCTCCTTGAGTACGCGCTTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGC 
ILRAD700_sensitive      CCTCTCCTTGAGTACGCGCTTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGC 
                        ************************************************************ 
 
H65_resistant           TGTTCTCTTCATGCCTGTAGTGAAAGTTCCGCAGACTGTCGCCATAGTTGTGTTTTTCAT 
H89_resistant           TGTTCTCTTCATGCCTGTAGTGAAAGTTATGCAGACTGTCGCCATAGTTGTGTTTTTCAT 
H988_sensitive          TGTTCTCTTCATGCCTGTAGTGAAAGTTACGCAGACTGTCGCCATAGTTGTGTTTTTCAT 
H1008_sensitive         TGTTCTCTTCATGCCTGTAGTGAAAGTTCCGCAGACTGTCGCCATAGTTGTGTTTTTCAT 
ILRAD700_sensitive      TGTTCTCTTCATGCCTGTAGTGAAAGTTACGCAGACTGTCGCCATAGTTGTGTTTTTCAT 
                        ****************************  ****************************** 
 
H65_resistant           TGCCATTATACTGTCTGGGATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGT 
H89_resistant           TGTCATTATACTGTCTGGGATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGT 
H988_sensitive          TGTCATTATACTGTCTGGGATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGT 
H1008_sensitive         TGCCATTATACTGTCTGGGATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGT 
ILRAD700_sensitive      TGCCATTATACTGTCTGGGATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGT 
                        ** ********************************************************* 
 
H65_resistant           GTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTGCTCGTTCTCTGGCGT 
H89_resistant           GTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTGCTCGTTCTCTGGCGT 
H988_sensitive          GTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTGCTCGTTCTCTGGCGT 
H1008_sensitive         GTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTGCTCGTTCTCTGGCGT 
ILRAD700_sensitive      GTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTGCTCGTTCTCTGGCGT 
                        ************************************************************ 
 
H65_resistant           GATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H89_resistant           GATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H988_sensitive          GATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H1008_sensitive         GATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
ILRAD700_sensitive      GATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
                        *********************************************
164        Annex 
>TvY486_1103740F2  ACATATGGAGGCCACCACTTAC 
>TvY486_1103740R2  ATCACCAAAGTTGTAGCACAGAATC 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           ACATATGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGG 
H89_resistant           ACATATGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGG 
H988_sensitive          ACATATGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGG 
H1008_sensitive         ACATATGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGG 
ILRAD700_sensitive      ACATATGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGG 
                        ************************************************************ 
 
H65_resistant           TGCCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAA 
H89_resistant           TGCCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAA 
H988_sensitive          TGCCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAA 
H1008_sensitive         TGCCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAA 
ILRAD700_sensitive      TGCCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAA 
                        ************************************************************ 
 
H65_resistant           GGGGTTGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCT 
H89_resistant           GGGGTTGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCT 
H988_sensitive          GGGGTTGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCT 
H1008_sensitive         GGGGTTGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCT 
ILRAD700_sensitive      GGGGTTGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCT 
                        ************************************************************ 
 
H65_resistant           TGGGATGGTGATTATAGCCGCCTCACTTGTCATGACTTATTCGCTGCGCTGCAATTCCTA 
H89_resistant           TGGGATGGTGATTATAGCCGCCTCACTTGTCATGACTTATTCGCTGCGCTGCAATTCCTA 
H988_sensitive          TGGGATGGTGATTATAGCCGCCTCACTTGTCATGACTTATTCGCTGCGCTGCAATTCCTA 
H1008_sensitive         TGGGATGGTGATTATAGCCGCCTCACTTGTCATGACTTATTCGCTGCGCTGCAATTCCTA 
ILRAD700_sensitive      TGGGATGGTGATTATAGCCGCCTCACTTGTCATGACTTATTCGCTGCGCTGCAATTCCTA 
                        ************************************************************ 
 
H65_resistant           CGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGG 
H89_resistant           CGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGG 
H988_sensitive          CGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGG 
H1008_sensitive         CGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGG 
ILRAD700_sensitive      CGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGG 
                        ************************************************************ 
 
Annex         165 
H65_resistant           ATGCCACAACGGCACAGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGAGAATGA 
H89_resistant           ATGCCACAACGGCACAGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGAGAATGA 
H988_sensitive          ATGCCACAACGGCACAGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGAGAATGA 
H1008_sensitive         ATGCCACAACGGCACAGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGAGAATGA 
ILRAD700_sensitive      ATGCCACAACGGCACAGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGAGAATGA 
                        ************************************************************ 
 
H65_resistant           TGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCC 
H89_resistant           TGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCC 
H988_sensitive          TGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCC 
H1008_sensitive         TGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCC 
ILRAD700_sensitive      TGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCC 
                        ************************************************************ 
 
H65_resistant           TGTATTAAAGAAAATACACCTGATGATGACCACGTGCTCCATTTCCTTCTTTGTCACGCT 
H89_resistant           TGTATTAAAGAAAATACACCTGATGATGACCACGTGCTCCATTTCCTTCTTTGTCACGCT 
H988_sensitive          TGTATTAAAGAAAATACACCTGATGATGACCACGTGCTCCATTTCCTTCTTTGTCACGCT 
H1008_sensitive         TGTATTAAAGAAAATACACCTGATGATGACCACGTGCTCCATTTCCTTCTTTGTCACGCT 
ILRAD700_sensitive      TGTATTAAAGAAAATACACCTGATGATGACCACGTGCTCCATTTCCTTCTTTGTCACGCT 
                        ************************************************************ 
 
H65_resistant           CTTTGTATTTCCAACGCTTATCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCT 
H89_resistant           CTTTGTATTTCCAACGCTTATCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCT 
H988_sensitive          CTTTGTATTTCCAACGCTTATCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCT 
H1008_sensitive         CTTTGTATTTCCAACGCTTATCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCT 
ILRAD700_sensitive      CTTTGTATTTCCAACGCTTATCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCT 
                        ************************************************************ 
 
H65_resistant           TGCGATTCTGTGCTACAACTTTGGTGAT 
H89_resistant           TGCGATTCTGTGCTACAACTTTGGTGAT 
H988_sensitive          TGCGATTCTGTGCTACAACTTTGGTGAT 
H1008_sensitive         TGCGATTCTGTGCTACAACTTTGGTGAT 
ILRAD700_sensitive      TGCGATTCTGTGCTACAACTTTGGTGAT 
                        **************************** 
 
 
166        Annex 
>TvY486_1103740F3  TTCCTTCTTTGTCACGCTCTTTAT 
>TvY486_1103740R3  CAGTAAACGCTGCTACGTCTTAAA  
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
H65_resistant           TTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCA 
H89_resistant           TTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCA 
H988_sensitive          TTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCA 
H1008_sensitive         TTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCA 
ILRAD700_sensitive      TTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCA 
                        ************************************************************ 
 
H65_resistant           CAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTT 
H89_resistant           CAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTT 
H988_sensitive          CAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTT 
H1008_sensitive         CAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTT 
ILRAD700_sensitive      CAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTT 
                        ************************************************************ 
 
H65_resistant           TGGCACAACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTC 
H89_resistant           TGGCACAACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTC 
H988_sensitive          TGGCACAACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTC 
H1008_sensitive         TGGCACAACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTC 
ILRAD700_sensitive      TGGCACAACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTC 
                        ************************************************************ 
 
H65_resistant           CCGCTTTCTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGC 
H89_resistant           CCGCTTTCTCTTCACTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGC 
H988_sensitive          CCGCTTTCTCTTCACTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATAC 
H1008_sensitive         CCGCTTTCTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGC 
ILRAD700_sensitive      CCGCTTTCTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGC 
                        ************** ******************************************* * 
 
H65_resistant           AGTACCTTACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGAT 
H89_resistant           AGTACCTTACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGAT 
H988_sensitive          AGTACCTTACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGAT 
H1008_sensitive         AGTACCTTACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGAT 
ILRAD700_sensitive      AGTACCTTACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGAT 
                        ************************************************************ 
 
Annex         167 
H65_resistant           GGTGTACGGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCA 
H89_resistant           GGTGTACGGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCA 
H988_sensitive          GGTGTACGGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCA 
H1008_sensitive         GGTGTACGGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCA 
ILRAD700_sensitive      GGTGTACGGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCA 
                        ************************************************************ 
 
H65_resistant           GCTGATGGGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGT 
H89_resistant           GCTGATGGGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGT 
H988_sensitive          GCTGATGGGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGT 
H1008_sensitive         GCTGATGGGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGT 
ILRAD700_sensitive      GCTGATGGGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGT 
                        ************************************************************ 
 
H65_resistant           CGTGTACGCTTTGCCCTAAGGCCACAAGTTACAACATTCAGCAACATAATATTTTTCTTT 
H89_resistant           CGTGTACGCTTTGCCCTAAGGCCACAAGTTACAACATTCAGCAACATAATATTTTTCTTT 
H988_sensitive          CGTGTACGCTTTGCCCTAAGGCCACAAGTTACAACATTCAGCAACATAATATTTTTCTTT 
H1008_sensitive         CGTGTACGCTTTGCCCTAAGGCCACAAGTTACAACATTCAGCAACATAATATTTTTCTTT 
ILRAD700_sensitive      CGTGTACGCTTTGCCCTAAGGCCACAAGTTACAACATTCAGCAACATAATATTTTTCTTT 
                        ************************************************************ 
 
H65_resistant           AAGACGTAGCAGCGTTTACTG 
H89_resistant           AAGACGTAGCAGCGTTTACTG 
H988_sensitive          AAGACGTAGCAGCGTTTACTG 
H1008_sensitive         AAGACGTAGCAGCGTTTACTG 
ILRAD700_sensitive      AAGACGTAGCAGCGTTTACTG 
                        ********************* 
 
168        Annex 
Sequencing performed on TvY486_0041960 using 2 resistant and 3 sensitive T. vivax strains 
 
 
TvY486_0041960F1  TGCTGAAGTGACATCGAAGG 
TvY486_0041960R1  ACGACACCAGCGTGTAAGTG 
 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           TGCTGAAGTGACATCGAAGGTTATAAAAGGTTCTTTCCTGCCCCCACCGCACTCGAGGCA 
H89_resistant           TGCTGAAGTGACATCGAAGGTTATAAAAGGTTCTTTCCTGCCCCCACCGCACTCGAGGCA 
H988_sensitive          TGCTGAAGTGACATCGAAGGTTATAAAAGGTTCTTTCCTGCCCCCACCGCACTCGAGGCA 
H1008_sensitive         TGCTGAAGTGACATCGAAGGTTATAAAAGGTTCTTTCCTGCCCCCACCGCACTCGAGGCA 
ILRAD700_sensitive      TGCTGAAGTGACATCGAAGGTTATAAAAGGTTCTTTCCTGCCCCCACCGCACTCGAGGCA 
                        ************************************************************ 
 
H65_resistant           CCGTACGCAACGCACCTGACGCGCTCTGTTCTCCGCCTGCCTGTTGTCCGGCTGCTTTCC 
H89_resistant           CCGTACGCAACGCACCTGACGCGCTCTGTTCTCCGCCTGCCTGTTGTCCAGCTGCTTTCC 
H988_sensitive          CCGTACGCAACGCACCTGACGCGCTCTGTTCTCCGCCTGCCTGTTGTCCAGCTGCTTTCT 
H1008_sensitive         CCGTACGCAACGCACCTGACGCGCTCTGTTCTCCGCCTGCCTGTTGTCCAGCTGCTTTCC 
ILRAD700_sensitive      CCGTACGCAACGCACCTGACGCGCTCTGTTCTCCGCCTGCCTGTTGTCCAGCTGCTTTCT 
                        ************************************************* *********  
 
H65_resistant           TAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGCTTCGGAGGTCTACGTGTAT 
H89_resistant           TAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGCTTCGGAGGTCTACGTGTAT 
H988_sensitive          TAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGCTTCGGAGGTCTACGTGTAT 
H1008_sensitive         TAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGCTTCGGAGGTCTACGTGTAT 
ILRAD700_sensitive      TAGCTGCCGGCGCGCACAATGCTTTTTGGATTTACCTCCGCTTCGGAGGTCTACGTGTAT 
                        ************************************************************ 
 
H65_resistant           GTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCTCAAGTGCCTGGTGTCTGCA 
H89_resistant           GTGACCTGCATTATCCTTGGCATTGCGATTCTCACGCCCCTCAAGTGCCTGGTGTCTGCA 
H988_sensitive          GTGACCTGCGTTATCCTTGGCATTGCGATTCTCACGCCCCTCAAGTGCCTGGTGTCTGCA 
H1008_sensitive         GTGACCTGCGTTATCCTTGGCATTGCGATTCTCACGCCCCTCAAGTGCCTGGTGTCTGCA 
ILRAD700_sensitive      GTGACCTGCGTTATCCTTGGCATTGCGATTCTCACGCCCCTCAAGTGCCTGGTGTCTGCA 
                        ********* ************************************************** 
Annex         169 
H65_resistant           CCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGATCCGGACGCCAAGCCAACC 
H89_resistant           CCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGATCCGGACGCCAAGCCAACC 
H988_sensitive          CCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGATCCGGACGCCAAGCCAACC 
H1008_sensitive         CCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGATCCGGACGCCAAGCCAACC 
ILRAD700_sensitive      CCGCGCTTTATGGTCGACTACTACAAGTATGTGTCGGGTGATCCGGACGCCAAGCCAACC 
                        ************************************************************ 
 
H65_resistant           CCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGTGCAGTGTCATTGGTGACACAA 
H89_resistant           CCCCCCATCTTCTGGGCTAACATTCTCACATTCTAAAGTGCAGTGTCATTGGTGACACAA 
H988_sensitive          CCCCCCATCTCCTGGGCTAACATTCTCACATTCTACAGTGCAGTGTCATTGGTGACGCAG 
H1008_sensitive         CCCCCCATCTTCTGGGCTAACATTCTCACATTCTACAGTGCAGTGTCATTGGTGACGCAA 
ILRAD700_sensitive      CCCCCCATCTCCTGGGCTAACATTCTCACATTCTACAGTGCAGTGTCATTGGTGACGCAG 
                        ********** ************************ ******************** **  
 
H65_resistant           ATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGC 
H89_resistant           ATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGC 
H988_sensitive          ATACTTTTTGGACCCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGC 
H1008_sensitive         ATACTCTTCGCCCCCACAGTTCTCACTCGCACGGTCAGGCGCCGCTCCTTGAGTACGCGC 
ILRAD700_sensitive      ATACTTTTTGGACCCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGC 
                        ***** ** *  ******************************* **************** 
 
H65_resistant           TTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGCTGTTCTCTTCATGCCTGTA 
H89_resistant           TTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGCTGTTCTCTTCATGCCTGTA 
H988_sensitive          TTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGCTGTTCTCTTCATGCCTGTA 
H1008_sensitive         TTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGCTGTTCTCTTCATGCCTGTA 
ILRAD700_sensitive      TTCACCCTTGCCATCACATCCATGATGATTGAGATCGTGGCTGTTCTCTTCATGCCTGTA 
                        ************************************************************ 
 
H65_resistant           GTGAAAGTTACGCAGACTGTCGCCATAGTTGTGTTTTTCATTGCCATTATACTGTCTGGG 
H89_resistant           GTGAAAGTTACGCAGACTGTCGCCATAGTTGTGTTTTTCATTGTCATTATACTGTCTGGG 
H988_sensitive          GTGAAAGTTCCGCAGACTGTCGCCATAGTTGTGTTTTTCATTGCCATTATACTGTCTGGG 
H1008_sensitive         GTGAAAGTTACGCAGACTGTCGCCATAGTTGTGTTTTTCATTGCCATTATACTGTCTGGG 
ILRAD700_sensitive      GTGAAAGTTCCGCAGACTGTCGCCATAGTTGTGTTTTTCATTGCCATTATACTGTCTGGG 
                        ********* ********************************* **************** 
 
H65_resistant           ATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGTGTCGT 
H89_resistant           ATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGTGTCGT 
H988_sensitive          ATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGTGTCGT 
H1008_sensitive         ATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGTGTCGT 
ILRAD700_sensitive      ATTGGTAAGTCACATATGGAGGCCACCACTTACACGCTGGTGTCGT 
                        **********************************************




CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           CACTTACACGCTGGTGTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTG 
H89_resistant           CACTTACACGCTGGTGTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTG 
H988_sensitive          CACTTACACGCTGGTGTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTG 
H1008_sensitive         CACTTACACGCTGGTGTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTG 
ILRAD700_sensitive      CACTTACACGCTGGTGTCGTCCATGCCGTCAAAGTTCATGTCCGCTGCCATGTTTGGCTG 
                        ************************************************************ 
 
H65_resistant           CTCGTTCTCTGGCGTGATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H89_resistant           CTCGTTCTCTGGCGTGATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H988_sensitive          CTCGTTCTCTGGCGTGATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
H1008_sensitive         CTCGTTCTCTGGCGTGATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
ILRAD700_sensitive      CTCGTTCTCTGGCGTGATAACATCGGTGCTGCAGTGCGTGATCAAGGGGTCGATGGAGAA 
                        ************************************************************ 
 
H65_resistant           CACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTGGGTTGGTGATTAT 
H89_resistant           CACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTGGGTTGGTGATTAT 
H988_sensitive          CACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCCTGGGTTGGTGATTAT 
H1008_sensitive         CACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCCTGGGTTGGTGATTAT 
ILRAD700_sensitive      CACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCCTGGGTTGGTGATTAT 
                        ******************************************** *************** 
 
H65_resistant           GACCGTGGCGCTCATCATGGCGCACTCGCTGCGCTACATTTCCTACGCACAGGAGAACGT 
H89_resistant           GACCGTGGCGCTCATCATGGCGCACTCGCTGCGCTACATTTCCTACGCACAGGAGAACGT 
H988_sensitive          GACCGTGGCGCTCATCATGGCGCACTCGCTGCGCTACATTTCCTACGCACAGGAGAACGT 
H1008_sensitive         GACCGTGGCGCTCATCATGGCGCACTCGCTGCGCTACATTTCCTACGCACAGGAGAACGT 
ILRAD700_sensitive      GACCGTGGCGCTCATCATGGCGCACTCGCTGCGCTACATTTCCTACGCACAGGAGAACGT 




Annex         171 
H65_resistant           TGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGGATGCCACAACGACAC 
H89_resistant           TGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGGATGCCACAACGACAC 
H988_sensitive          TGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGGATGCCACAACGACAC 
H1008_sensitive         TGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGGATGCCACAACGACAC 
ILRAD700_sensitive      TGCTGAGTACCGCATGATGAAGCAAGCGAATAGTGACGAGGGCGGATGCCACAACGACAC 
                        ************************************************************ 
 
H65_resistant           AGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGGGAGTGTAGACGAAGAGGCGGG 
H89_resistant           AGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGGGAGTGTAGACGAAGAGGCGGG 
H988_sensitive          AGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGGGAGTGTAGACGAAGAGGCGGG 
H1008_sensitive         AGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGGGAGTGTAGACGAAGAGGCGGG 
ILRAD700_sensitive      AGACGGTGAAAACGAGCCCGTTGCCAAGATGGAGGAGGGGAGTGTAGACGAAGAGGCGGG 
                        ************************************************************ 
 
H65_resistant           CATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCCTGTATTAAAGAAAATACA 
H89_resistant           CATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCCTGTATTAAAGAAAATACA 
H988_sensitive          CATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCCTGTATTAAAGAAAATACA 
H1008_sensitive         CATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCCTGTATTAAAGAAAATACA 
ILRAD700_sensitive      CATGACAACGGCAGAGCAACTCACGGCAACACCTGTCCTGCCTGTATTAAAGAAAATACA 
                        ************************************************************ 
 
H65_resistant           CCTGATGATGACCACGTGCTTCATTTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCT 
H89_resistant           CCTGATGATGACCACGTGCTTCATTTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCT 
H988_sensitive          CCTGATGATGACCACGTGCTTCATTTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCT 
H1008_sensitive         CCTGATGATGACCACGTGCTTCATTTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCT 
ILRAD700_sensitive      CCTGATGATGACCACGTGCTTCATTTCCTTCTTTGTCACGCTCTTTATATTCCCGAGTCT 
                        ************************************************************ 
 
H65_resistant           TGTCTTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAA 
H89_resistant           TGTCTTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAA 
H988_sensitive          TGTCTTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAA 
H1008_sensitive         TGTCTTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAA 
ILRAD700_sensitive      TGTCTTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTACAA 
                        ************************************************************ 
 
 
172        Annex 
H65_resistant           CTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCT 
H89_resistant           CTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCT 
H988_sensitive          CTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCT 
H1008_sensitive         CTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCT 
ILRAD700_sensitive      CTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCT 
                        ***************************************************** 
 
 
Annex         173 
TvY486_0041960F3  TCTTGTCCTTCCCATTGACC 
TvY486_0041960R3  AAGGTACTGTTAGGGCAAAGC 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           TCTTGTCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTA 
H89_resistant           TCTTGTCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTA 
H988_sensitive          TCTTGTCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTA 
H1008_sensitive         TCTTGTCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTA 
ILRAD700_sensitive      TCTTGTCCTTCCCATTGACCGAGACCACAACTGGTTTGGCACGCTTGCGATTCTGTGCTA 
                        ************************************************************ 
 
H65_resistant           CAACTTTGGCGAGGCCGTTGCCAATTTTGGCACAACGTTCAAGTGCATATGGCCCTCGCG 
H89_resistant           CAACTTTGGTGAGGCCGTTGGACGCTTCTCCACAACGTTCAAGTGCATATGGCCCTCGCG 
H988_sensitive          CAACTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCTCGCG 
H1008_sensitive         CAACTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCTCGCG 
ILRAD700_sensitive      CAACTTTGGTGATGCAGCAGGACGCTTTGGCACAACGTTCAAGTGCATATGGCCCTCGCG 
                        ********* ** ** *  *     **   ****************************** 
 
H65_resistant           ACGCGTTTTACTCATCCTCACCCTCTCCCGCTTTCTCTTCATTGTGCCCATCTTTCTCTG 
H89_resistant           ACGCGTTTTACTCATCCTCACCCTCTCCCGCTTTCTCTTCATTGTGCCCATCTTTCTCTG 
H988_sensitive          ACGCGTTTTACTCATCCTCACCCTCTCCCGCTTTCTCTTCATTGTGCCCATCTTTCTCTG 
H1008_sensitive         ACGCGTTTTACTCATCCTCACCCTCTCCCGCTTTCTCTTCATTGTGCCCATCTTTCTCTG 
ILRAD700_sensitive      ACGCGTTTTACTCATCCTCACCCTCTCCCGCTTTCTCTTCATTGTGCCCATCTTTCTCTG 
                        ************************************************************ 
 
H65_resistant           TGTCTTTAAATACATCCCGGGACATGCAGTACCTTACATTCTCATGTTTCTCGTTGGATT 
H89_resistant           TGTCTTTAAATACATCCCGGGACATGCAGTACCTTACATTCTCATGTTTCTCGTTGGATT 
H988_sensitive          TGTCTTTAAATACATCCCGGGACATGCAGTACCTTACATTCTCATGTTTCTCGTTGGATT 
H1008_sensitive         TGTCTTTAAATACATCCCGGGACATGCAGTACCTTACATTCTCATGTTTCTCGTTGGATT 
ILRAD700_sensitive      TGTCTTTAAATACATCCCGGGACATGCAGTACCTTACATTCTCATGTTTCTCGTTGGATT 
                        ************************************************************ 
 
H65_resistant           GACGAACTACACGGGTACACTGTCGATGGTGTACGGGCCGATTACGCCTGGGCTTGTGAC 
H89_resistant           GACGAACTACACGGGTACACTGTCGATGGTGTACGGGCCGATTACGCCTGGGCTTGTGAC 
H988_sensitive          GACGAACTACACGGGTGCACTGTCGATGGTGTACGGGCCGATTACGCCTGGGCTTGTGAC 
H1008_sensitive         GACGAACTACACGGGTGCACTGTCGATGGTGTACGGGCCGATTACGCCTGGGCTTGTGAC 
ILRAD700_sensitive      GACGAACTACACGGGTGCACTGTCGATGGTGTACGGGCCGATTACGCCTGGGCTTGTGAC 
                        **************** ******************************************* 
174        Annex 
 
H65_resistant           TGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATGGGCATTTCTCTGCTTGCTGGTGCCTC 
H89_resistant           TGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATGGGCATTTCTCTGCTTGCTGGTGCCTC 
H988_sensitive          TGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATGGGCATTTCTCTGCTTGCTGGTGCCTC 
H1008_sensitive         TGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATGGGCATTTCTCTGCTTGCTGGTGCCTC 
ILRAD700_sensitive      TGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATGGGCATTTCTCTGCTTGCTGGTGCCTC 
                        ************************************************************ 
 
H65_resistant           TTTCGCATCGCTGATTGCCATCGGTGTCGCGTACGCTTTGCCCTAACAGTACCTT 
H89_resistant           TTTCGCATCGCTGATTGCCATCGGTGTCGCGTACGCTTTGCCCTAACAGTACCTT 
H988_sensitive          TTTCGCATCGCTGATTGCCATCGGTGTCGTGTACGCTTTGCCCTAACAGTACCTT 
H1008_sensitive         TTTCGCATCGCTGATTGCCATCGGTGTCGTGTACGCTTTGCCCTAACAGTACCTT 
ILRAD700_sensitive      TTTCGCATCGCTGATTGCCATCGGTGTCGTGTACGCTTTGCCCTAACAGTACCTT 
                        ***************************** ************************* 
 
Annex         175 
Sequencing performed on TvY486_1103760 using 2 resistant and 3 sensitive T. vivax strains 
 
 
>TvY486_1103760 F2 CGCTACATTTCCTACGCACA 
>TvY486_1103760 R2 ATGCCAATGGGCAGTCTTAG 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           CGCTACATTTCCTACGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAAT 
H89_resistant           CGCTACATTTCCTACGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAAT 
H988_sensitive          CGCTACATTTCCTACGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAAT 
H1008_sensitive         CGCTACATTTCCTACGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAAT 
ILRAD700_sensitive      CGCTACATTTCCTACGCACAGGAGAACGTTGCTGAGTACCGCATGATGAAGCAAGCGAAT 
                        ************************************************************ 
 
H65_resistant           AGTGACGAGGGCGGATGCCACAACGACACAGACGGTGAAAACGAGCCCGTTGCCAAGATG 
H89_resistant           AGTGACGAGGGCGGATGCCACAACGACACAGACGGTGAAAACGAGCCCGTTGCCAAGATG 
H988_sensitive          AGTGACGAGGGCGGATGCCACAACGACACAGACGGTGAAAACGAGCCCGTTGCCAAGATG 
H1008_sensitive         AGTGACGAGGGCGGATGCCACAACGACACAGACGGTGAAAACGAGCCCATTGCCAAGATG 
ILRAD700_sensitive      AGTGACGAGGGCGGATGCCACAACGACACAGACGGTGAAAACGAGCCCATTGCCAAGATG 
                        ************************************************ *********** 
 
H65_resistant           GAGGAGGGGAGTGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACA 
H89_resistant           GAGGAGGGGAGTGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACA 
H988_sensitive          GAGGAGGGGAGTGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACA 
H1008_sensitive         GAGGAGGGGAGTGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACA 
ILRAD700_sensitive      GAGGAGGGGAGTGTAGACGAAGAGGCGGGCATGACAACGGCAGAGCAACTCACGGCAACA 
                        ************************************************************ 
 
H65_resistant           CCTGTCCTGCCTGTATTAAAGAAAATACACCTGATGATGACCACGTGCTTCATTTCCTTC 
H89_resistant           CCTGTCCTGCCTGTATTAAAGAAAATACACCTGATGATGACCACGTGCTTCATTTCCTTC 
H988_sensitive          CCTGTCCTGCCTGTATTAAAGAAAATACACCTGATGATGACCACGTGCTTCATTTCCTTC 
H1008_sensitive         CCTGTCCTGCCTGTATTAAAGAAAATACACCTGATGATGACCACGTGCTTCATTTCCTTC 
ILRAD700_sensitive      CCTGTCCTGCCTGTATTAAAGAAAATACACCTGATGATGACCACGTGCTTCATTTCCTTC 
                        ************************************************************ 
176        Annex 
H65_resistant           TTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCACAACTGG 
H89_resistant           TTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCACAACTGG 
H988_sensitive          TTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCACAACTGG 
H1008_sensitive         TTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCACAACTGG 
ILRAD700_sensitive      TTTGTCACGCTCTTTATATTCCCGAGTCTTGTCTTTCCCATTGACCGAGACCACAACTGG 
                        ************************************************************ 
 
H65_resistant           TTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTTTGGCACA 
H89_resistant           TTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTTTGGCACA 
H988_sensitive          TTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTTTGGCACA 
H1008_sensitive         TTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTTTGGCACA 
ILRAD700_sensitive      TTTGGCACGCTTGCGATTCTGTGCTACAACTTTGGTGATGCAGCAGGACGCTTTGGCACA 
                        ************************************************************ 
 
H65_resistant           ACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTCCCGCTTT 
H89_resistant           ACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTCCCGCTTT 
H988_sensitive          ACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCGCCCTCTCCCGCTTT 
H1008_sensitive         ACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTCCCGCTTT 
ILRAD700_sensitive      ACGTTCAAGTGCATATGGCCCTCGCGACGCGTTTTACTCATCCTCACCCTCTCCCGCTTT 
                        ********************************************* ************** 
 
H65_resistant           CTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGCAGTACCT 
H89_resistant           CTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGCAGTACCT 
H988_sensitive          CTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGCAGTACCT 
H1008_sensitive         CTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGCAGTACCT 
ILRAD700_sensitive      CTCTTCATTGTGCCCATCTTTCTCTGTGTCTTTAAATACATCCCGGGACATGCAGTACCT 
                        ************************************************************ 
 
H65_resistant           TACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGATGGTGTAC 
H89_resistant           TACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGATGGTGTAC 
H988_sensitive          TACATTCTCACGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGATGGTGTAC 
H1008_sensitive         TACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGATGGTGTAC 
ILRAD700_sensitive      TACATTCTCATGTTTCTCGTTGGATTGACGAACTACACGGGTGCACTGTCGATGGTGTAC 
                        ********** ************************************************* 
 
H65_resistant           GGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATG 
H89_resistant           GGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATG 
H988_sensitive          GGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATG 
H1008_sensitive         GGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATG 
ILRAD700_sensitive      GGGCCGATTACGCCTGGGCTTGTGACTGCAGGGCAGAAGCTGATGGCCGGGCAGCTGATG 
                        ************************************************************
Annex         177 
H65_resistant           GGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGTCGTGTAC 
H89_resistant           GGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGTCGTGTAC 
H988_sensitive          GGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGTCGTGTAC 
H1008_sensitive         GGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGTCGTGTAC 
ILRAD700_sensitive      GGCATTTCTCTGCTTGCTGGTGCCTCTTTCGCATCGCTGATTGCCATCGGTGTCGTGTAC 
                        ************************************************************ 
 
H65_resistant           GCTTTGCCCTAAGACTGCCCATTGGCAT 
H89_resistant           GCTTTGCCCTAAGACTGCCCATTGGCAT 
H988_sensitive          GCTTTGCCCTAAGACTGCCCATTGGCAT 
H1008_sensitive         GCTTTGCCCTAAGACTGCCCATTGGCAT 
ILRAD700_sensitive      GCTTTGCCCTAAGACTGCCCATTGGCAT 





Sequencing performed on TvY486_0011610 using 2 resistant and 3 sensitive T. vivax strains 
 
TvY486_0011610 F1  CAAATATGCTCCTGGGCTTCT 
TvY486_0011610 R1  ATGACAAGTGAGGCGGCTAT 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
 
H65_resistant           CAAATATGCTCCTGGGCTTCTCCTCGGCCGCAGAACTGTACACGTATGTGACGTGCGTTA 
H89_resistant           CAAATATGCTCCTGGGCTTCTCCTCGGCCGCAGAACTGTACACGTATGTGACGTGCGTTA 
H988_sensitive          CAAATATGCTCCTGGGCTTCTCCTCGGCCGCAGAACTGTACACGTATGTGACGTGCGTTA 
H1008_sensitive         CAAATATGCTCCTGGGCTTCTCCTCGGCCGCAGAACTGTACACGTATGTGACGTGCGTTA 
ILRAD700_sensitive      CAAATATGCTCCTGGGCTTCTCCTCGGCCGCAGAACTGTACACGTATGTGACGTGCGTTA 
                        ************************************************************ 
 
H65_resistant           TCCTTGGCATTTCGTTTCTCCTGCCGCTTAAAGTCATGGTATCTGCACCGCGCTTTATGA 
H89_resistant           TCCTTGGCATTTCGTTTCTCCTGCCGCTTAAAGTCATGGTATCTGCACCGCGCTTTATGA 
H988_sensitive          TCCTTGGCATTTCGTTTCTCCTGCCGCTTAAAGTCATGGTATCTGCACCGCGCTTTATGA 
H1008_sensitive         TCCTTGGCATTTCGTTTCTCCTGCCGCTTAAAGTCATGGTATCTGCACCGCGCTTTATGA 
ILRAD700_sensitive      TCCTTGGCATTTCGTTTCTCCTGCCGCTTAAAGTCATGGTATCTGCACCGCGCTTTATGA 
                        ************************************************************ 
178        Annex 
H65_resistant           CCGACTACTACAAGTACGCAACTGGTGACCCGGATGCCGAGCCGAACAATCCTTTTTTTT 
H89_resistant           CCGACTACTACAAGTACGCAACTGGTGACCCGGATGCCGAGCCGAACAATCCTTTTTTTT 
H988_sensitive          CCGACTACTACAAGTACGCAACTGGTGACCCGGATGCCGAGCCGAACAATCCTTTTTTTT 
H1008_sensitive         CCGACTACTACAAGTACGCAACTGGTGACCCGGATGCCGAGCCGAACAATCCTTTTTTTT 
ILRAD700_sensitive      CCGACTACTACAAGTACGCAACTGGTGACCCGGATGCCGAGCCGAACAATCCTTTTTTTT 
                        ************************************************************ 
 
H65_resistant           GGGCAAATGTCCTCGGTATTTACGCCGCGGCGTCGCTGGTTGTACAAATGCTCTTCGCCC 
H89_resistant           GGGCAAATGTCCTCGGTATTTACGCCGCGGCGTCGCTGGTTGTACAAATGCTCTTCGCCC 
H988_sensitive          GGGCAAATGTCCTCGGTATTTACGCCGCGGCGTCGCTGGTTGTACAAATGCTCTTCGCCC 
H1008_sensitive         GGGCAAATGTCCTCGGTATTTACGCCGCGGCGTCGCTGGTTGTACAAATGCTCTTCGCCC 
ILRAD700_sensitive      GGGCAAATGTCCTCGGTATTTACGCCGCGGCGTCGCTGGTTGTACAAATGCTCTTCGCCC 
                        ************************************************************ 
 
H65_resistant           CCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGCTTCACCTTTGCCG 
H89_resistant           CCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGCTTCACCTTTGCCG 
H988_sensitive          CCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGCTTCACCTTTGCCG 
H1008_sensitive         CCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGCTTCACCTTTGCCG 
ILRAD700_sensitive      CCACAGTTCTCACTCGCACGGTCAGGCGCCTCTCCTTGAGTACGCGCTTCACCTTTGCCG 
                        ************************************************************ 
 
H65_resistant           TCTCGTCCATGCTGGCTGGGGCGGCAGTTATCCCTCTGATGCCTGTAGTGAAAGTTACGC 
H89_resistant           TCTCGTCCATGCTGGCTGGGGCGGCAGTTATCCCTCTGATGCCTGTAGTGAAAGTTACGC 
H988_sensitive          TCTCGTCCATGCTGGCTGGGGCGGCAGTTATCCCTCTGATGCCTGTAGTGAAAGTTACGC 
H1008_sensitive         TCTCGTCCATGCTGGCTGGGGCGGCAGTTATCCCTCTGATGCCTGTAGTGAAAGTTACGC 
ILRAD700_sensitive      TCTCGTCCATGCTGGCTGGGGCGGCAGTTATCCCTCTGATGCCTGTAGTGAAAGTTACGC 
                        ************************************************************ 
 
H65_resistant           AGACTGTCGCAATGGTTGTGCTCTTTGTCTCCATTTTCCTCTCTTCGATGGGAAAGGCGT 
H89_resistant           AGACTGTCGCAATGGTTGTGCTCTTTGTCTCCATTTTCCTCTCTTCGATGGGAAAGGCGT 
H988_sensitive          AGACTGTCGCAATGGTTGTGCTCTTTGTCTCCATTTTCCTCTCTTCGATGGGAAAGGCGT 
H1008_sensitive         AGACTGTCGCAATGGTTGTGCTCTTTGTCTCCATTTTCCTCTCTTCGATGGGAAAGGCGT 
ILRAD700_sensitive      AGACTGTCGCAATGGTTGTGCTCTTTGTCTCCATTTTCCTCTCTTCGATGGGAAAGGCGT 
                        ************************************************************ 
 
H65_resistant           ATTTGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGGTG 
H89_resistant           ATTTGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGGTG 
H988_sensitive          ATTTGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGGTG 
H1008_sensitive         ATTTGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGGTG 
ILRAD700_sensitive      ATTTGGAGGCCACCACTTACACGCTGGTGTCGTCCATGCCGCCAAAGTTCATGTCCGGTG 
                        ************************************************************
Annex         179 
H65_resistant           CCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAAGG 
H89_resistant           CCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAAGG 
H988_sensitive          CCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAAGG 
H1008_sensitive         CCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAAGG 
ILRAD700_sensitive      CCATGTTTGGTGCCTCGCTCTGTGGCGTGATAACGTCGGTGCTGCAGTGCGTGATCAAGG 
                        ************************************************************ 
 
H65_resistant           GGTCGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTG 
H89_resistant           GGTCGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTG 
H988_sensitive          GGTCGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTG 
H1008_sensitive         GGTCGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTG 
ILRAD700_sensitive      GGTCGATGGAGAACACATATGAGTCTGTACTGAAGCAGTCGTACATCTACTTCTCCCTTG 
                        ************************************************************ 
H65_resistant           GGATGGTGATTATAGCCGCCTCACTTGTCAT 
H89_resistant           GGATGGTGATTATAGCCGCCTCACTTGTCAT 
H988_sensitive          GGATGGTGATTATAGCCGCCTCACTTGTCAT 
H1008_sensitive         GGATGGTGATTATAGCCGCCTCACTTGTCAT 
ILRAD700_sensitive      GGATGGTGATTATAGCCGCCTCACTTGTCAT 
                        ******************************* 
 
 
